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Background and aims: Symptoms attributed to indoor air work environments 
may persist even without observed significant deficiencies in indoor air 
quality. This kind of symptomatology may lead to disability, which can cause 
severe restrictions in daily life and interfere with work participation. Disability 
due to indoor environments is poorly understood from the medical 
perspective, and effective treatments are lacking. 
The main aim of this thesis was to characterize indoor air-related disability 
and develop interventions for symptom management. We evaluated whether 
clinical intervention including counseling has an impact on the quality of life 
(QOL) and work ability of patients with indoor air-related symptoms and work 
disability; and developed a randomized controlled trial (RCT) setting to 
evaluate the effect of cognitive-behavioral therapy (CBT) and psychoeducation 
on workers’ QOL and work ability. Furthermore, we carried out thorough 
clinical characterization of the possible medical causes of disability among a 
group of patients. In addition, we explored the self-reported intolerance 
attributed to different environmental factors and its associations with 
disability on a population level, using a maternity clinic sample. 
Material and methods: This thesis consists of four individual studies, 
which all comprised working-aged adults. The first RCT (Study I) recruited 55 
participants from consecutive patients examined at the Finnish Institute of 
Occupational Health (FIOH) for a suspected occupational disease. The 
inclusion criteria for work disability were a self-assessed decreased work 
ability and indoor air-related sick leave days during the preceding year. The 
RCT setting evaluated the effect of the intervention (counseling by a physician 
and psychologist given counseling for symptom management) on self-assessed 
work ability, sick leave days, QOL, and illness worries, which were our 
outcome measures. 
Clinical characterization (Study II) was conducted of 12 patients who were 
referred to FIOH for clinical evaluation due to responsiveness to workplace 
indoor air, and a disabling condition that interfered with work participation 
despite improvements to occupational facilities and adjustments to work. The 
clinical evaluation was based on structured somatic, psychological and 
psychiatric evaluations; allergy tests; and measurements of respiratory 
function and the autonomic nervous system. The questionnaires gathered data 
on self-assessed disability, insomnia, pain, anxiety, depression and burnout.  
In Study III, FIOH created an RCT setting, and recruitment was carried out 
in collaboration with five large occupational health service (OHS) units. The 
RCT recruited patients who had sought medical advice from OHS due to 
recurrent medically unexplained multiorgan symptoms and disability 
attributed to the indoor work environment. After baseline clinical 




treatment groups (psychoeducation or CBT) and a treatment-as-usual group. 
Questionnaires were completed at baseline and at follow-up at 3, 6, and 12 
months. The primary outcome was health-related QOL, and the secondary 
outcomes included measures of factors that could impact on work ability and 
functioning in daily life. 
The questionnaire survey (Study IV) was based on a sample of 680 
pregnant women, who were recruited at maternity clinics in the Kuopio region, 
in Eastern Finland. The participants were asked about annoyance with 12 
environmental factors, symptoms, behavioral changes, and the extent to which 
their intolerance had disturbed their work, household responsibilities or social 
life. The study concentrated on exploring intolerance attributed to chemicals, 
indoor molds and electromagnetic fields (EMFs). 
Results: In the clinical studies (Study I, II), patients’ symptoms manifested 
in multiple organ systems, with no medical explanation and in spite of 
workplace interventions and the absence of exposure-related causes of 
symptomatology. Most patients with asthma presented normal lung function 
tests but reported abundant respiratory symptoms. Co-occurrent somatic 
diseases and psychiatric disorders were frequently present. Often patients 
presented a variety of signs of distress (multiple pain, insomnia, burnout) and 
had environment-related health concerns. The patients were worried about a 
serious disease or loss of health due to indoor air (Study I). Almost all the 
patients reported reactions triggered mainly by indoor molds; the majority 
reported sensitivity to odorous chemicals and one fourth to electric devices 
(Study II). The need to avoid certain environments had led to restrictions in 
several life areas, such as work participation, socializing and leisure activities. 
Disability indicated a higher severity on self-assessment scales than in 
physician assessments.  
Physician and psychologist counseling for symptom management showed 
no effect on self-assessed work ability and QOL after the six-month follow-up 
(Study I). 
In Study IV, the participants (n=680) evaluated their intolerance in the 
time prior to their pregnancy. Of the study group, 33% reported symptoms 
related to chemicals, indoor molds or EMFs, and 15% had made behavioral 
changes to avoid the symptoms. In terms of disability, 8.4% experienced at 
least ‘some’ difficulties related to any of the three environmental factors, 2.2% 
‘very much’ or ‘extreme’, and 0.9% ‘extreme’ difficulties. Of the latter 2.2% 
(n=15), all reported intolerance to indoor molds, and two thirds also to 
chemicals. Of these 15 participants, 12 reported having had to change 
apartments or jobs to avoid symptoms due to intolerance, and four reported 
having done both. As the severity of disability increased, the number of organ 
systems, behavioral changes, and the co-occurrence of intolerance to various 





Conclusions: Chronic indoor air-related symptomatology fulfills WHO’s 
criteria for idiopathic environmental intolerance (IEI). The symptomatology 
includes comorbidity of somatic and psychiatric diseases that does not explain 
the disability. A similar phenomenon, symptomatology and comorbidity, is 
described in functional somatic syndromes (FSS).  
Effective treatment interventions are required for indoor air-related 
disability prevention. The usefulness of treatment approaches that have shown 
to be efficient for FSS, such as different CBTs, should be evaluated in the 
treatment of IEI. 
The estimate of the prevalence of intolerance to environmental factors, 
depends on the definition of intolerance. The manifestation of intolerance to 
various environmental factors forms an increasing severity continuum, 
ranging from annoyance to severe disability. As regards environmental 
intolerance with severe disability, indoor molds seem to be the most common 





Tausta ja tavoitteet: Työpaikan sisäilmaan liittyvä oireilu saattaa pitkittyä 
silloinkin, kun merkittäviä puutteita sisäilman laadussa ei todeta. 
Tämänkaltainen oireilu voi rajoittaa merkittävästi elämänpiiriä ja työkykyä. 
Lääketieteellinen ymmärrys sisäilmaan liittyvästä toimintakykyä 
heikentävästä oireilusta ja sen hoitokeinoista on puutteellinen. 
Väitöskirjatyön pääasiallisena tavoitteena oli tutkia sisäilmaan liittyvää 
pitkittyvää oireistoa, joka heikentää toimintakykyä, ja kehittää interventioita 
oireilun hallintaan. Tavoitteina oli 1) arvioida parantaako tietojen anto ja 
neuvonta elämänlaatua ja työkykyä potilailla, joilla oli sisäilmaan liittyen 
oireita ja työkyvyn heikentymistä; 2) luoda satunnaistettu kontrolloitu 
koeasetelma, jossa tutkitaan kognitiivisen käyttäytymisterapian (KKT) ja 
psykoedukaation vaikutusta elämänlaatuun ja työkykyyn. Kolmantena 
tavoitteena oli tutkia ryhmä potilaita huolellisin kliinisin tutkimusmenetelmin 
ja arvioida mitkä löydökset selittävät heikentynyttä toimintakykyä. Lisäksi 
tavoitteena oli tutkia väestötason herkkyyttä eri ympäristötekijöille ja sen 
vaikutusta toimintakykyyn, mikä toteutettiin äitiysneuvolakyselyssä.  
Aineisto ja menetelmät: Väitöskirjatyö koostuu neljästä erillisestä 
osatyöstä, joissa osallistujat olivat työikäisiä. Ensimmäiseen 
interventiotutkimukseen (osatyö I) rekrytoitiin 55 ammattitautiepäilyn vuoksi 
Työterveyslaitoksella (TTL) tutkimuksiin tullutta potilasta. 
Sisäänottokriteerinä oli heikentynyt itsearvioitu työkyky ja sairauspoissaoloja 
sisäilmaan liittyvien oireiden vuoksi viimeisen vuoden aikana. 
Satunnaistetussa kontrolloidussa tutkimusasetelmassa arvioitiin intervention 
(lääkärin toteuttama tietojen anto ja ohjaus sekä psykologin ohjaus 
oirehallintaan) vaikutusta itsearvioituun työkykyyn, sairauspoissaolopäiviin, 
elämänlaatuun ja sairaushuoliin. 
Kliininen tutkimus (osatyö II) toteutettiin 12 potilaalla, jotka oli lähetetty 
TTL:lle arvioon työpaikan sisäilmaan liittyvän työkykyä heikentävän 
pitkittyneen oireiston vuoksi.  Oireisto oli jatkunut huolimatta työpaikan 
korjaustoimista ja työjärjestelyistä. Kliinisessä tutkimuksessa käytettiin 
strukturoituja somaattisia, psykologisia ja psykiatrisia menetelmiä; 
allergiatutkimuksia; hengitystoiminnan ja autonomisen hermoston 
tutkimuksia. Arviossa käytettiin myös kyselyitä, joissa kartoitettiin mm. 
toimintakykyä, unettomuutta, kipua, ahdistuneisuutta, masennusta ja 
työuupumusta. 
Kolmannessa osatyössä luotiin satunnaistettu kontrolloitu 
tutkimusasetelma, joka käynnistettiin yhteistyössä TLL:n ja viiden suuren 
työterveyshuoltoyksikön kanssa. Tutkimukseen rekrytoitiin potilaita, jotka 
olivat hakeutuneet työterveyshuoltoon työpaikan sisäilmaan liittyvien 
toistuvien ja usean elinjärjestelmän oireiden takia. Oireet olivat heikentäneet 
työkykyä eivätkä ne olleet selittyneet lääketieteellisillä syillä. Alkututkimusten 
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jälkeen valitut osallistujat satunnaistettiin kahteen psykososiaaliseen 
hoitoryhmään (psykoedukaatio tai KKT) ja tavanomaisen hoidon ryhmään. 
Seurantakyselyt toteutettiin lähtötilanteessa ja 3, 6 sekä 12 kuukauden 
kuluttua. Päävastemuuttujana oli terveyteen liittyvä elämänlaatu, ja lisäksi 
kartoitettiin lukuisia työ- ja toimintakykyyn vaikuttavia tekijöitä. 
Neljäs osatyö oli Kuopion alueen äitiysneuvola-asiakkaille toteutettu 
kyselytutkimus. Tutkimukseen osallistui 680 raskaana olevaa naista, joilta 
kysyttiin herkkyyttä 12 ympäristötekijälle ja herkkyyden vaikutusta oireisiin, 
arkielämään, työ- ja toimintakykyyn. Erikseen tarkasteltiin niitä, jotka 
ilmoittivat sietokyvyn alenemista kemikaaleille, sisäilman homeille ja 
sähkömagneettisille kentille. 
Tulokset: Kliinisissä tutkimuksissa (osatyöt I ja II) potilailla ilmeni oireita 
useasta elinjärjestelmästä ilman lääketieteellistä selittävää löydöstä ja oireet 
olivat jatkuneet huolimatta työpaikalla tehdyistä interventioista eikä 
ajankohtainen oireisto ollut selitettävissä sisäilmatekijöillä. Astmaa 
sairastavilla astma oli keuhkojen toimintakokeiden perusteella 
pääsääntöisesti hyvässä hallinnassa, vaikka heillä oli runsaasti astmaan 
sopivia oireita. Samanaikaisia muita somaattisia sairauksia ja psykiatrisia 
häiriöitä todettiin usein. Useilla potilailla oli monia oireita kuten laaja-alaista 
kipua, unettomuutta ja työuupumusta sekä huolta ympäristötekijöiden 
vaikutuksesta terveyteen. Osallistujilla todettiin huolestuneisuutta terveyden 
menettämisestä sisäilman takia (osatyö I). Oireiluherkkyys liittyi lähes kaikilla 
sisäilman homeisiin. Lisäksi valtaosa ilmoitti sietokyvyn heikentyneen 
hajusteille ja neljäsosa myös sähkömagneettisille kentille (osatyö II). Tarve 
välttää tiettyjä ympäristöjä oli johtanut rajoituksiin useilla elämänalueilla, 
kuten työssä, sosiaalisessa kanssakäymisessä ja vapaa-ajan aktiviteeteissa. 
Itsearvioitu toimintakyky oli arviointiasteikkojen perusteella huonompi kuin 
lääkärin arvioimana.  
Lääkärin tietojen annolla ja ohjauksella sekä psykologin antamalla 
oirehallinnan ohjauksella ei todettu vaikutusta itsearvioituun työkykyyn eikä 
elämänlaatuun kuuden kuukauden seurannassa verrattuna kontrolliryhmään 
(osatyö I). 
Osatyössä IV vastaajat (n=680) arvioivat herkkyyttään ympäristötekijöille 
ennen raskautta. Vastaajista 33 % raportoi saavansa oireita kemikaaleista, 
sisäilman homeista tai sähkömagneettisista kentistä ja 15 % oli tehnyt 
muutoksia eri elämänalueilla välttääkseen oireita. Vastaajista 8,4 % koki 
vähintään jossain määrin toimintakyvyn alenemaa liittyen herkkyyteen 
kemikaaleille, sisäilman homeille tai sähkömagneettisille kentille, 2,2 % 
raportoi merkittävää ja 0,9 % erittäin merkittävää toimintakyvyn 
heikentymistä. Kaikki merkittävää toimintakyvyn heikentymistä raportoivista 
(15 vastaajaa) ilmoittivat sietokykynsä heikentyneen sisäilman homeille ja 
kolmasosa myös kemikaaleille. Näistä 15 vastaajasta 12 ilmoitti joutuneensa 
vaihtamaan asuntoa tai työpaikkaa oireiden välttämiseksi, neljä vastaajaa oli 
vaihtanut sekä asunnon että työpaikan. Mitä vaikeampi toimintakyvyn 




enemmän oli ollut tarve tehdä arkielämän muutoksia. Lisäksi mitä vaikeampi 
toimintakyvyn heikentyminen oli, sitä useammalle ympäristötekijälle ilmeni 
samanaikainen herkkyys. 
Johtopäätökset: Pitkäaikainen sisäilmaan liittyvä oireisto täyttää WHO:n 
määrittelemän ympäristöherkkyyden (idiopathic environmental intolerance) 
kriteerit. Oireistoon liittyy samanaikaisia somaattisia sairauksia ja psykiatrisia 
häiriöitä, jotka eivät kuitenkaan selitä heikentynyttä toimintakykyä. 
Samanlainen oirekuva ja komorbiditeeti on kuvattu toiminnallisissa 
häiriöissä. 
Sisäilmaan liittyvän pitkäaikaisen oireiston hoitoon tarvitaan tehokkaita 
hoitomuotoja. Sellaisten hoitomuotojen, joilla on todettu vaikutusta 
toiminnallisiin häiriöihin, kuten erilaiset käyttäytymisterapiat, hyödyllisyyttä 
pitää tutkia ympäristöherkkyyden hoidossa. 
Arvio siitä, kuinka yleistä herkkyys ympäristötekijöille on, riippuu siitä, 
miten herkkyys on määritelty. Herkkyys eri ympäristötekijöille on jatkumo 
vähäisestä sietokyvyn alentumisesta oireistoon, joka rajoittaa merkittävästi 
toimintakykyä. Ympäristöherkkyys, johon liittyy merkittävää toimintakyvyn 




Since the 1970s, health complaints attributed to the indoor non-industrial 
work environment, at pollutant levels below toxic levels, have received 
increasing attention that have become a public health concern (Bluyssen et al. 
2016; Redlich et al. 1997; WHO 1983). This ill health may lead to functional 
restrictions in daily life and severe restrictions to work participation. Office 
workers’ case reports first raised this issue (WHO 1983), but later, other 
indoor environments such as hospitals, schools, public buildings and 
residences reported similar symptoms. Individuals typically describe 
symptoms as occurring while residing in a particular building and diminishing 
when away from it (Redlich et al. 1997). 
The perception of deficiencies in indoor air quality (IAQ) has been 
associated with impaired well-being and reports of discomfort and symptoms, 
mainly mucous membrane and respiratory symptoms, which ought to improve 
when indoor facilities are repaired (Redlich et al. 1997; Wolkoff 2013). Good 
practices and guidelines exist for recognizing and improving IAQ (Salonen 
2009; WHO 2009), as do laws and regulations for built environments which 
aim to ensure healthy living and indoor working conditions (In Finland, 
Decree on Housing Health 545/2015; Health Protection Act 763/1994). 
Research has not been able to explain indoor air pollutants’ long-term adverse 
health effects on individuals (Caillaud et al. 2018; Hetherington and 
Battershill 2013; Redlich et al. 1997; Thörn 1999; WHO 2009; Wolkoff 2013). 
Clinicians and patients face problems when these symptoms persist despite 
improvements to IAQ. The dilemma has been whether the persistent 
environment-related symptoms are due to exposure or to increased reactivity 
and responsiveness among individuals (Kipen and Fiedler 2002; Levy 1997; 
Rief and Broadbent 2007; Watanabe et al. 2003a). 
Numerous studies on human reactions to indoor air use symptom 
reporting. Symptoms attributed to indoor air environments can be unpleasant, 
disruptive, cause lost work time and reduced productivity, and may persist in 
some individuals despite remodeling of the building concerned or removal of 
the factors that provoke symptoms (Al-Ahmad et al. 2010; Edvardsson et al. 
2008; Redlich et al. 1997; Sauni et al. 2015; Thörn 1999). The chronic 
symptoms and disability of individuals attributed to a certain indoor air 
pollutant, or merely of indoor air, can impair quality of life (QOL), and cause 
considerable lifestyle limitations with social, occupational and economic 
consequences (Al-Ahmad et al. 2010; Edvardsson et al. 2008, 2013; Karvala et 
al. 2013, 2014; Söderholm et al. 2016).  
Previous studies on indoor air-related health problems have proposed a 
biopsychosocial approach to disability prevention (Karvala 2012; Thörn 1999), 
as well as interventions that generally aim to improve activity and 
participation among individuals with disabilities (WHO 2001). Since the 
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nature of indoor air-related disability has not been sufficiently medically 
characterized, methods for treatment and prevention are lacking. A lack of 
knowledge hampers the appropriate language for conceptualizing the indoor 
air-related disability phenomenon and impedes effective communication 
between patients and health care providers. In order to improve health care 
and gain a better understanding of the disability and its underlying 
mechanisms, a thorough medical and psychological characterization is 
needed, as well as controlled interventions for disability treatment. 
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2 REVIEW OF THE LITERATURE 
2.1 INDOOR AIR-RELATED SYMPTOMS AND DISEASES 
2.1.1 INDOOR AIR-RELATED SYMPTOMS 
The health complaints attributed to indoor environments range from comfort 
complaints to multiple symptoms and functional restrictions to daily life. 
These complaints typically occur while residing in a particular building and 
diminish when away from it. For some, however, they may persist. 
To describe the reactions/symptoms in indoor environments, in 1983 the 
World Health Organization (WHO) launched the term sick building syndrome 
(SBS) for the non-specific building-related combination of (general, mucosal 
membranes and skin) symptoms with an often unclear cause (WHO 1983, 
1986). However, SBS has failed to develop into a well-defined condition; it, has 
remained complex and inadequate because of its vagueness and dualistic 
nature (Thörn 1999; Wolkoff 2013). SBS includes transient non-specific 
symptoms of a multifactorial origin (individual, psychosocial, and 
environmental risk factors) with a possible relation to indoor pollutants 
(Marmot et al. 2006; Norbäck 2009), but no known long-term adverse health 
effects (Redlich et al. 1997). The core symptoms of SBS are typically 
characterized as follows (Redlich et al. 1997; Thörn 1999; WHO 1983): 
 
- Mucous-membrane irritation (eyes, nose, throat);  
- Dry skin, rash and pruritus;  
- Fatigue, headache and lack of concentration;  
- High frequency of airway infections;  
- Hoarseness, wheezing, shortness of breath and coughing;  
- Nausea and dizziness and  
- Enhanced or abnormal odor perception. 
 
In addition, the term SBS is regarded as a group phenomenon rather than 
a syndrome among individuals (Norbäck 2009). SBS gives no indication of 
symptom severity and does not differentiate transient non-specific symptoms 
from more severe health problems. 
Non-specificity of symptoms. Numerous questionnaire studies have shown 
that the perceived indoor air-related symptoms span a wide spectrum of organ 
systems, typically airways, the nervous system, mucosal membranes, and the 
skin, as well as general symptoms. In a Finnish study conducted at 122 
workplaces (with suspected indoor-air problems) with total of 11 154 
employees, the most common work-related symptoms that had occurred 
weekly during the past three months were an irritated, stuffy or runny nose 
(20%), eye symptoms (17%), fatigue (16%), skin symptoms (15%) or a hoarse, 
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dry throat (14%) (Reijula and Sundman-Digert 2004). Similar symptom 
spectrums have appeared in office environments (Bluyssen et al. 2016; 
Salonen et al. 2009a) and hospitals (Hellgren et al. 2011), as well as in 
buildings with no obvious IAQ deficiencies (Andersson and Stridh 1992; 
Purokivi et al. 2001) or following building repairs (Sauni et al. 2015). In 
addition, studies have reported similar symptoms with no symptom 
attributions to indoor spaces (Eriksson and Stenberg 2006; Norbäck and 
Edling 1991), and with different clinical conditions and no obvious medical 
reasons (Fink et al. 2007; Nimnuan et al. 2001). 
Later, Norbäck (2009) divided human reactions to the indoor environment 
into three main categories: 1) complaint reactions due to poor subjective IAQ, 
2) disease or building-related illness (e.g. legionellosis) that may be caused by 
factors in the indoor environment and 3) medical symptoms with an unclear 
cause, but with a possible relation to the indoor environment. 
Prevalence of symptoms. The prevalence data on indoor air-related 
symptoms come from self-reports and typically from cross-sectional surveys 
on specified samples (e.g. workforce or employees working in a certain 
building). The population-based data are limited, and mainly based on 
symptoms compatible with SBS, which are illustrated in Table 1. In a 
prospective study, the 10-year incidence of new onset of any work-related SBS-
symptom that occurred weekly was 9.4% in the municipality of Uppsala, 
Sweden (Zhang et al. 2012). The studies based on the definition of SBS do not 
properly describe the prevalence of indoor air-related symptoms because of 
their symptom attribution to work/home environments or because they do not 
question symptom attribution. 
As regards office building studies (not included in Table 1),  in a study of 
indoor workers from 28 companies (n=4029) in the Latium region of Italy, 
27% reported at least one of the 12 work-related symptoms compatible with 
SBS, and 32% at least one of the 18 work-related symptoms, and two-thirds 
(65%) complained of at least one perceived indoor problem (Magnavita 2015). 
In a Japanese sample of office employees (n=3335), 25% reported suffering 
from at least one building-related symptom (out of 19 symptoms) weekly 
(Azuma et al. 2015a). A large European research project, OFFICAIR, was 
conducted in 167 office buildings in eight European countries (Portugal, Spain, 
Italy, Greece, France, Hungary, the Netherlands, Finland) with a total of 7441 
office workers (Bluyssen et al. 2016). More than one‐third of the workers 
reported complaints about the indoor environment, and half of them had 
suffered from at least one building-related symptom in the preceding month. 
The most prevalent symptoms were dry eyes (31%) and headache (29%) 
(Bluyssen et al. 2016). 
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Table 1. Prevalence studies on symptoms related to SBS in the adult general population. 
Prevalence Case definition Method and sample Reference 
6–30%  Responding ‘yes’ to at least 
one (of 16) different 
symptoms in the preceding 
three months.  
No questions on attribution 
included 
Random sampling. 








4.3% Responding ‘yes’ to at least 
one weekly general, mucosal 
and skin symptom in the 
preceding three months.  
No questions on attribution 
included 














Responding ‘yes’ to at least 
one (of 16) weekly symptom, 
related to home or work 
environment  
OR 
Responding ‘yes’ to weekly 
symptoms from at least three 
(of five) symptom groups 
(general, skin, nasal, throat, 
eye)  
Random sampling. 
Postal survey in 










(5.0% of 260 
women) 
Responding ‘yes’ to at least 
one (of 16) work-related 
symptom 
OR 
Responding ‘yes’ to at least 
one (of 16) home-related 
symptom 
Random sampling. 








SBS, sick building syndrome. 
2.1.2 INDOOR AIR-RELATED DISEASES 
Dampness and molds in buildings are associated with the development of 
asthma. The epidemiological evidence of this association is mainly based on 
studies among children, as there is no causative evidence of asthma 
development among adults (Caillaud et al. 2018; Mendell et al. 2011; WHO 
2009). In addition, the scientific literature reveals no evidence of an 
association between indoor microbial exposure and the development of the 
following health outcomes: cancer, rheumatological and other immune 
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diseases, genotoxic and cardiogenic effects, or reproductive and development 
effects (Eduard 2009; IOM 2004; WHO 2009). Sporadic case reports of 
allergic alveolitis in damp non-industrial indoor environments have been 
published, often associated with the use of humidifiers (Mendell et al. 2011; 
WHO 2009). Building-related illness can include infectious diseases such as 
legionellosis, which has been associated with ventilation and air-conditioning 
systems (Norbäck 2009). 
Volatile organic compounds (VOCs) and formaldehyde indoors are 
associated with suggestive evidence of an increased risk of asthma (Hulin et 
al. 2012; WHO 2010). There is also evidence that second-hand tobacco smoke 
has adverse environmental exposure effects on the respiratory and circulatory 
systems, and plays a carcinogen role (lung cancer) in adults (WHO 2007). 
Indoor radon gas of soil origin, as a human carcinogen, increases the risk of 
lung cancer (WHO 2010). Exposure to airborne particulate matter has shown 
to affect respiratory and cardiovascular morbidity, aggravate asthma, and 
cause mortality from cardiovascular and respiratory diseases and from lung 
cancer (WHO 2013). 
2.1.3 FACTORS ASSOCIATED WITH INDOOR AIR-RELATED 
SYMPTOMS  
Indoor air-related symptoms, or SBS have been considered multifactorial in 
origin (Redlich et al. 1997). Various building-related factors, as well as 
individual and psychosocial factors, interact or coexist in these symptoms. 
They vary from case to case and have time-variance in the same person 
(Azuma et al. 2015a; Azuma et al. 2017; Bluyssen et al. 2016; Carrer and 
Wolkoff 2018; Lu et al. 2017; Magnavita 2015; Marmot et al. 2006; Norbäck 
et al. 1990; Norbäck 2009; Runeson-Broberg and Norbäck 2013; Thörn 1999; 
WHO 1983). The multifactorial nature and risk factors of indoor air-related 
symptoms are mainly based on associations with increased risks of reported 
symptoms compatible with SBS.  
Figure 1 presents a simplified model of the worker and the non-industrial 
work environment, and the relations between environmental determinants 
and health outcomes. The phenomenon (human health and well-being) has 
both physiological and psychological mechanisms and manifestations 
(Jaakkola and Jaakkola 2010).  
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Figure 1 Office environment model: the worker (inner circle) with domains of physical and 
psychological phenomena and the non-industrial work environment (outer circle-
inner circle) divided into physical and social environments (Jaakkola and Jaakkola 
2010).  
Building-related factors. In the non-industrial work environment, reports 
of health complaints have been associated with inadequate ventilation, high 
indoor temperatures, high or low relative humidity, type of ventilation (e.g. 
artificial, cooling system), molds in moisture-damaged buildings, cleaning 
activities, environmental tobacco smoke, several workers sharing a work area, 
visual display terminal work, lack of operable windows, carpet floor covering 
and an inappropriate visual, ergonomic or acoustic environment (Bluyssen et 
al. 2016; Mendell 1993; Norbäck 2009; Redlich et al. 1997; Salonen et al. 2013; 
Sundell et al. 2011; Wolkoff 2018). Similar health complaints and exposures 
have also been reported in home environments (Norbäck 2009; Wolkoff 
2018). Proximity to outdoor pollution such as traffic has also been linked to 
impaired IAQ (de Kluizenaar et al. 2016; Norbäck 2009), as have indoor 
pollutants emitted by building materials or equipment (Nielsen et al. 2017; 
Norbäck 2009; Norbäck et al. 1990; Redlich et al. 1997; Salonen et al. 2009a; 
Wells et al. 2017; Wolkoff 2013). Indoor manmade vitreous fibers (also called 
man-made mineral fibers or synthetic vitreous fibers) have also been 
associated with impaired IAQ (Salonen et al. 2009b; Schneider 2008). 
Inhaled chemicals. As regards inhaled chemicals, sensory irritation of the 
eyes and upper airways has been an essential endpoint for setting occupational 
exposure limits (Nielsen and Wolkoff 2017). The thresholds for sensory 
irritation (trigeminal stimulation) are typically several orders of magnitude 
higher than the corresponding odor thresholds (activation of nervus 
olfactorius). Odor perception per se is not associated with adverse health 
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effects (Wolkoff 2013). Findings regarding odor detection have not revealed 
altered odor thresholds in odor sensitive individuals (Hetherington and 
Battershill 2013) or different thresholds for sensory irritation among mild to 
moderate asthmatics (Wolkoff 2013). A review on the health effects of 
fragrances revealed that even when the measured maximum indoor 
concentrations of common airborne fragrances are close to or above their odor 
thresholds, they can still be far below the thresholds for sensory irritation 
(Wolkoff and Nielsen 2017). Human exposure studies shown no sensitization 
of the airways or toxic effects of fragrances; lung function effects have likely 
been due to olfactory-associated effects in airways (Wolkoff and Nielsen 2017).  
Data on indoor pollutants emitted by building materials or equipment (e.g. 
ozone, phthalates, VOCs, formaldehyde) have shown no evidence of adverse 
health effects at non-industrial exposure levels (Mandin et al. 2017; Nielsen et 
al. 2017; Norbäck et al. 1990; Norbäck 2009; Redlich et al. 1997; Salonen et al. 
2009a; Wells et al. 2017; Wolkoff 2013). Indoor pollutants of VOCs may be 
perceived at very low concentration levels, but their concentrations have been 
several orders of magnitude below their threshold limits for sensory irritation 
in non-industrial work environments (Mandin et al. 2017; Wolkoff 2013). 
Formaldehyde is a strong sensory irritant, but its concentrations in non-
industrial work environments have also been revealed to be too low to cause 
sensory irritation (Salonen et al. 2009a; Wolkoff 2013). 
Indoor molds. Dampness and molds in the indoor environment have been 
associated with respiratory symptoms (e.g. coughing, wheezing, dyspnea), 
upper respiratory symptoms and asthma development. However, evidence 
supporting a causal association with health effects in adults is insufficient 
(Caillaud et al. 2018; Mendell et al. 2011; WHO 2009). Eduard (2009) 
reviewed the toxicological and allergological evidence of the health effects of 
exposure to inhaled mold particles. According to the review, mold spore levels 
in common indoor environments have generally been lower than those in 
outdoor air, and a magnitude lower than those in workplaces in which fungi 
are used for production (e.g. food industry) or in highly contaminated 
environments. In damp buildings, the levels of airborne molds have shown to 
be mostly similar to or only moderately elevated in comparison to outdoor 
levels (Eduard 2009). The toxic mechanism of molds has not been associated 
with immunoglobulin (Ig)E-mediated allergy and its inflammatory mediators. 
It is considered non-allergic, as are other, different inflammatory 
mechanisms. However, the toxic mechanism of molds has not been verified 
(Eduard 2009).  
There is very low-quality long-term evidence that repairing mold-damaged 
houses and offices decreases asthma-related symptoms and respiratory 
infections among adults to a greater than no intervention (Sauni et al. 2015). 
In a recent follow-up study of 1175 office employees, building-related 
respiratory and other severe non-respiratory symptoms did not improve, 
despite multiple remediation activities over a seven-year period (Park et al. 
2018). 
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Individual factors. A number of studies have associated female gender 
with a higher prevalence of indoor air-related symptoms than male gender 
(e.g. Brasche et al. 2001; Mendell 1993; Runeson et al. 2006). A definite 
explanation for this over-presentation among women is lacking, but several 
suggestions exist, such as that females generally report psychosomatic 
symptoms more often (Stenberg and Wall 1995), females perceive 
psychological working conditions differently and possibly react differently to 
job stressors than men (Runeson et al. 2006), females tend to experience more 
health worries (Indregard et al. 2013), and females are more likely to identify 
odors than men (Dalton et al. 2002). Self-reported allergy, atopy and asthma 
have also been associated with a high manifestation of symptoms (Björnsson 
et al. 1998; Mendell 1993; Norbäck 2009; Runeson-Broberg and Norbäck 
2013; Runeson et al. 2006). A review by Norbäck (2009) found no consistent 
association between age and SBS symptoms. From the psychological aspect, a 
low sense of coherence (Runeson et al. 2003), a tendency to somatize 
(Berglund and Gunnarsson 2000), neuroticism (Gomzi et al. 2007), anxiety 
and aggression (Runeson et al. 2006), and anxiety and depression (Björnsson 
et al. 1998) have shown to associate with increased reports of symptoms, as 
have personality traits and personal vulnerability (Runeson et al. 2004; 
Runeson and Norbäck 2005). Increased stress load, measured by a nonverbal 
projective drawing test, has also revealed an association with SBS symptoms 
(Runeson et al. 2007). An inquiry among indoor workers showed that personal 
factors (gender, smoking habit and atopy), anxiety and depression, and 
environmental discomfort and job strain were associated with both SBS and 
other work-related symptoms (Magnavita 2015). Findings have also suggested 
that those reporting symptoms in general may be more prone to reporting 
problems with the indoor environment (Brauer et al. 2006; Brauer and 
Mikkelsen 2010). 
Psychosocial factors. There is explicit evidence that psychosocial 
factors are related to health, well-being, perceived comfort and symptoms in 
indoor non-industrial work environments (Bluyssen et al. 2016; Lahtinen et 
al. 1998, 2004; Marmot et al. 2006; Runeson-Broberg and Norbäck 2013). A 
wide range of psychosocial factors have shown to aggravate complaints 
attributed to indoor air, such as workload, work-related stress, work 
dissatisfaction, lack of control over one’s work situation, lack of social support, 
poor interpersonal relationships, role ambiguity, and conflicting work 
demands (Lahtinen et al. 1998, 2004; Runeson-Broberg and Norbäck 2013; 
Runeson et al. 2006). 
Cross-sectional data from a Whitehall II study of 4052 civil service office 
workers working in 44 buildings showed that the psychosocial work 
environment appeared to play a greater role in explaining differences in the 
prevalence of symptoms compatible with SBS than physical work 
environments (Marmot et al. 2006). In a Swedish cross-sectional study of a 
random sample of 1000 subjects aged 20–65 from the civil registration 
register, the most influential psychosocial factor in building-related symptoms 
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both at work and at home was poor social support, especially low supervisor 
support (Runeson-Broberg and Norbäck 2013). 
In a recent Finnish longitudinal study focusing on the effect of 986 
students’ psychosocial problems, increased socioemotional difficulties were 
associated with a higher number of indoor air-related symptoms (Finell et al. 
2018b). In addition, among school-age children, increased problems in 
teacher-student relations were related to perceived impaired IAQ (Finell et al. 
2018b). In another Finnish study of a working population (n=4633), the risk 
of reporting experiences of injustice (e.g. information, attitudes, 
remuneration) was significantly higher among those who perceived the indoor 
environment as harmful than among those with no such problems (Finell and 
Seppälä 2018). The risk was higher among respondents who reported harm 
from mold than among those who reported harm from only ventilation (Finell 
and Seppälä 2018). It has been suggested that awareness of psychosocial 
effects is important for the prevention of unnecessary escalation of 
psychosocial problems at workplaces that have observed and suspected indoor 
air problems (Bluyssen et al. 2016; Finell and Seppälä 2018). 
2.2 INDOOR AIR-RELATED DISABILITY 
Non-specific symptoms attributed to indoor air environments can be very 
unpleasant and disruptive for some individuals, causing loss of work and 
reduced productivity and disability (Redlich et al. 1997). Data on indoor air-
related disability are fragmented and scarce (the concept of disability is 
described in Section 2.5). Descriptions of disability are based on self-reports, 
and questionnaires have been used to evaluate the prevalence and nature of 
disability, and to objectify and quantify subjective feelings and sensations. 
Individuals’ perceptions of symptoms are typically elicited to obtain data on 
the associations of common risk factors. Persistent symptomatology that 
causes impaired QOL and impacts several aspects of daily life is revealed by 
follow-up studies of clinically examined patients (Edvardsson et al. 2008, 
2013; Karvala et al. 2013, 2014) and by qualitative approaches (Finell and 
Seppälä 2018; Söderholm et al. 2016). Among symptomatic individuals, 
multifaceted experiences of injustice are common (Finell et al. 2018a; Finell 
and Seppälä 2018; Söderholm et al. 2016). Previous findings have also shown 
adverse perceptions of other environmental factors, such as inhaled chemicals 
and electric devices (Edvardsson et al. 2008; Söderholm et al. 2016). Table 2 
presents the outlines and main findings of the studies that describe indoor air-
related disability.  
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2.2.1 FOLLOW-UP STUDIES OF CLINICALLY EXAMINED PATIENTS 
Two Swedish follow-up studies by Edvardsson et al. (2008, 2013) described 
the medical and social prognoses of patients who had initially been examined 
at an occupational and environmental clinic because of building-related 
symptoms (Table 2). Almost half of the patients had been exposed to 
environments with visible water damage, and the others to some other IAQ 
problems. At baseline investigations, the patients also reported health 
problems from dental fillings (4.0%), visual display terminal use (12.7%), and 
hypersensitivity to electricity (6.9%) (Edvardsson et al. 2008). At follow-up, 
nearly half of the patients claimed that their symptoms remained unchanged 
after seven years or more, despite actions taken at the workplace. The patients 
reported a wide range of symptoms, and the symptom profile had similarities 
to those of other patients with hypersensitivity to electricity or patients with 
visual display terminal-related skin symptoms (Edvardsson et al. 2008).  
The follow-up also showed that the patients’ symptoms had impacted their 
social life and ability to work (Edvardsson et al. 2008). The risk factors for 
work disability were symptom duration of over one year prior to first hospital 
visit, and the presence of wide-ranging symptoms at the time of the first visit. 
Symptoms were aggravated by various surroundings and factors, such as 
shopping, using public transportation, visiting a movie theater, using a 
printer, and/or reading newly printed newspaper (Edvardsson et al. 2008). 
The patients’ self-images and cognitive coping abilities differed from those of 
the general population, for example, female patients with a low negative self-
image were at an increased risk of being unable to work (Edvardsson et al. 
2013). The authors emphasized the importance of early, comprehensive 
rehabilitation measures (Edvardsson et al. 2008), and how certain personality 
traits may be risk factors for encountering and experiencing stressful work 
situations and contribute to the risk of developing long-standing building-
related non-specific symptoms under certain circumstances (Edvardsson et al. 
2013). 
Two Finnish studies followed patients initially examined in occupational 
medicine clinic for suspected occupational respiratory diseases related to mold 
exposure at the workplace (Table 2) (Karvala et al. 2013, 2014). The patients 
reported multiple symptoms, decreased QOL, long-standing limitations in 
everyday life and work disability of over 3–12 years. Those who had been 
diagnosed with occupational asthma induced by indoor molds reported more 
severe disability outcomes. Patients with occupational asthma were compared 
to patients in corresponding environments with work-exacerbation asthma or 
only symptoms (Karvala et al. 2013). Based on their use of asthma medication, 
the patients with occupational asthma also had more persistent asthma 
symptoms than other patients with asthma (Karvala et al. 2013). In addition, 
they had a strong risk for early withdrawal from work (Karvala et al. 2014). At 
follow-up, 40% of those diagnosed with occupational asthma were outside 
work life, in comparison to 23% of the work-exacerbated asthma subgroup and 
15% of the upper respiratory symptom subgroup (n=176) at baseline. Twelve 
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percent of patients reported that they had changed occupations, and 13% had 
changed employers because of dampness-related symptoms. A wide range of 
indoor air-related long-term symptoms increased the risk of impaired self-
assessed work ability. Those who evaluated their social work environment 
more negatively (social climate at workplace or co-operation with a 
supervisor) were at an increased risk of early withdrawal from work. When 
self-reported depression and somatization were taken into account, the risks 
remained significantly elevated. Long-term work disability outcomes were 
associated with mold exposure-related asthma, multiple symptoms and 
disability as a multifactorial origin not explained by medical conditions only 
(Karvala et al. 2014). 
A Canadian study followed 32 patients who were initially examined in a 
tertiary clinic for asthma or asthma-like symptoms attributed to documented 
mold exposures, 82% of whom were mold-exposed at work (Table 2) (Al-
Ahmad et al. 2010). The time from onset of exposure-attributed symptoms to 
the clinic assessment ranged from one to ten (mean 1.9) years. At the time of 
follow-up, none of them (n=17) had ongoing exposure to mold, and six (out of 
17, 35%) had asthma. The majority of the 17 respondents reported a long-
lasting non-specific symptom complex despite removal from/remediation of 
the mold exposure. Comparison of the mold-exposure patients to a group of 
individuals (n=233) with an SBS symptom cluster revealed a similar frequency 
of asthma-like symptoms and non-specific symptoms. The authors concluded 
that the subsample of mold-exposure patients had long-lasting symptoms that 
could not be explained by asthma or the current exposure (Al-Ahmad et al. 
2010). 
2.2.2 QUALITATIVE STUDIES 
The patients of a qualitative study (n=11) reported that living with non-specific 
building-related symptoms (NBRS) affected several aspects of their daily lives 
(Table 2) (Söderholm et al. 2016). The data were based on descriptive, written 
reports and telephone interviews. The effects on daily activities were diverse 
due to the heterogeneity of the trigger factors. Patients had difficulties with 
transportation, shopping, reading books/newspapers, going to the gym, 
visiting certain buildings and socializing with friends in general. They also 
reported financial difficulties. NBRS had an impact on social relationships, as 
well as emotional consequences from surrounding attitudes. Patients typically 
felt they were not taken seriously by health care professionals or others. They 
encountered disbelief and prejudice in relation to their suffering which they 
supposed to be due to a lack of knowledge regarding NBRS. Patients’ coping 
strategies included both problem-focused and emotionally focused strategies, 
such as struggling with their work ability, avoiding trigger factors, finding 
positive aspects, learning to accept and finding solutions, and making one’s 
home a sanctuary (Söderholm et al. 2016). 
Review of the literature 
30 
In order to study experiences of injustice, a Finnish qualitative study 
analyzed the content of 23 essays written by individuals who suffered from 
indoor air problems (Table 2) (Finell and Seppälä 2018). All the participants 
attributed their symptoms to their previous or present workplace. They had 
also experienced being blamed and objectified because of their many sick-
leave days and situations in which their work ability was evaluated due to 
indoor air-related health problems. Experiences of not being taken seriously 
or treated with respect, and instead being stigmatized, treated as a problematic 
object and left without help and care were common. A major factor behind 
experiences of injustice was the discrepancy between self-reported illness 
attributions and those validated by others (Finell and Seppälä 2018). Another 
study by Finell et al. (2018a) identified individuals’ (n=20) managements 
strategies for living with indoor air-related health problems (Table 2). The 
study identified six strategies that individuals used to protect their threatened 
identities: the normal individual (e.g. symptoms as normal bodily reactions to 
an unhealth environment), the good citizen (e.g. a diligent employee), the ideal 
individual (e.g. an ideal, strong character who had survived difficult 
conditions), the real sufferer (e.g. underlining the roles of others), the 
awakened sufferer (e.g. spiritual maturation, heightened morality and social 
relationship due to their experiences of suffering) and the promoter of in-
group rights (e.g. validating their own past or current suffering by referring to 
other suffers). The authors concluded that these coping strategies might 
interact effectively with individual suffering from contested illnesses (Finell et 
al. 2018a). 
2.2.3 OTHER REPORTS OF DISABILITY  
Other reports (not peer-reviewed) from Finland also reveal patients’ 
experiences of indoor air-related disability. An interview study of individuals 
with indoor air-related ill health (n=30), using public recruitment via 
magazines and on line, showed multiple symptoms: Using avoidance of 
perceived triggers as a main coping strategy, economic consequences, the 
importance of social support, negative experiences related to health care 
providers, and positive experiences of employers making workplace 
adjustments (Mäki and Nokela 2014). Homepakolaiset ry, a patient 
association, has commissioned three secondary education dissertations (final 
projects). Pimiä-Suwal (2017) describes the experiences of individuals (n=18) 
who suffer from indoor air-related health problems related to remaining 
employed. They reported challenges in maintaining their work ability and 
employment due to a lack of appropriate aid and support. They also reported 
controversy over their ill health, the lack of a proper diagnosis and failure to 
fulfil the official definition of disability (Pimiä-Suwal 2017). Another report on 
the experiences of factors that impact the ability to function among individuals 
(n=6) with indoor air-related ill health showed impaired QOL and a wide 
range of limitations in everyday functioning (Vesikallio and Väisänen 2018). 
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Avoiding triggers and situations that evoke symptoms appeared to be the most 
essential coping strategy, for example, avoiding indoor molds and other 
exposures, and restricting one’s living environment. In order to facilitate 
healing, individuals reported how they ensured that their basic needs were met 
– specific diets, medication and respiratory masks if needed. The interviews 
revealed experiences of loneliness, health care providers’ underestimations 
and individuals’ dissatisfaction with health care providers (Vesikallio and 
Väisänen 2018). A third report has gathered data on everyday life through 
theme interviews (n=3) and a questionnaire (n=101) (Lappalainen et al. 2018). 
The participants’ ill health had impacts on everyday life; on personal, 
occupational and environmental aspects. The participants experienced a lack 
of support and help from social and health care providers (Lappalainen et al. 
2018).  
The Finnish Trade Union of Education carried out a questionnaire study 
(not peer-reviewed) of indoor air-related problems (OAJ 2014). The survey 
had 529 respondents whom included supervisors in day care, directors, 
principals and safety delegates. The principals reported that 11% of the 
schoolteachers (total n=9500) had been on sick leave due to indoor air 
problems in the preceding two years. For 0.2% (n=19), the length of work 
absence had been over 90 days, and their inability to participate in work had 
persisted despite adjustments and repairs made to workplace facilities and 
workplace relocation (OAJ 2014). The teachers with long-term sickness 
absence and persistent indoor air-related ill health possibly represent a 
proportion of the cases with severe functional impairments. 
2.3 ENVIRONMENTAL INTOLERANCE 
Similar features of disability are seen in symptoms attributed to other 
environmental factors such as inhaled chemicals. Here, the term 
environmental intolerance (EI) covers all conditions with recurring, non-
specific symptoms in multiple organ systems attributed to environmental 
factors with no medical and exposure-related explanation (IPCS/WHO 1996; 
Lacour et al. 2005; MCS consensus conference 1999). Some individuals 
become intolerant/sensitive/reactive/responsive to very low levels of indoor 
pollutants which most people tolerate with no problems. SBS shares similar 
features and overlaps with EI (or multiple chemical sensitivity, MCS) (Bardana 
1997; Das-Munshi et al. 2007; Frías 2015; IPCS/WHO 1996; Hetherington and 
Battershill 2013; Staudenmayer 2001; Van den Bergh et al. 2017a; Watanabe 
et al. 2003b; Wiesmüller et al. 2003). A subset of SBS also develops MCS, a 
more general sensitivity to many environmental factors with symptoms that 
persist despite improvements to the original environments (Redlich et al. 
1997). 
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2.3.1 OVERVIEW AND DEFINITIONS 
Several criteria have been proposed for sensitivities/intolerances to various 
environmental factors, formerly often called MCS (described in detail in 
Appendix 1). The origin of MCS dates to the work of Randolph in the 1950s 
and 1960s (Randolph 1956, 1962), who described MCS patients with multiple 
chemical and food sensitivities and how they attempted to avoid various 
chemical substances and foods (Randolph 1956, 1962). Later, the Cullen 
criteria (Cullen 1987), for example, outlined the diagnostic features of MCS. 
Due to a lack of underlying exposure-related mechanisms, the causal criterion 
between exposure and symptoms was later removed (IPCS/WHO 1996). A 
workshop organized by WHO and two other United Nations agencies 
(IPCS/WHO 1996) stated that disorders that share similar symptomatologies 
associated with diverse environmental factors including chemicals (e.g. VOCs) 
and biological (e.g. molds), physical (electromagnetic fields, EMFs) and 
psychological (e.g. stress) factors (tolerated by the majority of people), should 
be labeled under one same term, idiopathic (I)EI, and this should replace 
terms such as MCS. Clinical assessment rules out conditions that require 
specific treatments, and the evaluation should be based on a biopsychosocial 
understanding (IPCS/WHO 1996).  
In 1999, an MCS consensus emphasized that symptoms associated with 
MCS must involve multiple organ systems (MCS consensus conference 1999). 
According to the consensus, the presentation of MCS includes individuals with 
minimal disability and mild occasional symptoms as well as those who are 
totally disabled by severe symptoms on a daily basis. It was recommended that 
any clinical diagnosis of MCS should be characterized using indices of life 
impact or disability, symptom severity, symptom frequency and sensory 
involvement (identification of which sensory pathways are altered) (MCS 
consensus conference 1999). To restrict MCS criteria to the more severe 
condition, Lacour et al. (2005) added the following: Central nervous system 
(CNS) symptoms (as the leading complaints) and at least one other symptom 
of another organ system, symptom duration of at least six months and 
significant lifestyle or functional impairments. Comorbidity should also be 
taken into account in the differential diagnostic procedure (Lacour et al. 
2005).  
Both the terms EI and IEI appear in the literature. IPCS/WHO (1996) has 
stated that IEI should only be used for clinically examined patients. In this 
thesis, the term IEI is restricted to clinically verified cases. EI is used as a 
general term to describe intolerance to environmental factors.  
The unifying term IEI brings together EIs to different environmental 
factors that share similar symptomatologies. However, other terms continue 
to exist, such as MCS or chemical sensitivity/intolerance; SBS, building-
related intolerance (BRI), NBRS, building-related disorders; electromagnetic 
(hyper)sensitivity, electro(hyper)sensitivity, hypersensitivity to EMFs; and 
infrasound hypersensitivity, wind turbine syndrome and vibroacoustic 
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syndrome (Baliatsas et al. 2012; Karvala et al. 2018b; Menzies and Bourbeau 
1997; Van den Bergh et al. 2017a; WHO 2005; Wiesmüller et al. 2003).  
The definitions of IEI are mainly based on intolerance to chemicals. In 
addition, in 2005, WHO, for example described the characteristics of patients 
with IEI attributed to EMFs (IEI-EMFs) (WHO 2005). Later, to improve the 
identification and management of patients by health care professionals, 
Baliatsas et al. (2012) reviewed the identifying criteria for individuals with IEI-
EMFs (in detail in Appendix 1). 
2.3.2 MECHANISMS OF ENVIRONMENTAL INTOLERANCE 
A number of theories have been proposed for the cause of EI and the 
mechanism by which the diverse environmental exposures produce a wide 
range of symptoms: Toxicological, neurotoxic, immunological, psychological, 
psychiatric, sociological and behavioral (Bell 1982; Bell et al. 1992; Graveling 
et al. 1999; Hetherington and Battershill 2013; Korkina et al. 2009; Labarge 
and McCaffrey 2000; Miller 1992; Staudenmayer et al. 2003a, b; Winder 
2002). Nonetheless, current scientific literature emphasizes that IEI is not 
organically based and cannot be explained by a toxicological response. 
Instead, findings support a biopsychosocial nature (Dantoft et al. 2015; 
Hetherington and Battershill 2013; Van den Bergh et al. 2017a). Although the 
majority of this evidence concerning IEI is based on chemicals, it can probably 
be generalized across different but similar conditions. In addition, no plausible 
physical explanations have been found for IEI attributed to EMFs and 
infrasound (from wind turbines) (Crichton and Petrie 2015; Hetherington and 
Battershill 2013; Rubin et al. 2005, 2011, 2014; Schmidt and Klokker 2014; 
Van den Bergh et al. 2017a). 
The biopsychosocial explanation is based on the integrative and 
multidimensional approach, with the behavioral and social aspects of the 
physiological, emotional and cognitive processes (Kipen and Fiedler 2002; 
Van den Bergh et al. 2017a). This explanation proposes that the central 
mechanisms of central sensitization, for example, expectancy and nocebo 
mechanisms, are involved in the development of the symptoms that occur in 
response to environmental triggers with no exposure-related direct 
physiological causes, and that these responses become linked to specific 
environmental cues (Van den Bergh et al. 2017a) (see also Section 2.3.6). 
Central sensitization can be defined as an amplified response of the CNS to 
any select stress input (Yunus 2015). The role of central mechanisms in MCS 
and in IEI-EMFs is supported by provocation/experimental studies that have 
found reactions related to expectations and prior beliefs (Das-Munshi et al. 
2006; Eltiti et al. 2018), as well as brain imaging during odor provocations in 
odor-sensitive individuals or increased capsaicin-induced secondary 
hyperalgesia (Hillert et al. 2007; Orriols et al. 2009; Tran et al. 2013a). 
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2.3.3 CLINICAL CHARACTERISTICS 
IEI has no commonly accepted definition. The conditions are descriptive and 
do not include any diagnostic test or specified symptom set. Characterization 
relies on self-reported non-specific symptoms, which are attributed to certain 
environmental factors or environments. The conditions can incorporate mild 
annoynce (Dantoft et al. 2015), although the more severe expression has more 
clinical relevance (Lacour et al. 2005). IEI should be diagnosed only after a 
thorough examination of the patients (IPCS/WHO 1996; Lacour et al. 2005; 
MCS consensus conference 1999).  
A Finnish review (Sainio and Karvala 2017) summarized the following 
distinctive features of the IEI condition (Bailer et al. 2008b; Dantoft et al. 
2015; Dalton and Jaen 2010; Das-Munshi et al. 2007; Eis et al. 2008; Gupta 
and Horne 2001; Hausteiner et al. 2007; Hetherington and Battershill 2013; 
IPCS/WHO 1996; Labarge and McCaffrey 2000; Lacour et al. 2005; Skovbjerg 
et al. 2009a; Van den Bergh et al. 2017a; Watanabe et al. 2003a, b): 
 
- Chronic condition and recurrent symptoms 
- Non-specific symptoms that involve several organ systems, including 
CNS 
- Symptoms in response to several different environmental pollutants at 
levels with no evidence of health hazards and tolerated by the majority 
of the general population  
- The mechanisms of how the environmental factor causes the physical 
symptoms cannot be proved  
- The relation to environmental exposures is based on the individual’s 
description  
- Symptoms are already initiated or induced when the harmful exposure 
is anticipated 
- Odor sensitivity to cues of harmful exposure  
- Recurrent symptoms may lead to significant restrictions in daily life 
- Symptoms are alleviated by avoidance 
- Difficult for patients to accept other than environment-related 
explanations for the symptoms 
- Concern that environmental factors cause health hazards 
- Spread of intolerance to other environmental factors, e.g., chemicals, 
electricity 
- Lack of specific clinical or medical findings 
- Comorbidity is common and can precede EI 
- Female predominance 
 
Data on IEI disability are mainly based on MCS patients and their self-
reported impaired well-being in everyday functioning. Restraints in the 
functional areas (activity and participation) of everyday life can appear in work 
activities (e.g. sick leave, part-time work, unemployment), leisure activities 
and socializing (e.g. isolation); while traveling, living in homes, visiting public 
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places, wearing normal clothing and eating a normal diet; in wellbeing (e.g. 
decreased QOL) and health behavior (e.g. increased health service use) or as 
financial consequences (e.g. loss of incomes) (Baliatsas et al. 2014; Black et al. 
1999, 2001; Dantoft et al. 2015; Gibson et al. 2011; Gibson and Vogel 2008; 
Katerndahl et al. 2012; Lavergne et al. 2010; Skovbjerg 2009; Watanabe et al. 
2003a). 
Previous findings support the that claim that the overall pathway to adverse 
consequences and disability in IEI is associated with situation-bound 
avoidance due to perceived symptom triggers (Dantoft et al. 2015; IPCS/WHO 
1996; Skovbjerg et al. 2009a, 2012b; Watanabe et al. 2003a). Attitudes in 
social surroundings and misunderstandings can also add to adverse illness 
behaviors and promote social and occupational restraints (Skovbjerg 2009; 
Watanabe et al. 2003a). Patients with IEI typically described encountering 
negative experiences of being misunderstood in health care and by other social 
sources when seeking support (Gibson et al. 2005, 2016; Skovbjerg 2009; 
Wiesmüller et al. 2003). 
2.3.4 PREVALENCE OF ENVIRONMENTAL INTOLERANCE 
Epidemiological surveys have been used to study the prevalence of EI and its 
manifestations in different populations. The findings endorse the 
heterogeneous nature of EI and the contribution of cultural and societal 
factors to its prevalence. There is no generally agreed EI definition for 
estimating prevalence. Case definitions of EI are based on self-reports, 
typically by a single-item question, and are associated association with 
environmental factor(s). Prevalence data are mainly from studies of 
intolerance to various chemicals (e.g. perfumes, air fresheners, cleaning 
solvents, fresh paints, freshly printed papers, cigarette smoke, pesticides, new 
furnishings, vehicle exhaust and, for example, hairdressers or departments in 
stores) and intolerance to EMFs (e.g. electric devices), but are limited to 
indoor environments (e.g. certain buildings, BRI). A recent study by Karvala 
et al. (2018b) showed prevalence differences between Finland and Sweden in 
self-reported EI attributed to chemicals (15.2% vs. 12.2%), EI to EMFs (1.6% 
vs. 2.7%), and in BRI (7.1% vs. 4.8%), respectively. 
Prevalence demographics have shown that EI can develop throughtout the 
lifespan, but onsets usually occur in middle age, and female gender is a risk-
factor (Dantoft et al. 2015; Watanabe et al. 2003a). In addition, as pregnancy, 
especially early pregnancy, increases the perception of odors and unpleasant 
qualities, this may increase reporting of EI (Cameron 2014; Nordin et al. 2004, 
2005, 2007). The association between education or socio-economic class and 
EI is inconsistent (Dantoft et al. 2015; Kipen and Fiedler 2002; Watanabe et 
al. 2003a). 
Different degrees of severity. EI spans different degrees of severity 
ranging from unpleasantness or annoyance to multiorgan symptoms leading 
to lifestyle changes and functional impairments and representing different 
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degrees of severity (Berg et al. 2008; Dantoft et al. 2015). Prevalence data on 
EI disability are still fragmented and severity is described non-uniformly with 
no precise severity measure for disability. The increasing severity of EI has 
been described by the grade of annoyance (Carlsson et al. 2005), the severity 
of symptoms (Caress and Steinemann 2004a), the strength of symptoms 
(Johansson et al. 2005), the frequency of symptoms (Meggs et al. 1996), the 
number of symptom groups (Björnsson et al. 1998), requiring CNS symptoms 
(Karvala et al. 2018a, b) and co-occurrence (Palmquist et al. 2014). The 
intolerance-related effects on lifestyle and behavior, and physician diagnosed 
EI have been used to define more severe conditions (Berg et al. 2008; Black et 
al. 2000b; Caress and Steinemann 2004a; Karvala et al. 2018a, b; Kreutzer et 
al. 1999). The different measures used in the literature for evaluating EI 
prevalence are illustrated in Figure 2. 
 
 
Figure 2 Different measures used for evaluating the prevalence of environmental intolerance 
(EI) in the literature. CNS, central nervous system. 
EI attributed to chemicals. Few previous studies have shown the 
spectrum of increasing severity (annoyance, symptoms, behavioral 
consequences) of EI attributed to chemicals (Berg et al. 2008; Black et al. 
2000a; Johansson et al. 2005). In one Danish population-based sample, 45% 
of the 4242 participants reported annoyance due to at least one of the eleven 
inhaled chemicals, 27% reported intolerance-related symptoms, 3.3% had 
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made one or more adjustments to their social lives or occupational conditions 
because of symptoms, and 0.5% reported having done both (Berg et al. 2008). 
In the same study, women reported more symptoms and adjustments to 
personal lifestyle than men, but gender had no effect on reporting adjustments 
to social life or occupational conditions (Berg et al. 2008). In a Swedish 
population-based sample, 33% of 1387 participants reported being bothered 
by strong odors, half of them had moderate or severe symptoms, and 19% 
reported intolerance-related affective and behavioral consequences 
(Johansson et al. 2005). 
Annoyance. Prevalence has shown higher estimates when patients are 
asked questions about unpleasantness or annoyance, feeling ill or unwell, 
being sick, and being bothered by an environmental exposure (Figure 2). 
According to these questions, EI attributed to chemicals or odors varied from 
4.1% to 52% in population-based (US, Australian, Swedish, Danish) samples 
of adults (Berg et al. 2008; Carlsson et al. 2005; Dantoft et al. 2017; Johansson 
et al. 2005; Meggs et al. 1996; NSW Department of Health 2003). More severe 
annoyance has been associated with more greatly impaired health and daily 
function (Carlsson et al. 2005). It has been suggested that annoyance is a 
mediating factor between exposure and health effects (Berglund et al. 1987; 
Dantoft et al. 2015) and that it is affected by prior positive and negative 
experiences with the exposure (Greenberg et al. 2013; Van Thriel et al. 2008). 
A Swedish study showed that annoyance and symptoms mediated perceived 
pollution and health risk perception in environments with non-toxic levels of 
odorous pollution (Claeson et al. 2013). 
Increased sensitivity. EI has also been determined by asking if respondents 
consider themselves to be allergic or unusually sensitive to everyday exposures 
in comparison with other people. According to the responses, EI attributed to 
chemicals varied from 11% to 16% in population-based samples in the USA 
(Caress and Steinemann 2004a, b; Kreutzer et al. 1999). 
Symptoms related to the environment. If symptoms were required, the 
prevalence of EI to chemicals fell to 12%–33 % in the (Danish, Swedish, 
Finnish) samples (Berg et al. 2008; Johansson et al. 2005; Karvala et al. 
2018b; Palmquist et al. 2014). The number and nature of symptoms vary 
extensively, and are commonly categorized into different organ systems 
depending on their expression (Dantoft et al. 2015). CNS symptoms have been 
seen as a characteristic feature of a more severe condition (Lacour et al. 2005). 
For example, when the definition of EI required multiorgan symptoms 
including CNS symptoms, the prevalence of EI to chemicals fell from 12.2% to 
8.0% in a Swedish sample, and from 15.2% to 10.0% in a Finnish population-
based sample (Karvala et al. 2018b). 
Adverse effects on lifestyle or behavior. When lifestyle or behavioral 
alterations were studied, the prevalence of EI to chemicals fell to 0.4%–20.7% 
in (Danish, Swedish and US) samples (Berg et al. 2008; Caress and 
Steinemann 2004a; Johansson et al. 2005; Kreutzer et al. 1999). Typical 
adjustments are made to behavior due to symptoms in personal lifestyle, social 
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life and in occupational conditions such as changing personal hygiene 
products; using a special diet or protective clothes; taking precautions at home 
or being careful with home furnishing; moving to a new home; avoiding social 
situations, public spaces, stores and transportation; leaving or changing 
employment or inability to work. Due to intolerance to chemicals, 1.5% of a US 
population-based sample reported losing their jobs and 0.8% reported moving 
houses (Caress and Steinemann 2004a), and 0.8% of the Danish adult 
population reported having left employment permanently (Berg et al. 2008). 
Physician-diagnosed EI. Self-reported physician-diagnosed (or medically 
diagnosed) EI has been used to define the more severe EI phenomenon. 
According to this definition, EI to chemicals in (German, Swedish, Finnish, 
Japanese, Australian, Danish, Canadian and US) population-based samples 
have varied between 0.5% and 6.5% (Azuma et al. 2015b; Caress and 
Steinemann 2009, 2004a; Dantoft et al. 2017; Fitzgerald 2008; Hausteiner et 
al. 2005; Karvala et al. 2018b; Kreutzer et al. 1999; NSW Department of Health 
2003; Palmquist et al. 2014; Park and Knudson 2007; Steinemann 2018b). In 
a recent US study, the prevalence rate was as high as 12.8% for self-reported 
physician-diagnosed EI to chemicals (Steinemann 2018a). 
EI attributed to EMFs. The prevalence rates for EI attributed to EMFs 
have varied between 0.1% and 20.9% in (Swedish, Finnish, Swiss, US, 
Austrian,  Dutch, German, Taiwanese and English) population-based samples 
on the basis of responses to various definition questions, such as being allergic 
or (hyper)sensitivity, experiencing annoyance, having health symptoms, 
having adverse health effects due to electric devices or EMFs, or physician-
diagnosed hypersensitivity to EMFs (Baliatsas et al. 2015a; Blettner et al. 
2008; Carlsson et al. 2005; Eltiti et al. 2007; Hillert et al. 2002; Karvala et al. 
2018b; Levallois et al. 2002; Mohler et al. 2010; Palmquist et al. 2014; Schreier 
et al. 2006; Schröttner and Leitgeb 2008; Tseng et al. 2011; Van Dongen et al. 
2014). 
Building-related intolerance. Population-based prevalence studies of 
EI to certain buildings (e.g. BRI) are sparse (Table 3). A few population-based 
studies on BRI have separated the prevalence of any building-related 
symptoms from the more severe ones (Karvala et al. 2018a, b; Palmquist et al. 
2014). More severe BRI was defined as reported BRI with CNS symptoms, and 
secondly, reported physician-diagnosed BRI (Table 3). The presumption was 
that the cases with a physician diagnosis represented a more severe condition, 
and perhaps more functional impairments, than self-reported BRI. Women 
generally reported BRI more often than men (Karvala et al. 2018b). BRI 
appeared to be a long-lasting condition, of 12 years on average (Karvala et al. 
2018a). In addition, daily or weekly building-related symptoms had 
significantly more negative emotional and behavioral impact than monthly 
symptoms (Karvala et al. 2018a).  
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Table 3. Prevalence studies of building-related intolerance in adult general populations. 







Responding ‘yes’ to: ‘Are you 
getting symptoms from residing 
in certain buildings (non-specific 
building related symptoms) that 
you were not getting symptoms 
from before or that you believe 
most other people are not getting 
symptoms from?’ (= BRI) 
OR 
Random sampling. 

















Affirmative response to BRI 
(above) and reporting at least one 









Responding ‘yes’ to: ‘Have you 
been diagnosed with a BRI by a 
physician?’ 
Swedish sample 






Affirmative response to BRI 
OR 
Affirmative response to BRI and 
reported weekly mucosal/airway, 
skin, and general symptoms 
Combined survey of 
both (above) Swedish 




CNS, central nervous system; BRI, building-related intolerance. 
 
 
Co-occurrence of different EIs. It is characteristic that among 
individuals with EI (to chemicals), the number of symptom-evoking exposure 
substances increases over time, and a higher number of triggering substances 
are seen in more severe cases (Winder 2002). In a sample of 2072 
Californians, reporting being chemically sensitive was a strong predictor of 
reporting being sensitive to EMFs, and the prediction was strongest if 
chemical sensitivity had been diagnosed by a physician (Levallois et al. 2002). 
In the study, 8.4% of those who reported chemical sensitivity reported 
sensitivity to EMFs, whereas among those not sensitive to chemicals, 1.8% 
reported sensitivity to EMFs (Levallois et al. 2002). A Swedish study showed 
co-prevalence of EI attributed to chemicals and EI to any electrical factor 
among 4.8% (Carlsson et al. 2005). Later, another Swedish study showed co-
prevalence of EI attributed to chemicals, certain buildings, EMFs, and 
everyday sounds (Palmquist et al. 2014). In the same study, 12.1% of 
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respondents reported only one type of EI (chemicals, certain buildings or 
EMFs), 3.1% reported two of the different varieties, and 0.4% all three. The 
prevalence estimates for the co-occurrence of physician-diagnosed EI were 
3.4% (only one type of EI), 0.7% (two types of EI), and 0.06% (all three) 
(Palmquist et al. 2014). An overlap between building-related non-specific 
symptoms and various EI has also been shown in clinical settings (Edvardsson 
et al. 2008; Söderholm et al. 2016). The overlap between different types of EI 
suggest that various EIs represent the same phenomenon. 
2.3.5 COMORBIDITY 
The comorbidity of somatic diseases and psychiatric disorders is prevalent in 
EI. This has typically been shown using cross-sectional designs and self-
reports, but longitudinal data are scarce. Most comorbidity data are from both 
epidemiological and clinical studies of MCS. 
In epidemiological surveys, a typical somatic MCS comorbidity is that of 
asthma and allergic rhinitis. In MCS, the co-prevalence of asthma has varied 
from 10% to 42%, depending on the sample (Baldwin and Bell 1998; Bell et al. 
1993, 1996a; Caress and Steinemann 2004a), and that of allergic rhinitis from 
8% to 44% (Baldwin and Bell 1998; Bell et al. 1993, 1996a). Clinical studies 
have also shown co-occurrence of asthma and rhinitis with MCS (Katerndahl 
et al. 2012). In a population-based combined Swedish and Finnish sample, the 
co-prevalence of asthma was 28% among individuals with BRI (Karvala et al. 
2018a). In general, asthma is a common chronic disease, and has a prevalence 
of 9.4% in the Finnish adult population (Pallasaho et al. 2011). A Swedish 
population-based study expressed multimorbidity in asthma/allergy with 
intolerance to chemicals and BRI as a higher risk than comorbidity with either 
one of the two intolerances (Lind et al. 2017).  
A number of studies have investigated the comorbidity of psychiatric 
disorders in MCS. In comparison, in general populations, a review of 174 
surveys across 63 countries providing pooled prevalence data showed that on 
average one in five (18%) adults had experienced a common mental disorder 
in the past 12 months, and 29% had experienced one at some point in their 
lifetime (Steel et al. 2014). The period prevalence of mood disorder was 5.4% 
with a pooled lifetime prevalence of 9.6%. For anxiety disorders, the pooled 
period prevalence was 6.7% with a lifetime prevalence of 12.9% (Steel et al. 
2014). In a general population sample of Finnish adults (n=6005), depressive 
and anxiety disorders were found among 6.5% and 4.1%, respectively (Pirkola 
et al. 2000).  
As regards comorbidity in IEI, a review by Bornschein et al. (2001) showed 
how eight investigations found well-defined psychiatric disorders in 36%–
100% of IEI/MCS patients. Of these psychiatric disorders, somatoform 
disorders were the most prevalent, ranging from 17% to 72% among patients 
with IEI/MCS (Bailer et al. 2008b; Black et al. 2001; Bornschein et al. 2002; 
Caccappolo-van Vliet et al. 2002; Eis et al. 2008; Hausteiner et al. 2003, 2006; 
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Witthöft et al. 2008), and 2%–4% in two population-based samples of self-
reported MCS cases (Bell et al. 1996a; Jason et al. 2000).  In addition, the co-
prevalence of current and lifetime anxiety disorders were 10% and 3%–13%, 
respectively, in two population-based samples (Bell et al. 1996a; Jason et al. 
2000). In patients with IEI/MCS, a comorbid current anxiety disorder was 
seen in 15%–71%, and a lifetime anxiety disorder in 7%–56% (Bailer et al. 
2008b; Black et al. 2000b, 2001; Bornschein et al. 2002; Caccappolo-van Vliet 
et al. 2002; Hausteiner et al. 2003, 2006; Saito et al. 2005; Witthöft et al. 
2008). Similarly, the co-prevalence of current and lifetime depression 
disorders were 22% and 7%–49%, respectively, in two population-based 
samples (Bell et al. 1996a; Jason et al. 2000). Among patients with IEI/MCS, 
a comorbidity of current depression was found in 10%–40%, and lifetime 
depression in 7%–83% (Bailer et al. 2008b; Black et al. 2000b; Caccappolo-
van Vliet et al. 2002; Eis et al. 2008; Hausteiner et al. 2003, 2006; Witthöft et 
al. 2008). Some questionnaire-based studies have also reported associations 
between SBS and depression or anxiety (Björnsson et al. 1998; Kinman and 
Griffin 2008; Magnavita 2015). 
2.3.6 SIMILARITIES WITH FUNCTIONAL SOMATIC SYNDROMES 
The phenomenon of EI and functional somatic syndromes (FSS) are similar 
and overlap substantially (Bailer et al. 2005; Barsky and Borus 1999; Lacour 
et al. 2005; Kipen and Fiedler 2002; Wiesmüller et al. 2003). These conditions 
cover a complex of prolonged physical symptoms for which adequate 
examination does not reveal explanatory causes in terms of a somatic or 
psychiatric disease or exposure (Barsky and Borus 1999; Kipen and Fiedler 
2002; Rief et al. 2017; Wiesmüller et al. 2003). Both conditions hold an 
increased burden of disability and diminished QOL (Harris et al. 2009; 
Jackson et al. 2006; Kjellqvist et al. 2016), female preponderance, comorbid 
conditions (e.g. anxiety, depression) (Henningsen et al. 2003, 2007), great use 
of health services and work withdrawal due to inability to work (Aamland et 
al. 2012; Frías 2015; Rief and Broadbent 2007). Similar predisposing factors 
together with maintaining factors (e.g. cognitive and emotional processes with 
external or a monocausal attributional traits, illness worry, rumination, illness 
behavior and emotional distress) have been associated with the onset and 
maintenance of adverse reactions (Figure 3) (Brown 2004; Deary et al. 2007; 
Henningsen et al. 2007, 2018; Rief and Broadbent 2007; Witthöft et al. 2006). 
Central mechanisms (central sensitization) have suggested that the 
development and maintenance of adverse reactions play an essential role, due 
to dysfunctional cognitions that may increasingly enhance reactions to actual 
or anticipated stimuli (Bell et al. 1996b; Henningsen et al. 2007, 2018; Kipen 
and Fiedler 2002; Rief and Broadbent 2007; Van den Bergh et al. 2017a; 
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Figure 3 Schematic model of bodily distress etiology by Henningsen et al. (2018). Note: The 
distinction of vulnerability/triggering and aggravating/maintaining factors is to some 
extent artificial, as most factors influence both sides. (Figure reproduced with 
permission from S. Karger AG, Basel.) 
Symptoms with no clear underlying medical disease are common in all 
areas of medicine (Henningsen et al. 2007, 2018; Nimnuan et al. 2001). The 
prevalence of FSS (or functional somatic symptoms) has widely varied 
between 10% and 50% in patients in general practice and special health care, 
depending on the case definition and study sample (de Waal et al. 2004; Fink 
et al. 1999; Nimnuan et al. 2001; Reid et al. 2001; Toft et al. 2005). 
Terminology. Chronic disabling bodily distress (or FSS) (Figure 3) has a 
variety of names for which adequate examination does not provide sufficient 
explanation in terms of a defined medical disease, such as a bodily distress 
disorder or syndrome, functional (somatic) syndrome or disorder, functional 
somatic symptoms, somatization, medically unexplained (physical) symptoms 
or persistent physical symptoms (Fink and Schröder 2010; Henningsen et al. 
2018; Wessely et al. 1999). The proposition of unifying the terminology aims 
to abolish patient-blaming and the stigmatization of mind-body dualism (e.g. 
somatization, medically unexplained symptoms) (Barsky and Borus 1999; 
Creed et al. 2010; Fink and Rosendal 2008; Nimnuan et al. 2001; Yunus 2015). 
The diagnostic approach to FSS varies across and within medical specialties 
(Henningsen et al. 2007). The name of the syndromes typically depends on the 
medical specialty and signifies the main symptoms or the implied cause, for 
example, a typical facial pain, chronic benign pain syndrome, chronic pelvic 
pain or premenstrual syndrome, fibromyalgia, hyperventilation syndrome, 
irritable bowel syndrome, somatoform disorders, and IEI (or MCS, BRI, 
hypersensitivity to EMFs) (Fink and Rosendal 2008; Henningsen et al. 2007; 
Nimnuan et al. 2001; Wessely et al. 1999). Many of these terms are classified 
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10th Revision (ICD-10). In addition, the term ‘somatic symptom disorder’, in 
the upcoming 5th edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM), will cover some of the above (Henningsen 2018). Somatic 
symptom disorder is a plausible candidate for an overarching term (Hubley et 
al. 2016). Each of the various above-mentioned syndromes is described as a 
unique diagnostic entity with its own characteristics. Clinical presentations 
can vary considerably, in terms of, for example, symptom severity, duration 
and comorbidity (Kroenke et al. 2007). However, they seem to overlap to a 
large extent and reflect the same phenomenon (Aaron and Buchwald 2001; 
Barsky and Borus 1999; Bornschein et al. 2001; Fink et al. 2004, 2007; Fink 
and Schröder 2010; Kipen and Fiedler 2002; Nimnuan et al. 2001; Wessely et 
al. 1999). 
2.3.7 MANAGEMENT OF ENVIRONMENTAL INTOLERANCE 
EI has been considered a chronic, potentially disabling condition that is stable 
over time, with resistant cognitions concerning environmental stimuli. 
Evidence-based effective treatments are currently unavailable. The current 
knowledge regarding EI mechanisms supports the idea that biopsychosocial 
aspects are involved in the onset and maintenance of adverse health effects. 
Within the biological spectrum, evidence points towards abnormal responses 
in the CNS, i.e. central sensitization, and shared mechanisms with FSS (Yunus 
2007). This supports the use of similar strategies as those in the managements 
of FSS, such as cognitive-behavioral therapy (CBT) (e.g. Henningsen et al. 
2018; Van Dessel et al. 2014). 
Numerous treatments have been used for MCS (or IEI), but data on 
interventions are mainly based on case reports and/or uncontrolled set-ups 
(NICNAS and OCSEH 2010). Many management regimes are based on 
toxicological/exposure hypotheses and thus focus on (short-term or long-
term) avoiding the agents that trigger symptoms (NICNAS and OCSEH 2010). 
This aspect has included treatments aiming to raise the immunity against 
exposure, for example, special dietary or nutritional supplements, 
detoxification and desensitization techniques, holistic or body therapies, 
prescription medicines, and behavioral therapies (Dantoft et al. 2015; Das-
Munshi et al. 2007; NICNAS and OCSEH 2010; Somerville 2001; Watanabe et 
al. 2003b). In terms of explanations for CNS sensitization, some randomized 
controlled trial (RCT) studies of mindfulness-based techniques have shown 
positive effects on the perception of illness, coping strategies and improved 
sleep quality, but these have had no overall impact on daily life or reactions 
following exposures (Hauge et al. 2015; Sampalli et al. 2009; Skovbjerg et al. 
2012a). RCT studies of transcranial magnetic stimulation have shown positive 
effects on symptom severity, but have had no effects on impairments in MCS 
(Tran et al. 2014, 2017). Case reports have shown limited benefits from 
antidepressant pharmacological treatments and/or desensitization therapy 
(e.g. Stenn and Binkley 1998). 
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Published reports on treatment models for patients are mainly based on 
FSS. For example, the Nova Scotia Environmental Medicine Clinic in Canada 
has designed a model of integrated care, a multidisciplinary approach for 
multiple chronic conditions, to address the specific needs of patients with 
reduced functioning (Sampalli et al. 2012, 2016). The treatment model in the 
Research Clinic for Functional Disorders and Psychosomatics in Aarhus, 
Denmark, has developed an education program for the assessment and 
treatment of FSS, the Extended Reattribution and Management (TERM) 
model (Fink et al. 2002; Fink and Rosendal 2015). The TERM intervention is 
largely based on CBT and includes various steps in diagnostic assessments and 
planning of management courses with patients, as well as treatments and 
interview techniques (Fink et al. 2002; Fink and Rosendal 2015). In recent 
years, several national guidelines on FSS management have been published 
(e.g. in the Netherlands, Denmark and Germany) containing the principles of 
different management options that use a stepped-care approach based on the 
stages of FSS severity (mild, moderate, severe) (olde Hartman et al. 2017). The 
guidelines also emphasize the doctor-patient relationship and 
communication, as well as the importance of providing a targeted, tangible 
explanation in the patient’s language of the cause of their symptoms 
(Henningsen 2018; olde Hartman et al. 2017). 
Environmental control and avoiding exposures that trigger symptoms is a 
typical coping outcome among affected individuals with IEI. It is natural that 
individuals who interpret sensation as a sign of illness and a disabling 
condition seek medical advice from health care providers, which can also in 
itself be a source of maintaining stability of perception in adverse conditions 
(Barsky et al. 2005; Dantoft et al. 2015; Rief and Broadbent 2007; Skovbjerg 
et al. 2009b; Watanabe et al. 2003a). Possible opposing views among health 
care professionals regarding the underlying mechanisms of ill health and a 
lack of validation may set a barrier to complying with the CNS sensitivity 
approaches of management strategies, and lead to, for example, avoidance. A 
Danish study described general practitioners’ experiences (n=691) of patients 
with self-reported MCS (Skovbjerg et al. 2009b). It showed that many (46%) 
practitioners find it difficult to meet patients’ expectations (Skovbjerg et al. 
2009b); this is typically reported in the health care of patients with medically 
unexplained symptoms (Dowrick et al. 2004; Frostholm et al. 2005). The 
Danish study showed a pragmatic approach to dealing with patients in health 
care (Skovbjerg et al. 2009b). In terms of MCS etiology, 28% of the 
practitioners provided a somatic/biological explanation, and 7% primarily a 
psychological explanation. Regarding clinical advice, 75% recommended that 
the patients avoid chemical exposures that provoke symptoms and 12% 
advised avoiding all exposure to chemicals, whereas 2.8% did not advise 
avoiding common airborne chemicals. The general practitioners who did not 
advise avoidance perceived the patients’ conditions as more likely to be 
psychological (Skovbjerg et al. 2009b). This pragmatic approach to 
recommending avoidance to patients may be the only tool in health care for 
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providing advice regarding the management of health consequences related to 
environments (Dantoft et al. 2015). The lack of evidence-based treatment 
options calls for well-conducted randomized trials that evaluate the effect of 
possible therapeutic options. 
2.4 MANAGEMENT OF INDOOR AIR-RELATED 
DISABILITY 
Laws and regulations on the built environment in Finland regulate building 
constructions, improvements and renovations that aim to assure healthy living 
and working conditions (Decree on Housing Health 545/2015; Health 
Protection Act 763/1994). The Occupational Safety and Health Act 
(738/2002) aims to improve the healthiness and safety of work and the work 
environment in order to ensure and maintain the health, work ability and 
functional capacity of employees, to prevent work-related illnesses and 
accidents and to eliminate work environment hazards to the health of 
employees. 
Various guidelines for recognizing and solving IAQ problems exist (e.g. 
WHO 2009). In the assessment and management of IAQ problems, the role of 
the occupational health service (OHS) is to collaborate in risk assessments, 
workers’ health evaluations and surveillance in cases of clinical examinations 
and health promotion, or when other risk factors need to be taken into account 
(Carrer and Wolkoff 2018; Magnavita 2015). In Finland, guides are available 
for health care providers and workplaces which aim to prevent disability and 
impaired well-being and health problems among employees related to indoor 
work environments (Haahtela et al. 1993; Haahtela and Reijula 1997; Majvik 
1998; Lahtinen et al. 2006; Salonen et al. 2014; Patient exposed to moisture 
damage: Current Care Guidelines Abstract 2016; Latvala et al. 2017). 
For symptomatic individuals, the strategies of management actions have 
focused on making adjustments to improve environmental facilities, avoiding 
environments that trigger symptoms, and improving conventional treatments 
of underlying diseases. The concept of occupational disease varies in different 
countries as it is based on national legislation. In Finland, asthma induced by 
indoor air molds was classed an occupational disease in non-industrial work 
environments in the 1990s (Karvala et al. 2010). Since then, patients with 
asthma or asthma-like symptoms attributed to water-damaged work 
environments have been clinically examined. However, diagnostic tools do not 
differentiate between work-exacerbated asthma and occupational asthma 
(Karvala 2012). Study findings have shown that asthma as an occupational 
disease induced by indoor molds, has not succeeded in preventing disability 
(Karvala 2012). 
To avoid the exposure perceived as harmful is a natural effort to alleviate 
symptoms. According to a questionnaire study, over 60% of BRI respondents 
reported actively trying to avoid buildings that evoked symptoms (Karvala et 
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al. 2018a). In the context of IEI, being forced to avoid certain environmental 
pollutants due to symptoms may increase the development of disability 
(Dantoft et al. 2015; Watanabe et al. 2003a). Similarly, findings regarding 
chronic pain have supported the hypothesis that the fear of pain experience 
relates to avoidance behaviors leading to disability (Hartvigsen et al. 2018; 
Samwel et al. 2007; Wideman et al. 2013). In addition, in cases of chronic pain 
and anxiety disorders, higher degrees of cognitive and behavioral avoidance 
have predicted worse long-term outcomes (Beesdo‐Baum et al. 2012; Leeuw et 
al. 2007). For iatrogenic avoidance from support advice to avoidance, see 
Section 2.3.7. 
Adjustments to occupational facilities and conventional treatments of 
underlying disease have been insufficient to cure some individuals’ indoor air-
related disability. Previous studies support a biopsychosocial approach to 
disability prevention (Karvala 2012; Thörn 1999). In this context, however, 
effective and practical guidelines to target aid and support for these 
individuals with indoor air-related disability are lacking. Part of the challenge 
in indoor air-related disability may be that the disability has not been 
sufficiently characterized, and that appropriate language to conceptualize 
indoor air-related ill health manifestations and mechanisms for patients and 
health care providers to effectively communicate is needed. 
2.5 THE CONCEPTS OF FUNCTIONING AND DISABILITY 
WHO’s International Classification of Functioning, Disability, and Health 
(ICF) is a framework for classifying health and health-related domains and 
disability (WHO 2001). In the ICF context, functioning and disability are 
complex, interactive and dynamic states, consisting of interaction between an 
individual’s health and their personal features and the context in which the 
individual lives (Figure 4). The ICF context incorporates the biopsychosocial 
approach, in which both medical and social models are integrated. In ICF, the 
term functioning refers to body functions and structures (physiological and 
psychological), activities (level of capacity) and participation (level of 
performance). Disability (problems in functioning) is the negative outcome 
of impairments to body functions and structures, limitations to activities, and 
restrictions to participation (WHO 2001). Disability can be described as an 
imbalance between the individual and the environment (Gould et al. 2008), 
or something that restricts or limits (Martimo 2010). According to ICF, 
disability may occur in one or more of the three domains (bodily function, 
activities, participation), and does not require total dysfunction in any domain 
(WHO 2001). ICF views functioning and disability as outcomes of interactions 
between health conditions (diseases, disorders, injuries) and contextual 
(environmental and personal) factors (WHO 2001). The classic definition of 
health by WHO involves a state of complete physical, mental and social well-




Figure 4 Interactions between the components of International Classification of Functioning, 
Disability, and Health (ICF) (WHO 2001). 
In the ICF classification, environmental factors can include, for example, 
support and relationships, health professionals, social attitudes, architectural 
characteristics, legal and social structures, and climate and air quality (WHO 
2001). The ICF scheme has been criticized due to, for example, the dominant 
position of the medical approach, a possible overlap between mental functions 
and personal factors, and a lack of relevant items in the classificatios of the 
working environment (Heerkens et al. 2018). In addition, although personal 
factors play an essential part in functioning and disability, they are not 
currently classified in the ICF due to large social and cultural variance 
(Heerkens et al. 2018; WHO 2001). Personal factors can be, for example, age, 
gender, personality factors, attitudes, basic skills and behavior patterns, life 
situation and socioeconomic/sociocultural factors, and other factors that 
impact on the perception functioning of disability (Grotkamp et al. 2012; 
WHO 2001). 
Work disability is a major public health and economic concern. The term 
refers to individuals who have discontinued their participation in occupational 
activities (WHO 2001). Work (or occupational) disability is also defined as 
time off work, reduced productivity, or working with functional limitations as 
a result of either traumatic or non-traumatic clinical conditions (Schultz et al. 
2007). The concept of work ability includes several models and can be 
described in terms of the balance between human resources and work 
demands, and includes such aspects such as the workplace and environments 
outside work (Gould et al. 2008).  The term work ability is typically used in the 
context of promoting and maintaining work capacity and performance. The 
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definitions of work disability and work ability also depend on each 
independent evaluator’s perspective (Gould et al. 2008). For example, the 
emphasis in many welfare benefits is on disease-related dysfunctions. 
Bearing the above ICF biopsychosocial concept in mind, impaired 
functioning and disability can be affected by disease or illness, psychological 
and social reasons, including aspects of knowledge, and other barriers due to 
environmental and/or individual factors. Therefore, it is relevant to 
distinguish between disease and illness. Disease can be defined as an 
objective (demonstrable by) biological event involving the disruption of 
specific function and/or structure of body organs and systems due to 
pathological abnormalities (Eisenberg 1977). In contrast, illness (absence of 
above pathology) is a subjective experience or self-attribution that a disease is 
present, which creates physical discomfort, behavioral limitations and 
psychosocial distress; or a subjective experience of negative changes in well-
being (Eisenberg 1977; Spurgeon 2002; Yunus 2008). Disease can either make 
an individual feel ill, or have no impact on well-being. On the other hand, an 
individual may feel ill despite a lack of objective evidence of underlying disease 
(Coggon 2005). Biology and psychology are intertwined, thus patients with an 
illness can also suffer from a disease, or the other way around. Often the two 
go hand in hand (Coggon 2005; Yunus 2008). 
The concept of ICF provides a framework to address not only physical and 
psychological impairments (problems in body functions and structures), but 
also subsequent limitations to activities and restrictions to participation, 
resulting in a health state that impacts an individual’s ability to participate in 
life activities. Within the ICF model, the environmental and personal factors 
unique to an individual serve as possibilities to either support or hinder 
recovery (Figure 4). The ICF framework integrates the understanding of multi-
modal interventions for disability reduction, targeting interventions to 
improve activities and participation among patients with disabilities. In 
addition, it has been proposed that the ICF context is a suitable framework for 
measuring and evaluating functioning and disability, on both individual and 
population levels (Wasiak et al. 2007; WHO 2001). 
2.5.1 ASSESSMENT OF FUNCTIONING AND DISABILITY 
The assessment of functioning and disability provides essential data on health 
and well-being for adequate interventions and for allocating preventive and 
management actions, on both individual and population levels. On an 
individual level, the data are essential for promoting and monitoring patients’ 
health and well-being in everyday life, for example, as well as for targeting 
preventive actions. In addition to determining disability, it is important to 
clarify the remaining functional capacity, resources, strengths and coping 
mechanisms of the examined individual and the possibilities to support 
functioning (Tuisku et al. 2012). The data on functioning and disability are a 
crucial basis for all effective decision-making among health care providers. 
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Assessment tools. Assessment instruments and concepts provide a 
structure for collecting and evaluating data on functioning and disability. 
Therefore, various guides and recommendations exist for courses of action 
targeted at harmonizing and developing assessment strategies and for 
choosing the correct instruments for different contexts and goals. Assessment 
methods can sometimes require a wide-ranging scope, and different 
instruments for data collection. The data may have to be gathered from an 
array of simultaneous and non-simultaneous measures and observations, such 
as the individual’s own reports (reflecting subjective needs and experiences), 
health care providers’ (objective) measures and observations, network 
collaboration and individuals’ performance in practical situations such as trial 
work periods. Information across time also provides information on the course 
of functioning and disability. Comparing the data on functioning and 
disability, identifying possible disparities (e.g. between subjective and 
objective evaluations, or different functions) and determining the root causes 
of discrepancies are necessary for deciding on and taking the actions required 
for improvement (Vuokko and Tuisku 2017). 
Self-assessment tools provide an interactive evaluation and possibilities for 
follow-up, discussing one’s personal resources and limitations and for 
promoting work ability (Vuokko and Tuisku 2017). There are a range of 
different kinds of instruments. Typically, these instruments are allocated 
according to the specific purpose of use. Many focus on screening for diseases 
and/or symptom expression, such as screening scales of depression and 
anxiety symptoms. These screening instruments can indirectly (e.g. through 
severity of symptoms) provide information on disability. An item of 
functioning and disability can also be included in the instrument. For example, 
the depression scale of the Patient Health Questionnaire (PHQ-9) includes a 
single item that measures the severity of disability at work, home or in social 
duties (Kroenke et al. 2001).  
Another example of a functional self-assessment tool is the Sheehan 
Disability Scale (SDS), which elicits functional impairments and takes into 
account the three sub-domains of work, social life and home (Sheehan et al. 
1996). SDS is widely used in psychiatry, but also with other chronic illnesses 
such as FSS and IEI (Rief et al. 2017; Tran et al. 2013b). Some generic 
instruments also include different kinds of interviews and questionnaires for 
gathering information. For example, the generic assessment instrument based 
on the conceptual framework of ICF, WHO’s Disability Assessment Schedule 
version 2.0, has been launched for scoring disability associated with all 
physical and mental disorders, in both clinical and general population settings 
(Üstün et al. 2010). This instrument includes different methods for data 
collection and explores disability in the following domains: cognition, 
mobility, self-care, coping, life activities, and participation (Üstün et al. 2010).  
Although the work ability (or disability) aspect can be included in the above 
tools, some specific work-related questions and aspects aim to detect 
deterioration in work ability as early as possible in order to prevent work 
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disability. The subjective perception of work ability is a prognostic factor that 
predicts return to work and the course of work ability (Blank et al. 2008; 
Cornelius et al. 2011; Gould et al. 2008). Perceived work ability reflects many 
different dimensions of individual and environmental factors, as well as 
biopsychosocial approaches (Gould et al. 2008). The Work Ability Index 
(WAI) questionnaire combines several dimensions of work ability (current 
work ability, demands of the job, physician-diagnosed diseases, work 
impairments due to diseases, sick leave during the past year, own prognosis of 
work ability, mental resources) (Tuomi et al. 1998). The WAI contains two 
independent questions that predict the course of work ability: the individual’s 
own evaluation of current work ability (work ability score, WAS) and their own 
prognosis of work ability in two years’ time (Tuomi et al. 1998).  
Absenteeism at work is also a prognostic factor and refers to a possible 
imbalance between an employee’s resources and their work demands. Work 
absence (or sickness absence) can be measured by, for example, asking the 
individual how much time and/or how many sporadic periods they have 
missed from work because of ill health (Martimo 2010). The dimensions of 
self-efficacy, readiness for return to work, and sense of coherence and job 
strain have been associated with work disability and return-to-work outcomes 
(Jackson et al. 2014; Lagerveld et al. 2010; Loisel et al. 2005; Rashid et al. 
2018; Volker et al. 2015). For example, in chronic musculoskeletal disorders, 
higher self-efficacy levels are associated with greater physical functioning, 
participation in physical activity, health status, work status, satisfaction with 
performance, efficacy beliefs, and lower levels of pain intensity, disability, 
disease activity, depressive symptoms, presence of tender points, fatigue and 
presenteeism (productivity loss at work) (Martinez-Calderon et al. 2017).  
Individuals’ QOL has been used to describe the function and well-being of 
populations with medical conditions and to evaluate the effectiveness of 
treatment interventions (Heinonen et al. 2004). The term health-related QOL 
is often used. The roots of this term for health research lie in WHO’s definition 
of ‘health’ in 1948 (described above): the ‘well-being’ in this definition is 
probably the main factor in the conceptualization of QOL (Post 2014). 
Therefore, many QOL scales include at least the physical, emotional and social 
dimensions of health (Post 2014). To measure QOL, both specific instruments 
(e.g. group of patients, particular function, or disease) and generic 
instruments (can be used for comparing the health status of patients with 
different conditions) are used (Karvala 2012). Among the commonly used 
validated generic instruments for health-related QOL are, for example, the 
Quality of Life Survey (RAND)-Inventory (Hays et al. 1993), and the 15D scale 
instrument (Sintonen 1994, 2001). 
Illness perceptions (or experiences), include a range of individual, 
contextual and cultural factors, which influence outcomes such as emotional 
and cognitive response, recovery and disability, and coping strategies (Arat et 
al. 2018). Open-ended questions and different questionnaires are useful for 
gathering information on illness perceptions (e.g. concerns, consequences, 
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personal control, beliefs in ability or effect of treatment), but drawings can also 
be used to uncover how patients feel about their illness and identify 
idiosyncratic beliefs or misconceptions about the illness when determining 
future management methods (Petrie and Weinman 2012). 
Objective assessment tools can quantify individuals’ functioning and 
disability, their relation to health and diagnoses and monitor diseases. An 
example of a tool that is based on health care providers’ clinical interviews is 
the Social and Occupational Functioning Assessment Scale (SOFAS), which is 
used to quantify the severity of disability in social and occupational 
functioning (Goldman et al. 1992). Structured clinical interviews, as a basis for 
psychiatric diagnostics, contain aspects of suffering and disability (e.g. 
cognitive impairments, limitations to activities, restrictions to participation). 
Physiological measurements are an example of objective investigations of 
body functions and structures, such as flow-volume spirometry for measuring 
respiratory function. In some situations, assessment may require a 
comprehensive approach with objective observations from the functional 
environment and they may be best realized multi-professionally, through 
collaboration in a network (Tuisku et al. 2012). 
2.5.2 WORK DISABILITY PREVENTION 
Work disability intervention approaches have typically been reviewed in terms 
of primary, secondary and tertiary prevention. Primary prevention aims to 
prevent the onset of disability, secondary prevention aims to prevent 
progression from an acute condition to chronic disability habituation, and 
tertiary prevention aims to prevent the development of further disability in 
someone whose condition has evolved into a chronic state of disability 
(Gatchel 2004; Sullivan et al. 2005). Similarly, secondary work disability 
prevention refers to interventions that aim to enable the return to work as 
quickly as possible. Tertiary prevention attempts to avoid the consequences 
arising from workers developing progressive disability (Gatchel 2004; 
Sullivan et al. 2005). 
The major exploration of work disability prevention targets 
musculoskeletal disorders, namely low-back pain, perhaps because this is the 
most common reason for long-term absence and work disability in working 
populations worldwide (Hartvigsen et al. 2018; Loisel et al. 2005). The 
scientific knowledge regarding musculoskeletal disorders offers perspectives 
for the prevention of work disability, and most likely includes sections that can 
be generalized across similar conditions.  
Research on musculoskeletal disorders has shown substantial evidence of 
the various determinants of work disability prevention (Figure 5). These 
determinants can be linked not only to the patients’ personal characteristics 
(physical and psychosocial), but also to those of many stakeholders, such as 
the workplace, health care providers, compensation system, and local culture 
and society (Loisel et al. 2001, 2005). Therefore, the prevention of work 
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disability can involve a number of cooperation challenges in the multi-player 
decision-making system. In addition, most barriers to and facilitators of 
recovery and work ability have related more to psychosocial, workplace and 
management issues than to the emerging disease or disorder. The main point 




Figure 5  Work disability prevention arena (figure adapted and modified from Loisel et al. 2001). 
Biopsychosocial models have outlined possible psychosocial risk factors 
and behavioral, cognitive and emotional mechanisms to explain why some 
individuals experience more disability than others. In this context, findings 
have emphasized the importance of shifting the goals of intervention strategies 
in cases of chronic pain, and to aim to change beliefs and behaviors, typically 
focusing on risk factors such as pain catastrophizing, beliefs and expectancies 
(Hartvigsen et al. 2018; Sullivan et al. 2005). Individuals’ perceptions and 
expectations of personal and environmental issues may influence the decision 
to return to work. Psychological distress and fear, as intermediate factors, have 
explained some of the pathways to disability (Lee et al. 2015). The 
biopsychosocial framework of disability management and prevention 
encourages a collaborative approach involving early diagnostic triage and 
knowledge of evidence-based treatment and occupational interventions, the 
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identification of potential psychosocial and environmental barriers and 
impediments, and employee education and reassurance of health condition 
and self-care. It also supports activity with self-limiting barriers (Foster et al. 
2018; Loisel et al. 2005). Based on the principles of the biopsychosocial model, 
the individual is the active participant, and others serve only to facilitate the 
rehabilitation process (Schultz et al. 2000). 
The biopsychosocial approach has been modified in many different ways 
and applied as a framework to understand and treat the complexities of many 
health problems involving disability in preference to a purely biomedical 
(disease-based) approach (Henningsen et al. 2007, 2018; Rief and Broadbent 
2007; Schultz et al. 2007; Sullivan et al. 2005). In general, the biopsychosocial 
approach demands a conceptual shift from the linear way of thinking of the 
biomedical basis to an open system perspective (Martimo 2010), in which 
human health can be seen as a continuum rather than a dichotomy between 
the presence or absence of disease (Spurgeon 2002). 
Indoor air-related ill health lacks effective management and practical 
guidelines for work disability prevention (see Section 2.4). Despite the lack of 
intervention studies based on the biopsychosocial approach aiming to prevent 
work disability in indoor air-related ill health, similar approaches to those for 
other analogous disabling conditions can most likely be used to aid and 
support these individuals. Evidence of the role of CNS mechanisms in the 
development and maintenance of adverse health effects and disability is 
increasing in terms of many similar conditions (see Section 2.3.7). Cognitive 
behavioral approaches are typically used in the management of psychosocial 
risk factors for work disability, and intervene with individuals’ interpretation, 
evaluation and beliefs regarding illness and repertoire for coping with 
symptoms and disability (Sullivan et al. 2005). The term cognitive-behavioral 
does not refer to a specific intervention, but to a wide variety of intervention 
strategies that might include self-instruction (e.g., motivational self-talk), 
relaxation or biofeedback techniques, developing coping strategies (e.g., 
distraction, imagery), increasing assertiveness, interpersonal communication 
strategies, minimizing negative or self-defeating thoughts, changing 
maladaptive beliefs about symptoms and goal setting (Sullivan et al. 2005). In 
the active behavioral component, which is an essential part of CBT, one focus 
has been on changing and increasing the awareness of one’s own body 
sensations, behaviors/strategies and cognitions. In RCT interventions 
involving patients with FSS and CBT, including patient education, activity 
regulation strategies, and illness attribution replacement from monocausal or 
catastrophizing to more adaptive strategies, has shown to be effective. This 
also applies to patients suffering from disability in general (Allen et al. 2006; 
Deary et al. 2007; Escobar et al. 2007; Henningsen et al. 2018; Kleinstäuber 
et al. 2011; Speckens et al. 1995). 
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3 AIMS OF THE STUDY 
The data on the clinical description of and practices for indoor air-related 
disability and its prevalence are limited. The main aim of this thesis was to 
characterize indoor air-related disability and to develop interventions.  
 
This thesis consists of four studies. The aim of each study is followed by a 
rationale that includes the study background. 
 
1. To evaluate whether clinical intervention including counseling 
aimed at symptom management, has an impact on the QOL and 
work ability of patients with indoor air-related symptoms and 
work disability. In addition, to clinically evaluate and 
characterize these patients (Study I). 
 
Because the biopsychosocial model has shown to be an effective framework 
in work disability prevention, we designed an intervention with a 
multifactorial approach, aiming to improve health and coping, and to 
reduce environment-associated disability. 
 
2. To clinically evaluate the medical etiology of symptoms and 
disability related to indoor air, and to assess whether the 
condition fulfills the criteria of IEI (Study II). 
 
The medical characterization of indoor air-related disability is unclear. We 
studied whether the condition is a form of IEI. The characteristics and the 
mechanisms of the condition are the basis for the development of effective 
interventions. 
 
3. To study if the effectiveness of CBT and psychoeducation can be 
evaluated in the management of persistent indoor air-related 
non-specific symptoms (Study III). 
 
To develop effective interventions, we designed an RCT study with three 
interventions based on the biopsychosocial model. Our ultimate aim was 
to develop an intervention suitable for OHS patients with indoor air-
related disability.  
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4. To assess the prevalence of self-reported EI with different 
manifestations, including behavioral changes and disability 
(Study IV). 
 
The prevalence data on EI are sparse due to the phenomenon’s 
heterogenous nature and definitions. We studied how severe EI, defined in 
several ways, manifests in a Finnish maternity clinic population. 
Knowledge of prevalence is needed to understand the extent of the problem 
and the required actions. 
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4 MATERIALS AND METHODS 
4.1 STUDY POPULATIONS AND DESIGN (STUDIES I–IV) 
In all the individual studies, the participants were working-age adults. The 
clinical study (Studies I-III), participants were active in working life and 
recruited from among patients of the Finnish Institute of Occupational 
Health’s (FIOH) occupational medicine clinic (Studies I, II) or from among 
patients of OHS units (Study III). All the patients had symptoms related to 
indoor air factors in non-industrial workplaces, which had led to work 
disability that interfered with work participation (e.g. inability to work). The 
participants of the survey (Study IV) were pregnant women recruited from the 
ongoing Kuopio Birth Cohort (KuBiCo) in Eastern Finland. Table 4 
summarizes the design and population of the individual studies. 
 
 
Table 4.       Description of included studies. 
Study Study design Population 
I RCT and clinical 
(descriptive) 
characterization  
Workers (n=55) examined at FIOH clinic due to 
suspicion of an occupational disease, with symptoms 
and work disability related to indoor air 
II Clinical (descriptive) 
characterization  
Workers (n=12) referred to FIOH clinic for clinical 
evaluation because of responsiveness to factors in 
workplace indoor air, and a disabling condition that 
interferes with work participation despite adjustments to 
occupational facilities 
III RCT (protocol) Workers (n=60) seeking medical advice from OHSs with 
recurrent medically unexplained multiorgan symptoms, 
including respiratory symptoms and disability attributed 
to indoor work environment 
IV Prevalence survey 
(cross-sectional 
questionnaire study) 
Pregnant women (n=680) from maternity clinic cohort 
in region of Kuopio University Hospital 







Study I. The clinical characterization of 55 patients was conducted in an 
RCT setting. They were recruited between November 2010 and June 2012 
from among consecutive patients (n=194) examined at FIOH’s occupational 
medicine clinic. The patients had been referred from all over Finland by their 
OH physician or pulmonologist due to a suspected occupational respiratory 
disease, mainly asthma. At study intake, all the patients had respiratory 
symptoms attributed to factors in non-industrial workplace indoor air. 
Patients eligible for this study (assessed by a screening questionnaire) fulfilled 
the following inclusion criteria for the disability: i) self-assessed current WAS 
of ≤7 (scale 0–10; 0 represents total work disability, 10 indicates lifetime best 
work ability) (Tuomi et al. 1998) and ii) indoor air-related sick leave of ≥14 
days during the preceding year. A research physician informed the eligible 
patients of the study. The patients were excluded if they did not meet the 
inclusion criteria, were not active in working life (retired or unemployed) 
(n=115) or if they refused (n=24). The main reasons for refusing to participate 
in the study were mainly travel or timetable problems. 
The total number included in the random group assignment was 55. 
Randomization was performed so that the physician allocated every other 
participant into an intervention (INT) group (n=28) or treatment as usual 
(TAU) group (n=27), with an allocation ratio of 1:1. The group assignment was 
not blinded. After randomization, three patients dropped out of the INT group 
and two out of the TAU group. Thus, the total number of patients who received 
INT or TAU was 50. At the six-month follow-up, a total of six patients did not 
return the postal paper-and-pencil questionnaire. Therefore, the six-month 
follow-up analysis was of 44 patients (INT: n=21; TAU: n=23). Participant 
flow throughout the study, including the reasons for dropout, is shown in 
Figure 1 of Article I. 
All participants (n=55) took part in routine clinical examinations at FIOH 
and during the study they received possible concurrent health care in, for 
example, their own OHS units. The contents of the INT sessions and outcome 
measures are described in Section 4.4. The study protocol was registered to 
Single-center RCT (ISRCTN33165676). 
Study II. Study II was based on the clinical characterization of the 12 
patients referred by their OH physician to FIOH’s occupational medicine clinic 
for clinical evaluation. All the patients had increased responsiveness to non-
industrial workplace indoor air. Disability manifested as functional 
restrictions and had interfered with work participation (e.g. inability to work), 
despite improvements to occupational facilities and work adjustments. The 
referring physician had been unable to find a solution to manage the patient’s 
ill health and disability. The referring physician had also eliminated the 
obvious medical reasons for the symptoms. All the recruited patients agreed 
to participate in the study. They were recruited between June 2015 and 
November 2015, and the clinical examinations were finalized in March 2016. 
At study intake, the disabling condition suggested features of EI. Figure 6 
illustrates the study design. 




Figure 6 Description of study design and clinical examinations in Study II. 
During the clinical examinations, of the 12 patients, two withdrew from 
part of the study (one because of symptoms while at the clinic facilities, the 
other because of timetable scheduling problems and feeling dissatisfied with 
the study). Thus, the number of participants in the examination of the 
sympathetic response was ten, and the psychiatrist clinically evaluated eleven 
patients.  
Study III. The RCT was carried out by FIOH in collaboration with five 
large OHS units. The protocol of the study aimed to compare the effectiveness 
of two psychosocial treatments and TAU for persistent indoor air-related 
symptoms with work disability, among OHS unit patients. The feasibility of 
the study design was conferred and customized with proposals from two 
participating OHS units. Prior to study enrollment, one OHS unit also tested 
Patients referred to occupational medicine clinic 
 
All included 12 patients had 
responsiveness to factors in workplace indoor air, 
which had interfered with work participation, 
despite adjustments to occupational facilities 
Questionnaires completed prior to session 
 
Clinical session by a specialist in occupational medicine 
Clinical sessions (1–2) by a psychologist 
Clinical investigations of allergy and  
inflammation, respiratory function, and  
sympathetic response 
Additional visual expression interview 
Clinical session by a psychiatrist 
Clinical session by a pulmonologist 
Conclusions regarding individual treatment  
and rehabilitation plan by  
a multidisciplinary team 





the inclusion/exclusion criteria. The five OHS units (including three public 
and two private enterprises in the district of Helsinki and Uusimaa, Finland) 
joined the study consecutively: two units in January 2014, one in June 2014, 
one in August 2014 and one in March 2015. As this study, Study III, was 
ongoing, without follow-up results, this thesis only describes its protocol. 
The participants were recruited from (OHS) practices and an OH 
physician, assisted by an OH nurse, assessed their eligibility. Participants aged 
25 to 58 were recruited from among attendees of medical consultations at 
OHSs for indoor air-related symptoms and disability. The inclusion criteria 
were modified from WHO’s IEI criteria (IPCS/WHO 1996) and that of Lacour 
et al. (2005). The main inclusion criterion was the presence of indoor air-
related recurrent symptoms in ≥2 organ systems (including respiratory 
symptoms and symptoms in at least one of the following other symptom 
groups: dermal, musculoskeletal, neurological, cardiac, gastrointestinal, or 
general symptoms) and disability, with no obvious medical or exposure-
related explanation or factors that could affect the outcome of the intervention. 
The duration from the onset of the disabling symptom was limited to a 
maximum of three years. 
Before enrolling the participants, the recruiters from the OHS units 
participated in a 1–1.5-hour training session given by the researchers. The 
recruiters received a recruitment manual that included a description of the 
study proceedings, inclusion/exclusion criteria, patient information, informed 
consent, a questionnaire on indoor air pollutants and arrangements at the 
workplace, and prepaid envelopes for returning the enrolment documents, as 
well as a non-identifiable form to collect the reasons for refusal if inclusion 
criteria were met but the patient refused to participate. In order to aid and 
maintain the recruitment process during enrolment, information letters were 
available for the OHS units to inform workers and employers of the study 
collaboration. The researchers were also frequently in contact with the 
recruiters. 
The patients who were enrolled at FIOH prefilled a questionnaire and 
underwent a respiratory evaluation to distinguish asthma symptoms from 
functional respiratory symptoms. The examinations included a two-week 
diurnal measurement of peak expiratory flow (PEF) and bronchial 
hyperresponsiveness. A respiratory physician evaluated the respiratory 
findings and the participants received an individual report. Participants with 
uncontrolled asthma, or any other revealed exclusion criteria, were excluded 
before the random assignment. 
Randomization into the two INT and TAU groups was preprogrammed by 
the two researchers, using a numerical list of the tree arms. The allocation was 
grouped to contain participants from different OHS units, workplaces and of 
different genders with an allocation ratio of 1:1:1. After the clinical 
examinations, the researchers allocated the eligible participants into an 
individual CBT condition, psychoeducation or control (TAU) condition, which 
was next in order of listing after stratification. During the study, all the 
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participants received appropriate medical advice and treatment (determined 
as TAU) based on individual needs from their OHSs. The original study plan 
included four arms. The arm of applied relaxation group therapy that required 
group formation was excluded from the protocol due to recruitment process 
difficulties in ensuring completion of the study. Thus, based on the power 
calculations (for more detail, see Article III, page 6: Sample size), the initial 
target of 80 participants decreased to a total of 60.  
The participants answered web-based questionnaires through a secure 
internet connection prior to their examinations at FIOH, at baseline and at 
follow-up at 3, 6 and 12 months. The confidentiality of the participants is 
protected by an encryption key for personal details in the data. Participants 
were also asked to consent to the use of their medical records for evaluating 
TAU during the study. Figure 2 of Article III shows the participant flow, data 
collection and intervention program timeline. The contents of the intervention 
programs and the outcome measures are described in Section 4.4. The study 
protocol is registered in the ClinicalTrials.gov registry (NCT02069002). 
Study IV. The basis of the survey was that of the ongoing KuBiCo Study. 
The participants comprised pregnant women from the maternity clinics that 
serve all women who give birth at Kuopio University Hospital, which is the 
main maternity hospital in Eastern Finland, with about 2000–2500 deliveries 
annually. In Finland, in practice all pregnant women regardless of their 
socioeconomic status attend municipal maternity clinics that provide 
guidance in all matters related to pregnancy. Study recruitment was carried 
out via a web-based platform, which was used by more than two thirds of 
pregnant women in the region. At any stage of their pregnancy, these women 
are able to access the KuBiCo prospective data collection by signing their 
electronic informed consent. 
An electronic questionnaire (described in Section 4.3) on EI and its 
different manifestations was offered in the first trimester to all Finnish-
speaking pregnant women who participated in the KuBiCo during between 
July 2012 and February 2014. Altogether 680 women participated in this EI 
study. An exact participation rate cannot be given. Based on 2500 annual 
deliveries and taking in account the fact that the questionnaire was available 
to two thirds of the maternity clinic clients, approximately 27% of which were 
recruited for this study.  
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4.2 CLINICAL CHARACTERIZATION (STUDIES I–III) 
4.2.1 INDOOR AIR POLLUTANTS AT WORKPLACE (STUDIES I–II) 
Study I. The assessment of past and present exposure was based on objective 
measurements and investigations of the patient’s work environments, 
performed by the workplace. Detailed reports of working conditions and data 
on workplace investigations were collected by requesting them from the 
patients’ employers. The reports included technical inspections and quality 
measurements of the indoor air around the patients’ work environments. 
Physicians from FIOH also clinically interviewed the patients on their working 
conditions and exposures (and on indoor air pollutants in the home 
environment). For each patient, the indoor air microbial exposure level was 
classified into three categories (low, intermediate, high) based on the available 
data on microbiological measurement (Karvala et al. 2010). 
Study II. Data on deficiencies in indoor air quality and pollutants at the 
workplace (and at home), including adjustments made to work environments, 
were based on self-reports through questionnaires, structured clinical 
interviews, and data from the referring OHS physician. 
4.2.2 QUESTIONNAIRE INSTRUMENTS (STUDIES I–III) 
Table 5 summarizes the self-report questionnaires and domains used in 
Studies I–III. The questionnaires were filled in at baseline and at six-month 
follow-up (Study I), during the clinical evaluation (Study II), or at baseline and 
at 3-, 6-, and 12-month follow-ups (Study III). The questionnaires were in 
paper-and-pencil form (Studies I and II), or participants replied to web-based 
questionnaires via a secure internet connection (Study III). 
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I II III 
Work ability, occupational and psychosocial functioning 
   Current work ability, Work Ability Score (WAS) (Tuomi et al. 1998) x x x 
   Own prognosis of work ability two years from now (Tuomi et al. 1998) . x x 
   Sheehan Disability Scale (SDS) (Sheehan et al. 1996) . x . 
   Return-to-Work Readiness questionnaire (RTW-RQ)a (Tuisku et al. 2015) . x . 
   Return-to-Work Self Efficacy (RTW-SE)a (Tuisku et al. 2015; 
Lagerveld et al. 2010) 
. x . 
   Job strainb (Karasek et al. 1998; 
Theorell 1990) 
. x x 
   Sense of Coherence (SOC-13) (Antonovsky 1987) . x x 
   Need for Recovery (NRF) (Sluiter 1999) . . x 
Quality of life 
   Quality of Life Survey (RAND-36)-Inventory (Aalto et al. 1999;  
Hays et al. 1993) 
x . . 
   15D instrument (Sintonen 1994, 2001) . . x 
Respiratory functioning 
   Asthma Control Test (ACT)c (Nathan et al. 2004) x x x 
   Nijmegen (Van Dixhoorn and 
Duivenvoorden 1985) 
. x . 
Cognitive and emotional symptoms, and personality 
   Generalized Anxiety Disorder 7-item Scale (GAD-7) (Spitzer et al. 2006) . x x 
   Beck Anxiety Inventory (BAI) (Beck et al. 1988) . x . 
   Overall Anxiety Severity and Impairment Scale 
      (OASIS) 
(Campbell-Sills et al. 
2009) 
. x . 
   Patient Health Questionnaire (PHQ-9) (Kroenke et al. 2001; 
Kaila et al. 2012) 
. x . 
   Beck Depression Inventory (BDI) (Beck et al. 1961, 
1979) 
. x x 
   Insomnia Severity Index (ISI) (Morin 1993;  
Morin et al. 2011) 
. x x 
   Shirom-Melamed Burnout Measure (SMBM)b (Shirom and Melamed 
2006) 
. x . 
   Illness Worry Scale (IWS) (Robbins and 
Kirmayer 1996; 
Laakso et al. 2005) 
x . x 
   Acceptance and Action Questionnaire-II (AAQ-II) (Bond et al. 2011;  
Hayes et al. 2004) 
. x x 
   Penn State Worry Questionnaire (PSWQ) (Meyer et al. 1990) . x x 
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   Symptom Checklist-90 (SCL-90) somatization scale (Derogatis et al. 1973; 
Holi 2003) 
. x x 
   Toronto Alexithymia Scale (TAS-20) (Bagby et al. 1994; 
Taylor et al. 1988) 
. x . 
   Dissociative Experience Scale (DES) (Bernstein and 
Putnam 1986) 
. x . 
   Strategy and Attribution Questionnaire (SAQ) (Nurmi et al. 1995) . x x 
   Revised Paranormal Belief Scale (Toba) (Tobacyk 2004) . x . 
   Short Five (S5) personality inventory (Lönnqvist et al. 
2008) 
. x . 
   Intervention of Interpersonal Problems (IIP) (Horowitz et al. 2000) . . x 
   Social Readjustment Rating Scale (SRRS) (Holmes and Rahe 
1967) 
. x x 
Assessment of treatment alliance and satisfaction 
   Working Alliance Inventory (Horvath and 
Greenberg 1989) 
. . x 
   Treatment satisfaction (Seligman 1995) . . x 
Indoor air-related symptoms 
   Work environment-related symptoms (Andersson 1998; 
Reijula and Sundman-
Digert 2004) 
x x x 
   Symptom disturbance  x . . 
Environmental intolerances and concerns 
   Quick Environmental Exposure and Sensitivity 
      Inventory (QEESI) 
(Miller and Prihoda 
1999) 
. x x 
   Intolerance to indoor air molds  . x x 
   Intolerance to electromagnetic fields  . x x 
   Environmental-related health concerns  . x x 
Other characteristics 
   Prolonged multi-site pain     . x . 
   Alcohol Use Disorders Identification Test (AUDIT) (Saunders et al. 1993) . x x 
. = Not applicable.  
a Those who were not working. 
b Those who were working.  
c Those who had asthma. The Finnish version of the ACT. The ACT is a trademark of Quality Metric 
Incorporated 2002 GlaxoSmithKline. 
 
 
Work ability and occupational and psychosocial functioning. As 
an indicator of work ability, in WAS, individuals assessed their current work 
ability on a scale of 0 (total work disability) to 10 (work ability at its best). They 
also gave their own prognosis of their work ability two years from now using 
the options ‘fairly sure’, ‘not sure’, or ‘hardly’. These two items were taken from 
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the validated WAI which measures self-assessed work ability (Tuomi et al. 
1998). 
The SDS, self-reported functional measures, rated functional impairments 
in three sub-domains (work, social life, home), each on a scale of 0 to 10 
(higher scores indicating higher disability): 0 (no disability or impairment at 
all), 1–3 (mild), 4–6 (moderate), 7–9 (marked), 10 (extreme disability) 
(Sheehan et al. 1996). The SDS Total was the mean of the three subscales. 
Quality of life (QOL). Health-related QOL was measured using the 36-
item Quality of Life Survey Inventory (RAND-36) and its physical (RAND-
PCS) and mental component summary (RAND-MCS) scores (0–100) (Hays et 
al. 1993), Finnish version (Aalto et al. 1999).  
Another QOL measure, the 15-dimensional standardized 15D scale 
instrument, is composed of physical, mental and social well-being (Sintonen 
1994, 2001). In the 15D scale, each dimension has five grades of severity from 
1 (highest/best level) to 5 (lowest/worst level). The 15D is presented as a single 
sum score measure from 1 (full health) to 0 (dead), as well as a profile of each 
dimension. 
Respiratory functioning. For the asthma patients, the Asthma Control 
Test (ACT) defined the current self-assessed asthma control (Nathan et al. 
2004). ACT assesses the elements of asthma control over the previous four 
weeks, including asthma symptoms, everyday functioning, use of rescue 
medications, and night time awakenings. The ACT scale ranges from 0 to 25: 
‘controlled’ (≥20 points), ‘not well-controlled’ (16–19 points), and 
‘uncontrolled’ (≤15 points). 
Anxiety. For self-rated anxiety symptoms and the identification of clinical 
anxiety, three screening instruments were utilized: the Generalized Anxiety 
Disorder 7-item Scale (GAD-7) (Spitzer et al. 2006), the Beck Anxiety 
Inventory (BAI) (Beck et al. 1988), and the Overall Anxiety Severity and 
Impairment Scale (OASIS) (Campbell-Sills et al. 2009). A total sum score of a 
GAD-7 range between 0 and 21, and values of ≥10 indicates moderate or severe 
anxiety. The BAI included 21 items with a sum score of 0–63, and values of 
≥16 show moderate or severe anxiety. In the five-item OASIS (sum score 0–
20), values of ≥8 show high relevance of clinical anxiety. 
Depression. For symptoms of depression, the two widely used tools 
PHQ-9 (Kroenke et al. 2001), in Finnish (Kaila et al. 2012) and the Beck 
Depression Inventory (BDI) (Beck et al. 1961, 1979) were used. PHQ-9 has a 
sum score of 0–27 and values of 10–14 indicate moderate depression, and in 
the 21-item BDI (sum score 0–63), values of 14–19 indicate mild depression 
symptoms. 
Insomnia. The Insomnia Severity Index (ISI) was used to assess the 
severity of insomnia-related symptoms with seven questions (sum score 0–
28) (Morin et al. 2011). The responses were scored as subthreshold insomnia 




Burnout. In order to evaluate burnout symptoms, the Shirom-Melamed 
Burnout Measure (SMBM) recognized work-related burnout in facets of 
physical, cognitive, and emotional functioning (Shirom and Melamed 2006). 
The SMBM includes 14 items, each on a scale of 1 to 7: 1 (never or almost 
never), 2 (very infrequently), 3 (quite infrequently), 4 (sometimes), 5 (quite 
frequently), 6 (very frequently), 7 (always or almost always). The SMBM total 
(1–7) was the mean of the 14 items and was divided into mild, moderate, or 
severe burnout. 
Illness worries. The assessment of illness attributions and worry about 
being ill was performed using a nine-item Illness Worry Scale (IWS) (Laakso 
et al. 2005; Robbins and Kirmayer 1996). The response options for each item 
are ‘yes’ or ‘no’, and the IWS sum score (0–9) was calculated on the basis of 
the ‘yes’ answers. 
Somatization. Of the Symptom Checklist-90 (SCL-90) symptom 
inventory subscales, the 12-item somatization subscale reflects physical 
illness, focusing on cardiovascular, gastrointestinal, respiratory and other 
systems with autonomic mediation (Derogatis et al. 1973; Holi 2003). The 
mean (score 0–4) of the 12 items was calculated, each item on a five-point scale 
from 0 (not at all) to 4 (extremely). 
Indoor air-related symptoms. The current work environment-related 
symptoms were elicited using two items from FIOH’s Indoor Air 
Questionnaire (Reijula and Sundman-Digert 2004), which is based on the 
Örebro questionnaire (Andersson 1998). The questions were: 1) ‘Have you had 
any of the following symptoms or discomforts during the last three months?’ 
with response options ‘yes, every week’, ‘yes, sometimes’, or ‘never’ for each 
symptom; and 2) ‘If you answered ‘yes’, do you think that the symptoms are 
explained by your work environment’ (‘yes’, ‘no’ or ‘I don’t know’). Only 
weekly or more frequently occurring symptoms and those caused by the work 
environment were taken into consideration. In Study I, the included 
symptoms were divided into five categories representing different organ 
systems: 1) respiratory and eye symptoms (‘dyspnea’, ‘cough’, ‘cough 
disturbing sleep’, ‘wheezing of breath’, ‘hoarse or dry throat’, ‘irritated, stuffy 
and runny nose’, ‘irritation of the eyes’), 2) dermal symptoms (‘dry or flushed 
facial skin’, ‘dry, itching or red hands skin’), 3) neurological symptoms 
(‘headache’, ‘heavy head’, ‘difficulties in concentrating’), 4) general symptoms 
(‘fatigue’, ‘fever or chills’), and 5) musculoskeletal symptoms (‘arthralgia or 
rigidness’, ‘muscular and joint pain’). 
The symptom disturbance index (scale 0–30) was based on self-named (up 
to three) indoor air-related current symptoms, with a self-rated severity of how 
much each symptom bothered the patient on a scale of 0 (not at all) to 10 (very 
much). 
Environmental intolerances. Of the chemical intolerance screening 
instruments, the Quick Environmental Exposure and Sensitivity Inventory 
(QEESI), the Chemical Intolerance (CI) and the Life Impact scales were used 
(Miller and Prihoda 1999). Each scale contains 10 items from 0 to 10 and 
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produces a sum score from 0 to 100. In the CI scale, the response options for 
each item were ‘no problem at all’ (0), ‘moderate symptoms’ (5) and ‘disabling 
symptoms’ (10). A sum score of ≥40 indicated a high probability of intolerance 
to chemicals and a score of ≤20 low probability. Life Impact elicits the adverse 
effects of sensitivities on various life areas, including impact on diet, work 
ability or school attendance, choice of home furnishing, choice of clothing, 
ability to travel or drive, choice of personal care products, ability to be around 
others and enjoy social activities, choice of hobbies or recreation, relationships 
with spouse or family, and ability to perform household chores. The response 
options for each item were ‘not at all’ (0), ‘moderately’ (5) or ‘severely’ (10). In 
Life Impact, values of ≥24 indicate a high score. 
In addition, we measured self-rated intolerance to indoor air molds in 
moisture-damaged buildings and intolerance to EMFs, each on a scale of 0 (no 
problem at all) to 10 (disabling symptoms). 
Environmental-related health concerns. Health concerns regarding 
environmental exposures and indoor air exposures at the workplace were 
elicited on a scale of 0 (no concern at all) to 10 (extreme concern). 
Medical diseases. The participants were asked to report their physician-
diagnosed chronic diseases. Medication was also systematically elicited. 
Prolonged multi-site pain. Chronic multi-site pain was defined using 
three questions: 1) ‘Have you recently experienced aches or pains?’ (‘yes’ or 
‘no’); 2) ‘If yes, where on the body have the pains been?’ with options ‘yes’ or 
‘no’ for each 16 areas of the body (‘head’, ‘neck’, ‘upper back’, ‘shoulder’, 
‘brachium’, ‘forearm’, ‘arm’, ‘wrist’, ‘hand’, ‘lower back’, ‘hip’, ‘thigh’, ‘knee’, 
‘leg’, ‘ankle’, ‘foot’); and 3) ‘Have the pains continued over three months?’ 
(‘yes’ or ‘no’). Only pain over three months and in at least three different areas 
of the body was taken into consideration.  
Sick leave/work absence and physician visits. Studies I–III elicited 
the number of sick leave days, the reasons for work absence, and Studies II–
III the number of physician visits and their reasons during the time period 
under study. 
Workplace interventions. Measures and adjustments made at the 
workplace to solve the indoor problem were elicited, e.g. building repairs, 
other improvements, or relocation of the worker. 
Other background variables. The basic characteristics of variables 
were elicited, including education, professional status, workplace, marital 
status, and smoking and alcohol consumption habits. The level of education 
was classified as basic (only comprehensive school, high school or vocational 
school), mid-level (college or other upper secondary education), and high-level 
(university degree).  
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4.2.3 CLINICAL MEASUREMENTS (STUDIES I–III) 
In Studies I–III, the clinical examinations were carried out at the FIOH clinic.  
Table 6 summarizes the examination methods used in each individual study.   
 
Table 6.        Clinical measurements in Studies I–III.  
 
Investigations 
Study   
I II III 
Allergy and inflammation    
   SPTs to common environmental allergens and molds x x . 
   Serum total IgE x x . 
   Blood eosinophils (EOS) x x . 
Respiratory function    
   Flow-volume spirometry x x x 
   Non-specific bronchial hyperresponsiveness x x x 
   PEF monitoring for two weeks . x x 
   Fractional exhaled nitric oxide (FeNO) . x . 
Sympathetic response    
   Cardiovascular tests . x . 
   Hyperventilation Provocation Test (HVPT) . x . 
   Long-term recording of HRV in beat-to-beat intervals . x . 
   Salivary cortisol . x . 
SPTs, skin prick tests; IgE, immunoglobulin E; PEF, peak expiratory flow; HRV, heart rate variability. 
. = Not applicable. 
 
 
Allergy and inflammation. To assess sensitization, skin prick tests 
(SPTs) were carried out using a panel of common environmental allergens and 
different commercially available mold allergens. The panel of mold allergens 
included Aspergillus fumigatus, Penicillium expansum (ALK, Copenhagen, 
Denmark), Aspergillus mix (fumigatus, nidulans, niger), Cladosporium 
(herbarum, cladosporioides), Alternaria alternata, and Penicillium mix 
(digitatum, expansum, notatum) (Stallergenes SA, Antony, France). 
Sensitization to common environmental allergens was tested using SPTs with 
a panel of birch, alder, timothy, meadow fescue, mugwort, cat, dog, horse, cow 
(only in Study I), dust mites (Dermatophagoides pteronyssinus, 
Dermatophagoides farinae), and molds (Alternaria alternata, Cladosporium 
herbarum) (ALK, Copenhagen, Denmark). SPTs included a histamine 
hydrochloride (10 mg/ml) as a positive control and a diluent control. A wheal 
diameter of ≥3 mm with at least half of the histamine reaction and with no 
Materials and methods 
68 
reaction of (≥2 mm, dermographism) negative control, was considered 
positive. An individual was considered atopic when at least one positive SPT 
to common allergens was positive. 
Serum total IgE was measured using the Phadia UniCAP system (Phadia 
Uppsala, Sweden). Total IgE with values of <110 kU/L were regarded as 
normal. The number of blood eosinophils (EOS) was also calculated. 
Respiratory function. Lung function was measured using flow-volume 
spirometry with a bronchodilation test (Studies I, II) or without a 
bronchodilation test but with a bronchial hyperresponsiveness test (Study III). 
Spirometry was performed using a standard spirometer (Spirostar USB 
Medikro, Kuopio, Finland), in accordance with the American Thoracic 
Society/European Respiratory Society (ATS/ERS) guidelines (Miller et al. 
2005) and the predictive values for the Finnish population (Viljanen 1982). 
The cut-off values for decreased spirometric parameters were for the forced 
vital capacity (FVC) and the forced expiratory volume in one second (FEV1%) 
below 80% of predicted, and for the ratio of FEV1 and FVC below 75% of 
predicted. An increase of at least 12% (and >200 mL) in FEV1% or FVC 
bronchodilator response was regarded as a significant bronchodilator effect 
(GINA 2014, 2018). 
Non-specific bronchial hyperresponsiveness to histamine was tested 
according to the method of Sovijärvi et al. (1993). The provocative dose (PD) 
of inhaled histamine aerosol causing a 15% fall in FEV1 values (PD15) was 
measured. Hyperresponsiveness was classified as severe (PD15 ≤0.10 mg), 
moderate (PD15 0.11–0.40 mg), mild (PD15 0.41–1.60 mg) or none (PD15 
>1.60 mg). 
In two-week diurnal PEF monitoring, an average daily variability of >10% 
was considered excessive diurnal variability (GINA 2014, 2018). In addition, 
at least three positive bronchodilator responses (≥15% and 60 L) was 
considered a significant bronchodilator effect (Asthma: Current Care 
Guidelines Abstract 2012; Quanjer et al. 1997). 
Fractional exhaled nitric oxide (FeNO) was examined using an online 
chemiluminescence analyzer (NIOX, Aerocrine AB, Solna, Sweden) in 
accordance with the ATS/ESR recommendations (ATS/ERS 2005). FeNO was 
classified as low (<25 ppb), mildly increased (25–50 ppb) or highly increased 
(>50 ppb) (Dweik et al. 2011). 
Sympathetic response. Assessment of the autonomic nervous system 
(ANS) function was included in the evaluation of physiological stress and 
recovery processes in both laboratory and real-life settings. In laboratory 
testing, the hyperventilation provocation test (HVPT) (Vansteenkiste et al. 
1991) and cardiovascular tests assessed the individual reactivity of ANS and 
excluded organic disturbances in autonomic regulation. HVPT was used to 
evaluate a possible hyperventilation syndrome. The cardiac reactivity tests 
included controlled and uncontrolled breathing, slow deep breathing, the 
active orthostatic test and the sustained hand grip test (Laitinen et al. 2004; 
Piha and Seppänen 1991). Continuous electrocardiogram and peripheral blood 
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pressure were analyzed using special software for ANS metrics (WinCPRS, 
Absolute Aliens, Turku, Finland). The main indicator of sympathovagal 
balance in the short-term provocation tests was the ratio of low-frequency 
power to high-frequency power (LF/HF ration) in heart rate variability (HRV) 
at rest. A ratio of >2.8 was considered to indicate increased sympathetic 
dominance (Nunan et al. 2010). 
In real life settings, stress and recovery balance was determined from 
recordings of R–R intervals and analyses of HRV over three days (Föhr et al. 
2015), performed by a Firstbeat Bodyguard measurement device (Firstbeat 
Technologies Ltd, Jyväskylä, Finland). The analyses used the recovery 
percentage during a sleep period (from self-reported bedtime to awakening 
time). A recovery time of under 60% during sleep was used as an indicator of 
delayed recovery. This was based on findings that the mean of recovery time 
during sleep of the Finnish population (n=20 000, including 51 000 
measurement days), using HRV analysis, is 60% (Firstbeat Technologies Ltd 
2014). 
As an indicator of the hypothalamic-pituitary-adrenal (HPA) axis, salivary 
cortisol samples were taken three times a day over a two-day period: 
Immediately after awakening, 30 minutes after awakening, and in the evening. 
Salivary cortisol was analyzed using chemiluminescence immunoassay 
analytics (LIA, IBL Hamburg, Germany). The non-anxious population has 
reported a range of 3.3–6.1 nmol/L in salivary evening cortisol levels using 
competitive electrochemiluminescence immunoassay analytics (Vreeburg et 
al. 2010). The study reported the evening analysis, and levels of >6.1 nmol/L 
were considered as deviating from the non-distressed population. 
4.2.4 MEDICAL ASSESSMENTS (STUDIES I–II) 
The clinical evaluation (Studies I, II) was based on structured clinical 
interviews and questionnaires, clinical examinations, previous medical 
records, and data on IAQ deficiencies in work environments. 
Study I. The assessment included clinical evaluations by a specialist in 
occupational medicine and a pulmonologist, who focused on environment-
related asthma and working conditions and work-related exposures. In 
addition to somatic status, other health conditions were also determined. 
During the INT sessions, the psychologist recorded concerns and fears 
regarding the participants’ present health condition. 
Study II. The evaluation included systematic multidisciplinary 
evaluations by a specialist in occupational medicine, a pulmonologist, a 
psychiatrist and a psychologist. As the participants completed questionnaires 
prior to the clinical sessions, self-assessments could be utilized in the clinical 
evaluations.  
Somatic evaluation used a structured interview material and timeline sheet 
eliciting patients’ health conditions and diseases, symptom profiles and 
courses of illness, occupational and social functioning, deficiencies in IAQ and 
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prior adjustments at work and in the participants’ social lives. The onset time 
of symptoms extending to the disabling level and involving multiple organ 
systems was determined. Symptoms were grouped into six groups: respiratory 
or mucosal, dermal, CNS, musculoskeletal, cardiac and gastrointestinal 
symptoms. The respiratory evaluation aimed to recognize respiratory diseases 
and assess asthma control among asthma patients. 
The purpose of the psychiatric evaluation was to assess the presence of 
possible psychiatric disorders, and functioning in daily life and well-being, 
using structured interview methods and self-assessed measures. Structured 
Clinical Interview for DSM-IV Disorders (SCID I–II) (First et al. 1997) was 
used for symptom assessment and diagnostic interviews. Yale-Brown’s 
Obsessive Compulsive Scale (Y-BOCS) was used as a severity rating scale for 
obsessive-compulsive symptom dimensions (Moritz et al. 2002), and the 
Montgomery-Åsberg’s Depression Rating Scale (MARDS) as a screening and 
diagnostic tools for depression (Montgomery and Asberg 1979). The 
psychiatrist specified the psychiatric ICD-10 diagnoses after clinical findings 
in the psychological assessments. 
The psychological assessment aimed to clarify the potential predisposing 
and perpetuating factors, including the evaluation of cognitive, social and 
personality functioning.  The evaluation focused on the individuals’ resources 
and coping strategies using structured and validated questionnaires (as 
described in Table 5) and interviews: The Wechsler Adult Intelligence Scale IV 
(WAIS-IV) (Wechsler 2014) and the Wechsler Memory Scale-III (WMS-III) 
(Wechsler 1997). The evaluation included an additional semi-structured visual 
expression interview aiming to specify patients’ perceptions of conditions in 
terms of their own bodies and the environment (Tuisku and Haravuori 2016). 
Based on the physician interview, the SOFAS of the DSM-IV was used to 
rate the severity of disability in social and occupational functioning (Goldman 
et al. 1992). SOFAS has a scale of 1 to 100, with higher scores indicating an 
increasing level of functioning. In the study, SOFAS was presented by tertiles: 
51–70 (moderate or some difficulty), 71–80 (slight impairment), 81–100 
(good or superior functioning). 
4.2.5 CRITERIA OF IDIOPATHIC ENVIRONMENTAL INTOLERANCE 
The criteria that Study II used for IEI were based on 1) WHO’s consensus 
criteria (IPCS/WHO 1996), which cover the acquired condition with multiple 
recurrent symptoms attributed to various environmental factors that are well 
tolerated by most people and which cannot be explained by any somatic or 
psychiatric disorder; and 2) the stricter criteria of Lacour et al. (2005), which 
require symptom duration of ≥6 months with significant life-style or 
functional impairments and symptoms to be present in the CNS with at least 




4.3 MATERNITY CLINIC SURVEY (STUDY IV) 
The questionnaire was designed to assess the increasing severity of intolerance 
attributed to certain environmental factors and associated symptoms, 
behavior changes and disability (Table 7). The respondents were asked to 
apply their evaluations to the time prior to their pregnancy. 
The participants were asked to rate their annoyance with 12 different 
environmental factors on a scale of 0 (not at all) to 3 (very much). Those who 
considered themselves ‘not at all’ sensitive (n=50), were excluded from further 
questions on symptoms, behavioral changes and disability. As neurological 
and cognitive symptoms were regarded as CNS symptoms, the symptoms were 
divided into seven organ systems (Table 7).  
Definitions of EI. Determining the different EI definitions (A–F) helped 
identify the different degrees of EI, which represent increasing severity and 
the strictness of the criteria (Table 8). The definitions only took ratings of 
‘rather much’ or ‘very much’ annoyance (= intolerance) into account. 
Definition E was based on the EI criteria by Lacour et al. (2005).  
EI attributed to chemicals, indoor molds and EMFs. EI attributed 
to chemicals was determined if the respondent reported intolerance to ≥2 (out 
of the six) chemical items in Table 7. EI attributed to indoor molds was defined 
by reported intolerance to ‘indoor molds in moisture-damaged buildings’ and 
EI attributed to EMFs was defined by intolerance to EMFs. 
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Table 7.          Questions used in Study IV to assess environmental intolerance 
 
Items, questions and response optionsa 
Annoyance ‘Are you feeling ill or annoyed by the following types of environmental exposures or 
situations?’  
- Chemicalsb: 1) vehicle exhaust; 2) paint or paint thinner; 3) perfumes, air fresheners or other 
fragrances; 4) new furnishings such as new carpeting, flooring, shower curtain, or the interior of a 
new car; 5) fresh ink on newspapers; and 6) tobacco smoke 
- Indoor molds: indoor molds in moisture-damaged buildings 
- EMFs: electromagnetic fields 
- Other environmental factors: beauty salons or hair salonsc, detergent departments in shopsc, 
moldy odors, and dust 
Sensitivity ‘Are you exceptionally/unusually sensitive to the environmental exposures or situations 
above?’ 
Symptomsb ‘Have you ever had the following symptoms from the environmental exposures or 
situations listed above?’ 
- Neurological symptoms (e.g. headache, numbness, tingling) 
- Cognitive symptoms (e.g. memory deterioration, impaired concentration) 
- Pulmonary symptoms (e.g. dyspnea, coughing, wheezing)  
- Dermal symptoms (e.g. erythema, rash) 
- Muscles or joint pain 
- Gastrointestinal symptoms (e.g. flatulence, stomach ache) 
- Cardiac symptoms (e.g. palpitations) 
- General symptoms (e.g. fever, night sweats, fatigue, weight loss, increase in weight) 
Behavioral changesb ‘Have you made any behavioral changes to avoid the symptoms above?’ 
- Behavior or lifestyle change to minimize exposure 
- Changed interior decorations or furnishings at home 
- Moved to another apartment 
- Changed workplace, resigned from workplace or occupation 
- Taken vitamins, nutritional supplements, or changed diet  
- Eliminated the cause using antifungal agents or chemicals 
- Used protective equipment (e.g. respirator, gauntlet, clothing) 
Disabilityd ‘If you recognize the problems mentioned above, how difficult have these problems made 
it for you to do your work, take care of things at home or get along with other people?’ 
a Response options for each item: annoyance on a scale from 0 (not at all) to 3 (very much); sensitivity 
on a scale of 1 (not at all) to 4 (very much); symptoms ‘yes’ or ‘no’; behavioral changes ‘yes’ or ’no’; and 
disability on a scale of ‘not difficult at all’, ‘somewhat difficult’, ‘very difficult’, and ‘extremely difficult’. 
b Items are based on Black et al. (2000a). 
c Items are based on Kreutzer et al. (1999). 





Table 8. Definitions of environmental intolerance (EI) used in Study IV. 
Definitions of EIa 
A Feeling ill or annoyed (annoyance) by different environmental factors 
B Annoyance with symptoms 
C Annoyance with symptoms from multiple organ systems including the CNS (at 
least one CNS symptom and one non-CNS symptom) 
D Annoyance with multiple organ symptoms including CNS symptoms  
(= definition C) and behavioral changes (at least one behavioral change) 
Eb Annoyance with multiple organ symptoms including CNS symptoms, behavioral 
changes (= definition D) and disability  
Fc Annoyance with multiple organ symptoms including CNS symptoms, behavioral 
changes (= definition D) and severe disability. 
CNS, central nervous system. 
a EI definitions (A–F) overlap: individuals fulfilling the criteria of definition F are also included in 
definitions A–E, individuals with EI definition E are also included in definitions A–D, etc. 
b In definition E, disability included responses of ‘somewhat difficult’, ‘very difficult’ and ‘extremely 
difficult’ in the disability question in Table 7. 
c In definition F, disability responses ‘very difficult’ and ‘extremely difficult’ were combined to represent 
severe disability. 
 
4.4 INTERVENTIONS AND OUTCOMES (STUDIES I, III) 
Intervention in Study I. The aim of the intervention (RCT) was to reduce 
excess concerns and worries related to the indoor work environment, and to 
help the patient find ways in which to cope with symptoms. The INT 
participants received counseling by a specialist in occupational medicine and 
two sessions of counseling by a psychologist. Both the INT and TAU groups 
received ‘treatment as usual’. The physician counseling was one to two weeks 
after the first visit to FIOH, followed by the psychologist sessions, beginning 
on average two weeks later. The time between the two psychological sessions 
varied from three to nine weeks. In addition, all asthma patients received 
structured asthma education from a nurse. All sessions were conducted at 
FIOH. Table 9 summarizes the contents of the counseling sessions.  
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Table 9. Contents of counseling by physician and psychologist. 
Session I (counseling by physician, 45–60 minutes) 
General information about health risks associated with indoor environment  
- Overview of main indoor exposures and their health effects 
- Indoor dampness and mold as risk factors to respiratory health, other health effects not known 
- Spectrum of symptoms  
- Multifactorial background of symptoms (indoor exposures, individual, psychosocial factors) 
- Nature of symptoms (transient; sometimes persistent; may be disabling though not dangerous) 
General information about symptom management 
- Indoor air quality problems should be identified and solved 
- Asthma and other co-existing diseases should be recognized and treated 
- Maintaining normal activity levels is helpful (helps prevent long sickness absences from work)   
- Avoidance behavior may lead to symptom exacerbation 
- Physical exercise and smoking cessation have positive effects 
Listening to and reflecting on the patient’s experiences 
Session II (counseling by psychologist, 120 minutes) 
Interview and discussion concerning illness and how it limits everyday life 
- Identifying personal coping resources at work and during leisure time 
- Importance of health-related cognitions: The main purpose was to demonstrate the effect of 
thoughts on symptoms and behavior and to encourage patients to identify and challenge health-
related dysfunctional beliefs and develop alternative, less restrictive ways of thinking 
Personal Projects Analysis (PPA): Identifying goals at work and in one’s personal life to support 
well-being 
- Structured worksheets for PPA 
Appraising e.g. commitment to well-being goals 
- Identifying strategies of adaptation to illnesses and developing alternative behaviors 
- Naming health-supporting activities for the period before the next session and helping patients 
use them 
- All patients received worksheets to test their thoughts in symptom-provoking situations during 
the second session   
Session III (counseling by psychologist, 120 minutes) 
Evaluation of realization of health-supporting activities named in Session 2 
- Discussion on stress warning signs for which patient may need support and identification of 
personal resources for managing stress 
- Review of symptoms, how they limit everyday life and resources for coping at work and during 
leisure time 
- Continuation of discussion on challenging health-related concerns and developing alternative 
ways of thinking about health 




Study I outcomes. The primary outcome measures in the six-month 
follow-up were self-assessed current work ability and the total number of sick 
leave days and periods in the preceding six months. The secondary outcomes 
were QOL through the RAND-36 inventory tool, and illness worries through 
measurement of IWS. In addition, the symptom disturbance index and self-
assessed asthma control among patients with asthma was assessed using the 
ACT tool. The questionnaires of the outcomes are described in Section 4.2.2. 
Intervention in Study III. The main aim of the RCT including two 
different psychosocial interventions is to improve the QOL and work ability of 
workers with non-specific indoor-related symptomatology. The intervention 
programs (psychoeducation and CBT) have been developed at FIOH on the 
basis of knowledge of the previous RCT Study I and other previously studied 
intervention protocols for multiple similar ill health conditions (e.g. Allen et 
al. 2006; Escobar et al. 2007; Speckens et al. 1995; Woolfolk et al. 2007).  
Tables 10 and 11 show the contents of the two intervention arms. The 
individual psychoeducation session was held by a specialist in occupational 
medicine and a psychologist. The CBT consisted of 11 sessions and the arm was 
delivered by three psychologists who are licensed psychotherapists. Before 
treatment, the psychotherapists attended training sessions to ensure the 
integrity of the treatment and they were supervised during the study. The 
intervention programs were manualized. Depending on the participants’ 
approval, all the sessions were recorded for post hoc reliability to ensure 
intervention integrity.  
Study III outcomes. The primary outcome measure in the follow-up was 
health-related QOL, measured using the 15D instrument. Other information 
was also collected from the patients via questionnaires (i.e. cognitive, 
emotional and social functioning and psychiatric symptoms) as secondary 
outcomes (see Section 4.2.2). 
 
Table 10. Content of psychoeducation session. 
Session (counseling by physician and psychologist, 90 minutes) 
Information and discussion on 1) main indoor exposures, 2) symptoms and health risks 
associated with the indoor environment, and 3) factors that affect individual health 
behavior and symptom management: 
- Factors related to indoor air-associated symptoms: environment, risk communication 
and management of problems, reflection on individual situation 
- Explanation of indoor air-associated symptoms and diseases based on current scientific 
knowledge 
- Physiological consequences of acute and chronic stress 
- Stress management: reduction of physiological arousal through adaptive activities and 
deceleration of vicious circle of emotion-behavior-symptom-cognitions 
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Table 11. Summary of contents of cognitive-behavioral therapy (CBT). 
Sessions Contents 
1 Treatment overview and description of treatment as intervention focusing on 
behavioral training and monitoring. Situation analysis, patient symptoms and 
establishment of rapport. Setting of personal goals for intervention and filling 
in first part of symptom-emotion-cognition-monitoring form 
2–3 Discussion on how stress affects patients’ health and physiological 
consequences of stress. Coping strategies for stress and stress-reduction 
activities. Working with illness worries and symptom-perception interaction 
4–5 Personal strengths and vicious circle of symptom behavior. Patient’s 
dysfunctional health and indoor air-related beliefs e.g. catastrophizing and 
cognitive restructuring 
6–7 Evaluation of goals, discussion of obstacles to completing them. Validation of 
frustration and support of meaningful activities. Patient stress-reducing 
techniques and work-related activities 
8–9 Health-related information and discussion on how to react to contradictory 
information about health-related issues. Increased awareness of emotions and 
how they affect symptom perception 
10 Identifying warning signs that may affect recurrence of symptoms and working 
with patients to plan future actions if symptoms recur 
11 Follow-up and booster session three months after intervention 
 
4.5 STATISTICAL ANALYSES 
In Study I, the data set consisted of both continuous and categorial variables. 
For categorial variables, Fisher’s exact test examined whether the backgrounds 
of the two groups differed. Before handling the continuous variables, the 
normality of the variables was evaluated. Student’s t-test for normality 
distributed variables and Mann-Whitney’s test for non-normality distributed 
variables were applied. When comparing the baseline results to the follow-up 
results, the statistical tests were used for repeated measurements. The level of 
significance was set at p<0.05.  All analyses were carried out using SAS 9.4 
(SAS Institute In., Cary, NC, USA). 
Study II used SPSS Version 25.0 (IBM Corporation, Chicago, Illinois, USA) 
software for descriptive statistical analyses [frequency, mean, median, range, 
and standard deviations (SD)]. 
The plan in Study III is to analyze and report the statistics (frequencies, 
means, median, and SD) of the baseline and follow-up data. Categorical 
outcomes are analyzed using the χ2 test or Fisher’s exact test. When 
appropriate, the t-test and Mann-Whitney U test will be used to compare the 
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baseline and follow-up outcomes of the groups. Analysis of variance or 
covariance will be used for multiple comparisons of the groups, as well as for 
examining changes in the groups. Statistical analyses will be conducted using 
the latest version of IBM-SPSS for Windows (SPSS Illinois, Chicago, Illinois, 
USA) software. 
In Study IV, Kruskal-Wallis test was used to compare the grade of disability 
with the number of organ systems, the number of behavioral changes, and the 
co-occurrence of the three EI, to compare the three types of EI with the 
number of organ systems, and to compare the increasing severity of EI 
(definition A–F) with the co-occurrence of the three EIs. The χ2 test was used 
for the categorical variables. A p-value of <0.05 was considered statistically 
significant. If an individual fulfilled the stricter criteria for EI, they were also 
included in the lower severity EI definitions. For example, an individual 
fulfilling definition F (high intolerance) criteria also fulfilled EI definitions A–
E. An individual was only included in the analyses once. Co-occurrence of EI 
attributed to chemicals, indoor molds, and EMFs were shown by Venn 
diagrams. Proportions expressed as percentages of the sample calculated the 
prevalence values for these three EIs (with or without co-occurrence). 
Statistical analyses were performed using IBM-SPSS Version 24.0 for 
Windows (SPSS Illinois, Chicago, Illinois, USA) software. 
4.6 ETHICS 
All the participants signed an informed consent document. Studies I, II and III 
were approved by the Ethics Committee of the Hospital District of Helsinki 
and Uusimaa, Finland (Study I: approval number 61/13/03/00/2010, dated 
27.4.2010; Study II: approval number 81/13/03/00/15, dated 5.5.2015; and 
Study III: approval number 107/13/03/00/13, dated 17.12.2013 and its change 
in May 2015). Permission to conduct Study II was also granted by the Helsinki 
University Hospital and the FIOH ethical working group. Study IV was 
approved by the Ethics Committee of the Hospital District of Central Finland, 





5.1 CLINICAL CHARACTERISTICS OF PATIENTS WITH 
INDOOR AIR-RELATED DISABILITY (STUDIES I–II) 
Table 12 shows the basic characteristics of the patients in Studies I and II. The 
mean age of the patients in Study I was 46.5 (range 23.6–60.6 years) and in 
Study II, 49.8 (range 38.9–58.5). In both studies, most of the patients were 
female, highly educated and non-smokers. In Study I, the patients’ workplaces 
were schools and kindergartens (36%), offices (33%), hospitals (29%) or 
similar. In Study II, the workplaces were schools and kindergartens (67%), 
offices (17%), a hospital (8%) and a fire station (8%, n=1). 
In Study I, the mean of self-reported absence from work due to indoor air-
related symptoms was 90.8 days (median 60.0 days, SD 82.2) during the 
preceding year. In Study II, the mean absence from work was 88.6 days 
(median 15.5 days, SD 134.6).  
In Study I, Body Mass Index (BMI) was significantly higher (p<0.05) in the 
INT group than in the TAU group (INT vs. TAU; mean 30.1 kg/m2, SD 5.2 vs. 
mean 25.1 kg/m2, SD 4.2). The INT and TAU groups did not differ significantly 
in terms of any other clinical variable (gender, age, family status, education, 
workplace, self-assessed work ability, sick leave days, smoking habits, 
symptom duration, presence of asthma and time from the onset of asthma, 
indicators of atopy, results of spirometry and bronchial hyperresponsiveness, 




Table 12. Basic characteristics of patients in Studies I and II. 
 Study I  
(at baseline) 
Study II 




Female, n (%) 52 (94.5) 11 (91.7) 
Age, years, mean (SD) 46.5 (8.6) 49.8 (6.0) 
Married or cohabitating, n (%) 36 (65.5) 12 (100) 
Education   
   High-level, n (%) 19 (34.5) 6 (50.0) 
   Mid-level, n (%) 27 (49.1) 3 (25.0) 
   Basic, n (%) 9 (16.4) 3 (25.0) 
Non-smoker, n (%) 51 (92.7) 11 (91.7) 
Body mass index, kg/m2, mean (range) 27.9 (18.8–45.5) 26.9 (21.3–36.3) 
Duration of indoor air-related symptoms, years (range) 4.6 (0.6–23.0) 10.5 (2.0–25.0) 
Work absence days during preceding 12 months   
   Due to indoor air-related symptoms, days, mean (range) 90.8 (15–365) 88.6 (0–365) 
   Due to any reason, days, mean (range) . 92.4 (2–365) 
Physician visits during preceding 12 months   
   For indoor air-related symptoms, number, mean (range) . 13.0 (0–36) 
   For any reason, number, mean (range) . 14.8 (2–40) 
. = Not applicable. 
5.1.1 SYMPTOMS AND COURSE OF DISABILITY (STUDIES I–II)  
In Study I, the mean duration of indoor air-related symptoms was 4.6 (median 
2.5, range 0.6–23.0) years, and in Study II it was 10.5 (median 8.5, range 2.0–
25.0) years (Table 12). In Study II, the mean duration from onset to the time 
when symptoms extended to a disabling level was 7.8 (range 0.5–23.0) years, 
and from this extension point to the current evaluation time 2.7 (range 1.0–
7.0) years. 
Patients attributed their symptoms to workplace indoor environments in 
non-industrial workplaces. In Study I, 81% of patients (n=39/48, n=7 missing 
because of incomplete questionnaire responses) reported work-related 
symptoms in multiple organ systems occurring at least weekly. Further, the 
majority (65%, n=31/48) reported these symptoms in at least three organ 
systems (out of five systems). According to these weekly symptoms, the mean 
number of organ systems was 2.8 (SD 1.4). Of the patients who had asthma, 
13% (n=5/39, n=6 missing data) reported only work-related respiratory and 
eye symptoms (unpublished data). Most of the patients (72%, out of 55) 
reported laryngeal symptoms, such as hoarseness. Figure 2 in Article I shows 
the distribution of the symptoms in different organ systems. In Study II, all 12 
patients reported indoor air-related symptoms in at least three organ systems 
(mean 4.5, range 3–6), and all had neurological and respiratory symptoms. 
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5.1.2 INDOOR AIR POLLUTANTS AND WORKPLACE MEASURES 
(STUDIES I–II) 
In Study I, deficiencies in the IAQ of patients’ non-industrial work 
environments consisted of deficiencies in ventilation, dustiness, dampness or 
material emissions. Exposure to building moisture and mold at work was 
verified (among 55%) and classified as low among 7% (n=4) of the patients and 
as intermediate or high among 47% (n=26). There was no correlation between 
microbial exposure level and continuation of symptoms or number of organ 
systems with symptoms. For most of the patients (96%), previous measures 
had been taken to solve the indoor air problem at the workplace, e.g. building 
repairs, other environmental improvements or relocation of the worker. 
Despite workplace interventions, symptoms remained unchanged among 54% 
of the patients, and diminished among 29%. Among 13% the symptoms had 
disappeared. No environmental improvements had been made at work in the 
case of two (4%) patients.  
In Study II, most patients (n=10/12) described varied deficiencies in the 
IAQ of their previous work environments, mainly moisture and molds. The 
workplace facilities had been repaired or the worker had been relocated, and 
no significant exposure or deficiency in IAQ had been detected or suspected in 
their current work environments. For all the 12 patients, one or more of the 
following occupational adjustments had been made because of indoor air-
related symptoms: relocation (n=11), work schedule arrangement (n=1), 
sabbatical leave (n=4), part-time work (n=2), and/or working as a freelance in 
several jobs (n=1). Responsiveness to the triggers in the work environment had 
continued among all patients, despite the interventions. 
5.1.3 DISABILITY SCALES (STUDIES I–II) 
In Study I, the mean of self-assessed current WAS was 5.4 (SD 1.8, range 0–
7). It should however, be noted, that study intake required values of ≤7.  
In Study II, the mean of the self-assessed current WAS was 5.2 (2.4, range 
0–8). Further, the majority were not sure (n=8) or hardly sure (n=2) of their 
work ability in two years’ time. In Study II, the self-assessment disability scales 
indicated a higher disability severity than that of the SOFAS interview tool 
used in the physician’s interview. The mean of the SOFAS score was 78.3 (SD 
10.5, range 59–92), indicating a slight impairment, and the scores by tertiles 
were moderate or some difficulty (n=3), slight impairment (n=3), and good or 
superior functioning (n=6). On the inverse SDS, the mean scores were: SDS 
Work 6.1 (SD 2.7, range 1–10), SDS Social life 6.7 (1.9, 4–10), SDS Home 4.3 
(2.3, 0.5–9), and SDS Total 5.7 (1.8, 3.7–9.7). All patients scored ≥5 on at least 




5.1.4 SELF-REPORTED ENVIRONMENTAL INTOLERANCES, HEALTH 
CONCERNS AND AVOIDANCE BEHAVIOR (STUDIES I–II) 
Environmental intolerances and avoidance behavior. In Study II, the 
self-reported QEESI’s CI scores indicated a high probability of intolerance to 
chemicals among 67% (n=8) of the patients, and low probability among 33% 
(n=4). On QEESI’s Life Impact scale, ten patients showed a high score, 
representing adverse avoidance behaviors due to intolerance in various life 
areas. The mean of the CI score was 50.1 (range 4–91) and that of Life Impact 
was 55.5 (range 1–94). On the additional scale (0–10) of severity of intolerance 
to indoor air molds, 75% (n=9) patients scored 10, indicating disabling 
symptoms, and three patients responded with values of 1, 2, or 6 (scale 0–10) 
to the additional question analogues regarding EMFs of the QEESI. 
During the clinical interviews in Study II, patients reported restraints to 
activities imposed by their indoor air-related avoidance behaviors, including 
work participation (n=12), visiting various places (n=12), socializing (n=10), 
leisure activities (n=6) and moving or living in conventional homes (n=3). 
Environment-related health concerns. In the INT group (n=25) of 
Study I, during the psychologist’s counseling sessions, 60% (n=15) of the 
participants showed prevalent concerns about a serious disease or loss of 
health. Sixteen percent (n=4) of the participants were even afraid of dying. 
Among 52% (n=13), concerns were associated with indoor air problems. 
Among one fifth (n=5), symptoms had led to avoidance behavior and restricted 
personal life. Concerns about a serious disease not related to indoor air were 
identified among four (16%) patients. One third (n=8) reported concerns 
about poor asthma prognosis. 
In Study II, all the patients reported considerable environment-related 
concerns about loss of heath. On the health concerns scale (0–10), the mean 
value of environmental exposures was 8.8 (range 3–10), and for indoor air 
exposure at the workplace, 9.4 (range 7–10). 
5.1.5 SELF-REPORTED SIGNS OF DISTRESS (STUDIES I–II) 
In Study I, based on the psychologist’s interviews, 36% (9 out of 25) of the 
patients expressed current mental symptoms (depressive mood, feelings of 
anxiety, or sleeping problems), and one had previously suffered mental 
symptoms. 
The patients of Study II had somatic, characterized cognitive and emotional 
symptoms and health-related QOL using self-rated measures, the results of 
which are summarized in Table 13. Half of the patients (n=6) reported 
insomnia-related symptoms using the ISI instrument, and two of these had 
moderate or severe insomnia. In addition, two thirds (n=8) of the patients 




Table 13. Self-rated symptoms of anxiety, depression, insomnia, burnout, somatization and 
health-related quality of life in Study II. 
 All (n=12) 
Anxiety   
   GAD-7, mean (range) 4.8 (0–13) 
      Moderate anxiety (score 10–14), n 3 
   BAI, mean (range)a 7.0 (0–16) 
      Moderate anxiety (score 16–25), n 1 
   OASIS, mean (range)b 3.1 (0–10) 
      Identification of clinical anxiety (score ≥8), n 1 
Depression   
   PHQ-9, mean (range) 5.0 (0–12) 
      Moderate depression (score 10–14), n 2 
   BDI, mean (range)b 7.2 (1–17) 
      Mild depression (score 14–19), n 2 
Insomnia   
   ISI, mean (range) 9.3 (0–27) 
      Subthreshold insomnia (score 8–14), n 4 
      Moderate severity insomnia (score 15–21), n 1 
      Severe insomnia (score 22–28), n 1 
Burnout   
   SMBM total, mean (range)c 2.9 (1.4–4.6) 
      Mild or moderate burnout (score 2.3–3.7), n 5 
      Severe burnout (score ≥3.8), n 2 
Somatization   
   SCL-90 somatization, mean (range)a 1.2 (0.4–2.3) 
Quality of life   
   15D-score, mean (range) 0.84 (0.75–0.93) 
GAD-7, Generalized Anxiety Disorder; BAI, Beck Anxiety Inventory; OASIS, Overall Anxiety Severity 
and Impairment Scale; PHQ-9, Patient Health Questionnaire; BDI, Beck Depression Inventory; ISI, 
Insomnia Severity Index; SMBM, Shirom-Melamed Burnout Measure; SCL-90, Symptom Checklist-90. 
a n=10. 
b n=11. 




5.1.6 PHYSIOLOGICAL FUNCTION AS AN INDICATOR OF STRESS 
AND POOR RECOVERY (STUDY II) 
In the analysis of the ANS and HPA axis functioning (n=10) examinations, the 
time domain parameters of HRV showed no indications of significant clinical 
cardiovascular disorders. One patient’s resting blood pressure was above 
normal. Three patients’ LF/HF ratio at rest in a supine position was elevated 
(>2.8), and two of these also showed the highest values while standing. None 
of the patients showed pathognomonic responses in the HVPT test indicating 
hyperventilation syndrome. 
In a real-life setting, six (out of 10) patients showed insufficient recovery 
during sleep (recovery index <60%) in the long-term monitoring of HRV. In 
the salivary cortisol response, the cortisol levels in the evening salivary cortisol 
samples of three patients were elevated (>6.1 nmol/L). In total, three patients 
had both insufficient recovery in HRV during sleep and an elevated cortisol 
level. Further, six patients had either an elevated LF/HF ratio, insufficient 
recovery during sleep, or elevated evening cortisol levels. Table 14 shows the 
results of the examinations of the physiological function of stress and recovery. 
 
Table 14. Results of the examinations of sympathetic response used in Study II,  
mean (range).  
 N=10 
Laboratory testing at rest  
   Heart rate, bpm 66 (59–69) 
   RMSSD of adjacent RR-intervals, ms 34 (16–88) 
   Baroreceptor sensitivity, ms/mmHg 10 (6–17) 
   Systolic brachial blood pressure, mmHg 129 (100–154) 
   Diastolic brachial blood pressure, mmHg 80 (70–90) 
Active orthostatic test in laboratory  
   Power of low frequency band to high frequency band in  
   the spectral analysis of heart rate variability (LF/HF ratio) 
 
      Supine position 4.3 (0.7–21.0) 
      Standing 8.7 (1.0–23.0) 
Home monitoring  
   Heart rate variability in beat-to-beat R–R interval recording  
      Percentage of recovery during sleep (recovery index)a 56.1 (22.0–89.7) 
   Salivary cortisol  
      Evening sample, nmol/Lb 6.2 (1.8–15.9) 
RMSSD, root means square of successive differences. 
a Average of mean of three values over three days. 
b Average of mean of two different evening samples. 
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5.1.7 CO-OCCURRENT SOMATIC AND PSYCHIATRIC DISEASE 
(STUDIES I–II) 
In Study I, based on medical history and clinical examinations, 93% (n=51/55) 
of the patients had one or more current diseases or symptomatologies, which 
are summarized in Table 15. Twenty-two (40%) patients had a 
symptomatology or disease other than asthma. Based on the clinical 
assessment, the disease possibly contributed to disability in only one patient 
with subacute thyreoiditis. The respiratory symptoms of asthma patients 
(n=45) were not fully explained by their asthma condition. Other diseases had 
been treated under sufficient control. 
 
Table 15. Current diseases and symptomatologies of 55 patients in Study I. 
Diseases or symptomatologiesa N=55 
Asthma 
Allergic rhinitis or conjunctivitis 
Arterial hypertension 
Atopic eczema 
Chronic obstructive pulmonary disease 
Depression 






Obstructive sleep apnea 
Seronegative oligoarthritis 
Seropositive rheumatoid arthritis 
Panic disorder 
Paroxysmal trigeminal neuralgia 
Scleroderma 
Sjögren’s syndrome 
Subacute thyreoiditis  
Anxiety symptoms 
Low mood 
Low back pain 

























a An individual may have one or more diseases or symptomatologies. 
 
In Study I, 17% (n=8/45) of the asthma patients showed low lung function 
in spirometry according to FVC% or FEV1% (<80% of the predicted values) or 
a positive FEV1% bronchodilator response (≥12%). Three patients with 
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asthma had mildly raised FeNO (≥25 ppb). According to the ACT instrument, 
78% of the asthma patients’ asthma was ‘not well-controlled’ or ‘uncontrolled’. 
Table 16 summarizes the results of the examinations of allergy, inflammation 
and respiratory function, as well as the self-reported asthma control examined 
by the ACT instrument in Study I and II. 
 
Table 16.             Results of examinations of allergy, inflammation, and respiratory tract, and self-reported  
                            asthma control in Studies I and II. 
 Study I Study II 












Indicators of atopy     
   Positive skin prick testa     
      Common environmental allergens, n (%) 27 (49.1) 22 (48.9) 5 (41.6) 2 (33.3) 
      Molds, n (%) 2 (3.6) 2 (4.4) none none 
   Total serum IgE ≥110 kU/L, n (%) 11 (20.0) 8 (17.7) none none 
Blood EOS, x109/L, mean (SD) 0.14 (0.23) 0.15 (0.25) 0.15 (0.03) 0.13 (0.04) 
Spirometryb     
   FVC% predicted, mean (SD) 96.2 (13.4) 96.5 (14.4) 101.7 (13.5) 102.6 (15.8) 
   FEV1% predicted, mean (SD) 91.3 (16.6) 91.3 (17.8) 99.7 (14.1) 100.0 (17.3) 
   FEV1/FVC, mean (SD) 77.9 (7.1) 77.9 (7.1) 79.7 (4.3) 79.0 (4.8) 
   FEV1% bronchodilator response  









Bronchial hyperresponsivenessc     
   Severe, n (%) 1 (2.1) 1 (2.6) none none 
   Moderate, n (%) 2 (4.3) 2 (5.3) 1 (10.0) 1 (20.0) 
   Mild, n (%) 8 (17.0) 6 (15.8) 2 (20.0) 1 (20.0) 
   None, n (%) 36 (76.6) 29 (76.3) 7 (70.0) 3 (60.0) 
FeNO, ppb, mean (SD)b 11.9 (6.5) 12.2 (6.9) 14.6 (7.5) 14.0 (7.9) 
Average daily diurnal PEF variability over  









ACT     
   Controlled (≥20 points), n (%) . 10 (22.2) . 4 (66.6) 
   Not well-controlled (16–19 points), n (%) . 9 (20.0) . 1 (16.7) 
   Uncontrolled (≤15 points), n (%) . 26 (57.8) . 1 (16.7) 
IgE, immunoglobulin E; EOS, eosinophils; FVC, forced vital capacity; FEV1, forced expiratory volume in one 
second; FeNO, fractional exhaled nitric oxide; PEF, peak expiratory flow; ACT, Asthma Control Test (score 0–25). 
. = Not applicable. 
a At least one positive skin prick test. 
b n=54 in Study I. 
c n=47 in Study I; n=10 in Study II. 
d n=11 in Study II. 
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In Study II, 83% (n=10/12) of the patients had one or more current somatic 
diseases based on clinical evaluation and medical history: Asthma (n=6), 
benign arrhythmia (n=1), fibromyalgia (n=1), hypothyreosis (controlled by 
medication) (n=2), irritable bowel syndrome (n=2), anal fissure (n=1), 
migraine (n=2) and/or musculoskeletal disorder (n=4). We detected no low 
lung function in spirometry in any of those who had asthma (n=6) according 
to FVC% or FEV1% (<80% of the predicted values) or in positive FEV1% 
bronchodilator response (≥12%), and no excessive variability in daily diurnal 
PEF (>10% average daily variability) or in positive bronchodilator responses 
(≥15% and 60 L) (Table 16). The FeNO of two patients was mildly raised (≥25 
ppb), and one of these had asthma. According to the ACT, asthma was more 
often controlled (67%) than ‘not well-controlled’ or ‘uncontrolled’ (33%). The 
medical assessment revealed no need for additional somatic investigations. 
According to the ICD-10 diagnostic criteria in Study II, 73% (n=8/11) of the 
patients met the criteria for one or more psychiatric disorders, which are 
summarized in Table 17. Of these, five patients had one diagnosis and three 
patients had two or more. Based on their medical histories, two patients had 
previous psychiatric diagnoses (major depressive disorder, anxiety/phobic 
anxiety disorder, social phobia). Six patients fulfilled the diagnostic criteria for 
an anxiety disorder, two of whom also had a depressive disorder. One patient 
with anxiety and depressive disorders also had a personality disorder. Another 
two patients met the diagnostic criteria for a somatoform disorder. 
 
Table 17. Psychiatric disorders based on clinical evaluation. 
Psychiatric disordersa N=11 
Anxiety disorders 
   Social phobia 
   Specified phobic anxiety disorder 
   Other specified anxiety disorderb 
   Reaction to severe stress and adjustment disorder  
Depressive disorders 
   Moderate depressive disorder 
   Recurrent depressive disorder, current episode mild 
Somatoform disorders 
   Undifferentiated somatoform disorder 
   Somatoform autonomic dysfunction 
Personality disorders 














a An individual may have one or more psychiatric disorders. 
b Including features of panic and generalized anxiety disorders, autonomic dysfunction, anxiety and 
mental distress, and fluctuating anxiety with concerns of disease and avoidance behavior. 
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5.1.8 INDOOR AIR-RELATED DISABILITY (STUDIES I–II) 
Patients’ disability manifested as a condition with persistent and non-specific 
symptoms that patients attributed to pollutants in indoor air environments. In 
Study I, based on clinical evaluation, the patients’ disabilities were not 
adequately explained by any disease, and symptomatology had not diminished 
despite previous arrangements at workplace facilities. In Study II, according 
to the clinical evaluation, all 12 patients fulfilled the IEI criteria in terms of 
responsiveness to indoor molds (n=11). Nine of them also reacted to odorous 
chemicals, three to electric devices and one individual was responsive to only 
odorous chemicals. Symptom responsiveness appeared in different buildings, 
and/or were provoked by a wide range of odorous. Seven patients (out of 12) 
reported symptoms when in the vicinity of people who had been in a moisture-
damaged building. 
5.2 PREVALENCE OF ENVIRONMENTAL INTOLERANCE 
TO CHEMICALS, INDOOR MOLDS AND ELECTRIC 
DEVICES IN MATERNITY CLINIC SAMPLE  
(STUDY IV) 
The mean age of the 680 respondents in Study IV was 29.9 years (SD 4.8), 
ranging from 16 to 45. Of these, 90.9% (n=618) reported being non-smokers, 
and 94.9% (n=645) reported being at least somewhat annoyed by at least one 
of the inquired 12 environmental factors (Table 7, Section 4.3). The 
distribution of the degree of severity of annoyance attributed to the various 
environmental factors are shown in Table 2 of original Article IV. 
5.2.1 ENVIRONMENTAL INTOLERANCE 
Continuum from annoyance to disability. Of the respondents, 45.6% 
reported annoyance with chemicals, indoor molds, or EMFs (EI definition A, 
see definitions in Table 8, Section 4.3). Further, 33.2% reported symptoms 
related to at least one of these three EIs (Definition B), and 17.5% reported 
symptoms that contained CNS symptoms (Definition C), including behavioral 
changes (15.0%) (Definition D). In terms of disability, 8.4% experienced at 
least ‘some’ difficulties related to any of the three EIs (Definition E), 2.2% 
‘very’ many or ‘extreme’ (Definition F) and 0.9% ‘extreme’. Table 18 shows the 
distribution of prevalence of EIs among the various environmental factors and 
their combinations according to the increasingly strict criteria for the EI 
definitions (A–F) used in Study IV.  
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Table 18. Prevalence of environmental intolerances (EIs) according to EI definitions A–Fa 










I EI attributed to 
Any of the 12 
environmental 
factors 












A 457 (67.2) 310 (45.6) 198 (29.1) 222 (32.6) 20 (2.9) 
B 302 (44.4) 226 (33.2) 155 (22.8) 166 (24.4) 16 (2.4) 
C 145 (21.3) 119 (17.5) 80 (11.8) 93 (13.7) 9 (1.3) 
D 122 (17.9) 102 (15.0) 67 (9.9) 83 (12.2) 9 (1.3) 
E 68 (10.0) 57 (8.4) 39 (5.7) 52 (7.6) 5 (0.7) 
F 15 (2.2) 15 (2.2) 10 (1.5) 15 (2.2) 2 (0.3) 
EMFs, Electromagnetic fields.  
a An individual may have EI to one or more factors and may be included in various definitions A–F. 
 
 
Symptoms. Of those (n=226) who reported intolerance to one or more 
symptoms (EI definition B) attributed to any of the three (chemicals, molds, 
EMFs) items, 38.9% reported symptoms in at least three (out of 1–7) different 
organ systems. The symptoms occurred mostly in the CNS, pulmonary tract, 
and dermal systems. Figure 1 of Article IV presents the proportion of self-
reported symptoms in different organ systems in cases of EIs to chemicals, 
molds, EMFs and their combinations, as well as the mean numbers of organ 
systems. 
Behavioral changes. The (n=102) participants who had any of the three 
EIs according to EI definition D reported having made the following 
behavioral changes to avoid symptoms: behavioral or lifestyle changes to 
minimize exposure (n=65), changed interior decorations or furnishings at 
home (n=29), moved to another apartment (n=24), changed workplace, 
resigned from workplace or occupation (n=19), taken vitamins, supplements, 
or changed diet (n=47), eliminated the cause using antifungal agents or 
chemicals (n=16) and used protective equipment (n=55). Nine respondents 
(1.3%) reported both a move to another apartment and a change of workplace. 
Disability. All the participants (n=15) with ‘severe disability’ attributed 
their intolerance to indoor molds, and two thirds also to chemicals (Table 18; 
Table 4 of Article IV). Of these 15 participants, 12 reported having had to 
change apartment or job to avoid symptoms due to intolerance, four reported 
having done both. Among the 15 participants, the mean number of organ 
systems presenting symptoms was 4.4 (SD 2.0, range 2–7). 
All the six respondents who reported very severe (‘extremely difficult’) 
disability (as shown in Table 4 of Article IV) had CNS and pulmonary tract 
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symptoms, and five had dermal system symptoms. The mean number of organ 
systems involved was 4.8 (SD 2.1; range 2–7). 
Co-occurrence of EIs. Of the respondents who reported EI definition A 
to chemicals (n=198), indoor molds (n=222) or EMFs (n=20), 59%, 53%, and 
75%, respectively, reported at least one other type of EI. Furthermore, co-
occurrence of at least one other EI with definition E to chemicals, indoor molds 
or EMFs was reported by 87%, 65%, and 100%, respectively. Co-occurrence of 
the three types of EIs according to EI definitions A and E are shown with Venn 
diagrams in Figure 2 of Article IV. 
5.2.2 FACTORS ASSOCIATED WITH INCREASING SEVERITY OF 
DISABILITY 
As the number of difficulties increased, the number of organ systems, 
behavioral changes and overlaps of the three EIs also grew.  
Among the respondents with EI definition B (n=226), an association was 
found between increasing severity of disability and pulmonary tract symptoms 
(p=0.011), and nearly significantly for CNS symptoms (p=0.054). In addition, 
the more severe disability was also associated with a higher number of organ 
systems presenting symptoms (p<0.001), and with a higher number of 
behavioral changes (p<0.001). The aforementioned association was also seen 
in the EI definition C group (n=119, p=0.001). 
The association between the severity of disability and the co-occurrence 
(only one, two different types of EI, or all three EIs) of the three EIs (n=102, 
p=0.037; Table 4 of Article IV) was statistically significant. In addition, the 
increasing severity of the continuum of EI (definitions from A to F) was 
associated with the increasing overlaps of the three EIs (n=310, p<0.001). 
5.3 EFFECTIVENESS OF COUNSELING FOR QUALITY 
OF LIFE AND WORK ABILITY AMONG PATIENTS 
WITH INDOOR AIR-RELATED DISABILITY (STUDY I) 
After the six-month follow-up, the psychoeducation and counseling 
intervention provided no significant positive benefits in the following outcome 
measures (INT: n=21; TAU: n=23): self-assessed work ability (measured by 
WAS), illness worries (by IWS), health-related QOL domains (by RAND-PCS 
and RAND-MCS), Symptom disturbance index, and self-assessed asthma 
control (of those who had asthma, measured using the ACT instrument), as is 
presented in detail in Table 4 of Article I. Sick leave days and periods were not 
reported because of missing data in the six-month follow-up questionnaire. 
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5.4 TWO PSYCHOSOCIAL INTERVENTIONS TO 
MANAGE PATIENTS WITH INDOOR AIR-RELATED 
DISABILITY (STUDY III) 
Participant recruitment began in February 2014 and ended in February 2017. 
After the end point, the last intervention sessions were conducted in spring 
2017 and the following follow-up questionnaires until June 2018. Reporting of 
the results begins in 2018, and the results from the study follow-up are 
expected in 2019. 
During the RCT, finding eligible individuals at the OHS units, was 
challenging, despite support for maintaining recruitment. Because of the slow 
enrolment process, an attempt was made to expand the number of recruits 
during the study intake and the recruitment period was extended from the end 
of 2016 to the beginning of 2017. In addition, in May 2015, the Applied 
Relaxation Group Therapy arm was removed from study interventions to 




6.1 MAIN FINDINGS 
6.1.1 DISABILITY WITH PERSISTENT AND NON-SPECIFIC 
SYMPTOMS 
In the clinical studies (Studies I, II), the patients’ indoor air-related symptoms 
appeared to be long lasting and to involve several organ systems. Study II 
showed gradual exacerbation on the symptom spectrum as well as functional 
impairments. Previous clinical studies of similar clinical samples have shown 
that non-specific indoor air-related symptoms can persist over time (Al-
Ahmad et al. 2010; Karvala et al. 2014; Khalili et al. 2005). In addition, long-
lasting symptoms in multiple organ systems have been related to poor 
prognosis (Edvardsson et al. 2008). This seems to also occur among patients 
with mold-attributed asthma or asthma-like symptoms (Al-Ahmad et al. 2010; 
Karvala et al. 2014). In a study of an occupational clinic sample, the duration 
of more than one year and five or more symptoms were significant work 
disability risks (Edvardsson et al. 2008). In general, numerous somatic 
symptoms associate with lower physical and mental health and predict worse 
health status (Tomenson et al. 2013) and high rates of work disability (Rask et 
al. 2015). 
Our clinical studies (Study I, II) found no medical or exposure-related 
explanation for the persistent symptomatology. In a previous follow-up study 
also, persistent symptoms and disability were not fully explained by asthma or 
current exposure (Al-Ahmad et al. 2010). Our findings regarding persistent 
and recurrent indoor air-related non-specific symptoms with multiorgan 
progression, not explained by exposure or disease, are in accordance with the 
phenomenon of IEI and FSS.  
The patients’ respiratory symptoms were not fully explained by asthma. 
Among those with asthma (Study I, II), lung function tests were normal in 
most cases, but the patients reported abundant respiratory and multiorgan 
symptoms. According to the ACT questionnaire (Study I) most (78%) of the 
asthma patients reported ‘not well-controlled’ or ‘uncontrolled’ asthma, as 
well as multiple respiratory symptoms, limitations to activity, usage of short-
acting bronchodilation medication and poor self-assessed asthma control. The 
ACT score seemed to be lower than that in other studies of asthma patients 
(Romberg et al. 2014). The findings suggest that ACT based on self-assessed 
symptoms may exaggerate the non-control of asthma due to overlapping 
functional symptoms. Functional symptoms can be difficult to distinguish 
from asthma symptoms (Lehrer et al. 2002). 
The functional nature is supported by the fact that the majority (69%) of 
the asthma patients (Study I) reported symptoms in three or more organ 
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systems, including typical functional symptoms such as hoarseness (Hoy et al. 
2010). In Study II, all the patients had persistent multi-organ symptoms 
including CNS and respiratory symptoms, and disability was due to the 
recurrence of symptoms leading to avoidance. An increasing number of 
physical symptoms is a strong indicator of a non-organic nature and is a 
predictor of disability (Henningsen et al. 2007, 2018). Symptoms in multiple 
organs including CNS, as in SBS (Thörn 1999; Redlich et al. 1997; WHO 1983), 
are characteristic of IEI and FSS, as is disability that is not explained by 
medical conditions (Fink and Schröder 2010; Lacour et al. 2005; Rief et al. 
2017). 
6.1.2 DISABILITY WITH INCREASED REACTIVITY TO INDOOR 
POLLUTANTS 
Clinically (Study I, II), the patients attributed their work disability to indoor 
work environments. Different environmental factors were recognized at the 
patients’ workplaces as potential causes of impaired IAQ. However, they do 
not explain the persistent recurrent symptoms/responsiveness and avoidance. 
Similar indoor air pollutant levels are not regarded as an explanation for long-
term adverse health effects in non-industrial workplaces (Hetherington and 
Battershill 2013; Redlich et al. 1997; WHO 2009; Wolkoff 2013). The patients’ 
disability, symptoms and responsiveness to work and other indoor 
environments had continued despite interventions at their workplaces. 
The disability manifested in all the patients in Study II as a chronic state of 
responsiveness to the indoor work environment, which the patients attributed 
to indoor pollutants, mainly molds. However, in the patients’ current work 
environments, there was no evidence of or suspicion of harmful indoor 
exposures. Previous studies have shown that symptoms may persist despite 
building remediation (Al-Ahmad et al. 2010; Edvardsson et al. 2008; Sauni et 
al. 2015), even in cases in which the remediation is considered substantial or 
technically successful (Haverinen-Shaughnessy et al. 2008; Iossifova et al. 
2011), or when remediation activities are repeated over many years (Park et al. 
2018). In addition, as the symptoms were triggered by indoor air in one 
building, but then spread to other surroundings, it is unlikely that all these 
surroundings contain harmful indoor exposures. As an example of increased 
responsiveness, the majority of the patients in Study II reported symptoms in 
the vicinity of people who had been in a moisture-damaged building or near a 
moldy odor. These findings of persistent reactivity are in accordance with 
features of IEI (IPCS/WHO 1996; Lacour et al. 2005; MCS consensus 
conference 1999) in which individuals react to low levels of various everyday 
environmental exposures that are tolerated by most other people.  
Furthermore, Study II showed that responsiveness had spread to other 
triggers, which is typical of IEI (Dantoft et al. 2015; Van den Bergh et al. 
2017a). In addition to indoor molds, symptom triggers included odorous 
chemicals, and for some patients also electric devices. Previous provocation 
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studies have revealed no exposure-related evidence of physiological reactions 
caused by electric devices (Rubin et al. 2005, 2011). Our modified QEESI 
instrument, with its additional questions on indoor air molds and EMFs, 
supported the information gained from clinical history. A similar overlap has 
previously been seen in a few clinical samples (Edvardsson et al. 2008; 
Söderholm et al. 2016), and in a population-based questionnaire study 
(Palmquist et al. 2014). A survey of maternity clinic samples (Study IV) also 
showed that the greater the co-occurrence of EIs (chemicals, indoor molds, 
electric devices), the more severe was EI. 
Overall, the findings support the hypothesis that the increased reactivity to 
perceived indoor air pollutants in non-industrial work environments share 
features with EI and FSS. They strengthen the previous understanding that the 
different forms of EI share similarities and represent the same phenomenon 
(Dantoft et al. 2015; IPCS/WHO 1996; Van den Bergh et al. 2017a). 
6.1.3 ASSESSMENT OF INDOOR AIR-RELATED DISABILITY 
The assessment of functioning and disability showed difficulties in many 
functional areas in daily life: not only at work, but also at home, and in the 
patients’ social lives. As a sign of work disability, adjustments had been made 
at the workplaces of the patients in our clinical studies (Study I, II), but they 
also had high work absence rates during the past year and/or high health care 
seeking/utilization (physician visits during past year). These two factors have 
been predictors of work disability (Reis et al. 2011; Roberts et al. 2018; Sado 
et al. 2014), and are also typical of IEI and FSS (Bailer et al. 2005; Frías 2015; 
Henningsen et al. 2018). In general, work disability associates with impaired 
QOL (Idler and Benyamini 1997; Post et al. 2006) and psychosocial risk factors 
such as inappropriate fears and beliefs, catastrophizing, little hope of healing, 
loss of self-efficacy and lack of social support (Sullivan et al. 2005).  
Health-related QOL describes the physical, mental and social dimensions 
of functioning and well-being. In Study II, patients reported lower health-
related OQL when they measured it by the 15D score (0.84) than previous 
findings in the general population (0.94) or individuals with asthma (0.86), 
but similar levels to those individuals with any depressive disorder (0.84) or 
anxiety disorder (0.83) (Aromaa and Koskinen 2004; Koskinen et al. 2012; 
Saarni et al. 2006, 2007). 
Clinical examinations (Study I, II) did not find that impairments in body 
functions or structures explained the disability. However, the clinical 
interviews and self-assessment tools (Study II) revealed that the patients’ 
disabilities limited their activities and restricted their participation in 
everyday life because of individual avoidance behavior due to symptom 
triggers in certain surroundings. In IEI, disability is based on self-reported 
symptoms and limitations to everyday functioning, i.e. no laboratory test or 
other objective means is available to evaluate disability evaluation. In addition, 
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significant functional and lifestyle impairments are required by the extended 
MCS criteria (Lacour et al. 2005) that are applicable to IEI. 
The subjective SDS assessment tool (Study II) showed limitations to 
activities and participation restrictions to the varying domains of work, social 
life and functioning at home. Self-assessments (SDS and WAS) of disability in 
psychosocial (levels of activity and participation) environments showed higher 
severity of disability than the physician assessment using the SOFAS interview 
tool. A recent follow-up study of psychiatric patients at a tertiary outpatient 
clinic did not find this disparity between the subjective (SDS) and objective 
(SOFAS) measures (Laukkala et al. 2018). Instead, the measures were inter-
correlated, and both SOFAS and the SDS Work scores were associated with a 
return to work (Laukkala et al. 2018). In Study II, the disparity between 
subjective and objective measures may reflect the nature of the condition and 
is characteristic of IEI and FSS (Lacour et al. 2005; Watanabe et al. 2003a; 
Wessely et al. 1999).  
In Study II, patients’ functioning problems, enforced by their avoidance 
behaviors, applied to work participation, visiting various places, socializing, 
leisure activities and moving to or living in conventional homes. Avoidance 
behaviors were also seen in Study I. In addition, ten (out of 12) patients (Study 
II) reported adverse avoidance behaviors due to chemical intolerance in 
various life areas according to QEESI’s Life Impact scale. Skovbjerg (2009) 
concluded in her thesis that the most prominent coping strategy among 
individuals with MCS was avoidance of exposure to common environmental 
odors, and that in the persisting states, avoidance led to increased disability 
levels which impacted many aspects of everyday life. In a previous 
questionnaire study, over 60% of BRI respondents reported avoiding buildings 
that evoked symptoms (Karvala et al. 2018a). 
Avoidance behavior is also a well-established feature of FSS, for example, 
in chronic pain and in chronic fatigue syndrome (Hartvigsen et al. 2018; Nater 
et al. 2006; Samwel et al. 2007). The fear-avoidance model of chronic pain 
hypothesizes that the fear of pain experience leads (through cognitive, 
affective and behavioral processes) to avoidance behavior such as limitations 
to activities and disability (Wideman et al. 2013). There is a positive 
association between fear-avoidance and pain intensity (Kroska 2016). In 
addition, the avoidance model has expanded to include the influence of 
maladaptive learning process and disability beliefs in pain perception and 
behavior (Hartvigsen et al. 2018). Increasing evidence shows that CNS pain-
modulating mechanisms and pain cognitions play a major role in the 
development of disability (Hartvigsen et al. 2018; Rainville et al. 2001; Ursin 
and Eriksen 2001). It has been proposed that in IEI too, central sensitivity is 
involved in the development of a chronic disabling condition (Van den Bergh 
et al. 2017a). 
In previous epidemiologicals studies, symptoms and behavioral changes 
have described disability due to EI (Berg et al. 2008). In the maternity clinic 
survey (Study IV) the severity of EI disability was illustrated using the tenth 
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additional item of the PHQ-9. This item is originally a single severity measure 
in the depression scale and measures functioning (activity and participation) 
in daily life. The use of this item enabled us to identify individuals with 
functioning difficulties. Previously, in a primary care sample, this item 
correlated strongly with impairment in the domains of health-related QOL 
(Kroenke et al. 2001).  
Earlier, a high number of symptoms has been associated with functional 
impairments among individuals with IEI-EMFs (Baliatsas et al. 2014), which 
reflects the severity of the condition. Study IV further showed, based on the 
single item of PHQ-9, that as the grade of disability increased, the number of 
organ systems, behavioral changes and overlaps between EI and different 
environmental factors also grew. In Study IV, 1.3% of the respondents reported 
moving to another apartment and changing workplaces due to various forms 
of EI. In a previous Danish population-based study, due to chemical 
intolerance, 3.3% of study participants had made adjustments to their social 
lives or occupational conditions, and 0.5% to both (Berg et al. 2008). In a 
population cohort from the US, 1.5% reported losing their jobs and 0.8% 
moving house because of their hypersensitivity to chemicals (Caress and 
Steinemann 2004a). 
Within the ICF framework (WHO 2001), indoor air-related disability was 
successfully defined as limitations to activities and restrictions to participation 
in several areas in daily life. The disability was associated with individual 
avoidance behaviors due to symptom triggers in certain surroundings. It was 
not explained by medical disease and/or disruption of body 
functions/structures. Instead, disability and its dysfunctions were 
characterized by various instruments that assessed symptoms and 
functioning, including reports of symptoms and responsiveness (e.g. long-
term, gradual exacerbation, multiorgan, impaired QOL, discrepancy in 
objective evaluation, fears and worries, avoidance, co-occurrences, 
spreading), and in terms of workplace interventions, work ability, work 
absence and utilization of health care. 
6.1.4 SIGNS OF PHYSICAL AND EMOTIONAL DISTRESS  
The findings show that indoor air-related disability had various signs of 
distress. In Study II, the patients reported numerous signs of distress 
(physical, emotional, cognitive). Self-reports revealed prevalent insomnia-
related symptoms and multi-site pain. These are also typical features in FSS 
(Eliasen et al. 2018; Mariman et al. 2013) and MCS patients (Blanco et al. 
2016; Weiss et al. 2017), and are associated with work disability (Saltychev and 
Laimi 2018; Sivertsen et al. 2009). Our patients also reported work-related 
burnout in facets of physical, cognitive and emotional functioning. Job 
strain/burnout has been found to be a predictor of work disability (Salvagioni 
et al. 2017), and co-occurs with distress disorders such as impaired sleep, pain 
and anxiety (Ekstedt et al. 2006; Salvagioni et al. 2017). In the psychological 
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interviews of Study I, one third of the INT group described symptoms typical 
of depressive mood, sleeping problems, or anxiety. A previous population-
based follow-up study has shown that individuals who later began to attribute 
annoyance to environmental factors reported even at baseline, more health 
complaints, higher levels of stress, strain and lack of recovery, as well as more 
dissatisfaction with their work situation and lower personal social support 
than those who did not develop such environmental attribution (Eek et al. 
2010). 
Negative beliefs and great concerns regarding the effect of indoor air 
exposures on health were prevalent among the patients in the clinical studies 
(Study I, II). The counseling of the INT group (Study I) revealed prevalent 
concerns of a serious disease or a loss of health (60%), and in some, fears had 
led to avoidance and restricted personal life (20%). All the patients in Study II 
reported considerable health concerns related to indoor air environments. In 
previous findings, concerns regarding indoor air-related health hazards have 
been common (Bluyssen et al. 2016; Redlich et al. 1997). In general, health 
concerns attributed to environmental factors have been highly prevalent, and 
are typically encountered in IEI (Baliatsas et al. 2015b; Van den Bergh et al. 
2017a). Health concerns have positively associated with perception and the 
amplification of the physical symptoms of IEI and these health worries may 
contribute to the development of IEI (Bailer et al. 2008a; Van den Bergh et al. 
2017a). When an individual perceives certain environmental factors as health 
hazards, stress reactions can manifest as multiple organ symptoms (Van den 
Bergh et al. 2017a). The role of health anxiety and illness worries in FSS is also 
well established (Henningsen et al. 2018). Elevated concerns may predict the 
development of health complaints and lead to higher symptom reports (Rief 
and Broadbent 2007; Watt and Stewart 2000). Negative illness perceptions 
have also been associated with lower physical and mental health (Frostholm 
et al. 2007), as well as physical symptoms accompanied by health anxiety and 
considerable concerns (Tomenson et al. 2013). A pronounced high health 
threat can be subjectively valid even if its connection to the perceived source 
is tenuous (Bailer et al. 2008a; Brown 2004; Rief and Broadbent 2007). 
Our results support the hypothesis that individuals’ expectations of the 
symptoms and adverse effects of certain surroundings can induce and 
maintain health complaints (Van den Bergh et al. 2017a). It has been suggested 
that central mechanisms (central sensitization) play an essential role in the 
development and maintenance of adverse reactions. Dysfunctional cognitions 
may increasingly enhance the reactions to actual or anticipated stimuli (Bell et 
al. 1996b; Henningsen et al. 2007, 2018; Kipen and Fiedler 2002; Rief and 
Broadbent 2007; Van den Bergh et al. 2017a; Yunus 2007) (see Figure 3, 
Section 2.3.6). Further, increasing evidence proposes that expectancy and 
nocebo mechanisms are critically involved in the development of symptoms 
and in linking them to specific environmental cues (Martens et al. 2018; Van 
den Bergh et al. 2017a). The persisting illness attribution to environmental 
factors is associated with intensity of symptoms (Van Dongen et al. 2014). The 
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perception of a threat stimuli can lead to CNS activation including both early 
autonomic reactivity and later prefrontal responses to consciously attended 
fear and avoidant coping (Hofmann et al. 2012). Awareness of symptoms 
together with concerns can feed further into a vicious circle of adverse 
consequences, and the condition becomes worse, with subsequent 
chronification (McEwen 2007; Rief and Broadbent 2007; Van den Bergh et al. 
2017b). 
The physiological stress and arousal indicators in Study II showed 
insufficient recovery in the HRV recordings and raised evening cortisol levels 
in six (out of 10) patients, but there no specific profile emerged in the findings. 
Physiological arousal (Brosschot et al. 2006) due to stress and persevering 
illness cognition can be mediated and modulated by various complex 
mechanisms, such as the regulation of the ANS, HPA axis, and immune system 
(e.g. proinflammatory cytokines) (Yunus 2015). According to previous 
findings, physiological measurements do not necessarily correspond with 
symptoms and their severity (Van den Bergh et al. 2017b). In addition, the 
literature has shown similar inconsistent findings concerning HPA axis 
activity among individuals with clinical burnout (Grossi et al. 2015). ANS 
recordings have typically been used as arousal indicators in provocation 
studies. For example, a Swedish study of 18 individuals with MCS found that 
those with MCS expressed higher pulse rate and lower pulse rate variability as 
ANS responses during chemical exposure than healthy controls, as well as 
greater perceived odor intensities, more unpleasantness from the exposure, 
and increasing symptoms (Andersson et al. 2016). 
Overall, the cognitive and emotional processes of dysfunctional illness 
perceptions and illness worries are associated with high symptom reports in 
IEI (Bailer et al. 2008b; Staudenmayer 2001; van Dongen et al. 2014), FSS 
(Bailer et al. 2008b; Frostholm et al. 2007; Rief and Broadbent 2007) as well 
as in chronic diseases such as asthma (Horne and Weinman 2002; Lehrer et 
al. 2002). A plausible explanation is that mechanisms regulated by CNS, 
central sensitization, can act either with or without verified disease (Yunus 
2015). For example, psychological mechanisms, i.e. cognitive and emotional 
processes, have shown to mediate asthma exacerbation (e.g. Van Lieshout and 
MacQueen 2008), and are involved in the reporting of respiratory symptoms 
(Selinheimo et al. 2018), which may result in an overestimation of the severity 
of asthma (Selinheimo et al. 2018; Van Lieshout and MacQueen 2008). The 
differentiation of symptoms and their different mechanisms is essential for 
effective management strategies (Hubley et al. 2016; Yunus 2015).  
Recognition of the underlying signs of distress enables the use of various 




6.1.5 CO-OCCURRENCE OF SOMATIC AND PSYCHIATRIC DISEASES 
The clinical studies (Study I, II) revealed no medical diagnoses that fully 
explained the disability, although they did find a high co-occurrence of medical 
(somatic and psychiatric) diseases and other symptomatologies. In Study I, 
decreased work ability was associated with workplace indoor air-related 
asthma and the symptomatologies shared features with IEI and FSS. The 
overrepresentation of asthma in Study I can be explained by the study 
population consisting of FIOH’s patients with a suspected occupational 
disease. However, asthma was also prevalent in Study II among patients with 
indoor air-related disability. A previous epidemiological survey has shown a 
high co-prevalence of asthma (28%) among individuals suffering BRI (Karvala 
et al. 2018b). MCS has also shown to overlap with asthma to a great extent 
(Caress and Steinemann 2009; Katerndahl et al. 2012; Kipen and Fiedler 
2002; Lind et al. 2017). Asthma is associated with an increased risk of various 
work disability outcomes, such as job change, sickness absence, long-term 
work disability, and in combination with depression, an increased risk of work 
disability (Hakola et al. 2011; Kauppi et al. 2010; Thaon et al. 2008; Torén et 
al. 2009). Moreover, an acute onset or worsening of asthma symptoms has 
been associated with a variety of trigger factors, such as allergens, viral 
infections, emotional factors or irritants (GINA 2018; Vernon et al. 2012). 
Previous findings have suggested that excess asthma trigger perceptions 
are not explained by asthma and sensory irritation alone (Jaén and Dalton 
2014; Janssens et al. 2015; Janssens and Ritz 2013; Karvala et al. 2018c). It 
might be difficult for individuals to separate odor perception from sensory 
irritation, which may result in excessive reporting of sensory irritation due to 
odor cues (Jaén and Dalton 2014). Sensory thresholds for sensory irritations 
are typically an order of magnitude higher than the corresponding odor 
threshold (Nielsen and Wolkoff 2017; Wolkoff and Nielsen 2017). The 
manipulation of the perceived risk of exposure to a benign non-irritant odor 
may alter both the quality ratings of the odor and the symptom reports, as well 
as modulate the inflammatory airway response (Jaén and Dalton 2014). 
Depression and anxiety associate with asthma, its severity and respiratory 
symptom perceptions (Bogaerts et al. 2005; Brady et al. 2017; Brunner et al. 
2014; Eisner et al. 2005; Katon et al. 2007). The reverse is also true: Among 
asthma patients, concerns about experienced symptoms triggered by the 
environment may initiate cognitive and emotional processes (Chen and Miller 
2007; Jaén and Dalton 2014). It can be hypothesized that, among asthma 
patients, increased responsivity to low-dose levels of indoor pollutants and 
enhanced illness behavior may have an impact on the development, 
maintenance and worsening of IEI. 
In Study II, the majority of the patients met the ICD-10 criteria for one or 
more psychiatric disorder, mainly an anxiety disorder. However, the 
psychiatric symptoms (anxiety and depression) reported in the self-report 
questionnaires were quite modest in spite of the comorbidity of psychiatric 
disorders, which may reflect the patients’ resistance to psychological and 
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psychiatric labels (Watanabe et al. 2003a; Weiss et al. 2017). High psychiatric 
comorbidity is in line with results of previous studies of patients with MCS 
(Bornschein et al. 2001), and has also been seen in population-based studies 
(Bell et al. 1996a; Jason et al. 2000). In the context of indoor air-related 
disability, however, psychiatric comorbidity has formerly received little 
attention. Psychiatric disorders are also commonly encountered among 
patients with FSS (Blanco et al. 2016; Hamilton et al. 1996; Henningsen et al. 
2003). 
Comorbidity of physical and mental disorders associates with work 
disability (Catalina-Romero et al. 2012), and in Finland, since 2000 
psychiatric disorders have been a leading cause of disability pensions. The 
clinical studies (Study I, II), could not identify somatic diseases or psychiatric 
disorders as the major cause of disability, but psychiatric causes may certainly 
have contributed to it. 
Comorbidity must be recognized, because treating all identified diseases 
may reduce disability. 
6.1.6 ENVIRONMENTAL INTOLERANCE – PREVALENCE AND THE 
SEVERITY GRADIENT 
The findings of Study IV confirm that the prevalence of EI depends on its 
definition. Almost all the respondents reported being at least somewhat 
annoyed by an environmental factor. Prevalence rates differed when EI 
included different ratings of annoyance, symptoms, behavioral change, or 
disability. These dimensions represent different manifestations of EI, seen as 
a continuum of increasing severity, which in numerous previous studies has 
appeared as varying prevalence rates, depending on the definition used. Study 
IV succeeded in demonstrating the increasing severity continuum of EI in 
more details than previous studies (Berg et al. 2008; Björnsson et al. 1998; 
Caress and Steinemann 2004a; Carlsson et al. 2005; Johansson et al. 2005; 
Kreutzer et al. 1999; Palmquist et al. 2014). The findings reveal that EI with 
difficulties in daily life is surprisingly prevalent, and can be differentiated from 
annoyance, which is less disabling and could be encountered by half the study 
population. Figure 7 illustrates similar increasing severity of FSS (Fink and 
Rosendal 2015). In FSS, the stages of severity, as a basis for the stepped-care 
approach, corresponded with the different management options in clinical 




Figure 7 Increasing severity of functional somatic syndromes (FSS) and its’ stepped care 
(based on Fink and Rosendal 2015). TERM, the extended reattribution and 
management. 
Cultural and societal factors can affect symptom perception and reporting, 
and may contribute to the development of EI. Risk perception can be 
influenced by various aspects, such as heightened concerns about particularly 
dreaded consequences or lack of scientific information; mistrust, attitudes and 
beliefs about medicine; political or legal agendas and media and pressure 
group activity (MacGregor and Fleming 1996). For example, individuals in 
experimental studies who were given media warnings about the adverse effects 
of supposedly hazardous substances experienced more health-related 
concerns and symptoms attributed to the neutral exposure than those in the 
control group (Verrender et al. 2018; Winters et al. 2003; Witthöft and Rubin 
2013). 
Few previous surveys have determined the dominating environmental 
factors in severe EI cases. Palmquist et al. (2014) found that physician-
diagnosed EI attributed to chemicals was more common than EI attributed to 
certain buildings or to EMFs in a Swedish population-based sample. In Study 
IV, all respondents with ‘severe’ disability (2.2%) or ‘very severe’ disability 
(0.9%) attributed their EI to indoor molds, and two thirds to both molds and 
chemicals. The preponderance of EI attributed to indoor molds seen in clinical 
Study II and in epidemiological Study IV may reflect the general concern in 
Finland that indoor molds are an environmental health hazard. This was also 
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seen in a previous study of the working population in Finland, in which 11.4% 
perceived their workplaces’ indoor environment as harmful due to molds 
(Finell and Seppälä 2018). The differences between the environmental factors 
to which EI is attributed in different countries may reflect the risk perceptions 
of the population, when the difference is not attributable to other risk-factor 
profiles (Karvala et al. 2018b). 
6.1.7 BUILDING-RELATED INTOLERANCE  
Chronic indoor air-related symptomatology fulfills the WHO’s criteria for IEI 
(IPCS/WHO 1996). Previous findings concerning individuals with indoor air-
related non-specific symptoms attributed to indoor molds have recognized 
similarities with IEI (Al-Ahmad et al. 2010; Khalili et al. 2005). Disability, as 
IEI, can be encountered among individuals with indoor air-related ill health. 
Our findings further revealed indoor air-related disability as a phenomenon 
with persistent and recurrent non-specific symptoms in several organ systems 
attributed to indoor air factors (e.g. indoor molds), leading to avoidance and 
restrictions to several daily life functions. In addition, the disability shows 
various signs of distress and comorbid diseases with no medical or exposure-
related explanations. Our study findings add to the understanding of this 
phenomenon (Figure 8) (Norbäck 2009; Redlich et al. 1997; WHO 1983, 
2009). These findings strengthen the hypothesis that indoor air-related 
disability with an increasing severity gradient shares features with EI and FSS, 
and that BRI and other EIs seem to represent the same phenomenon (Dantoft 
et al. 2015; Das-Munshi et al. 2007; Rief et al. 2017; Van den Bergh et al. 
2017a; Watanabe et al. 2003a). Lacour et al. (2005) have previously 
summarized the overlap between EI and FSS, and these shared common 
mechanisms have been suggested as maintaining EI and FSS, i.e., sustained 





Figure 8 Manifestation of indoor air-related disability with typical characteristics. 
6.1.8 MANAGEMENT OF INDOOR AIR-RELATED DISABILITY 
So far, EI has been considered a chronic, stable condition, resistant to therapy 
(Bailer et al. 2008b; Black et al. 2001; Dantoft et al. 2015; Das-Munshi et al. 
2007; Eek et al. 2010; Lacour et al. 2005). There is a lack of research on the 
course of EI and controlled interventions aiming to reduce reactivity to the 
environment. In a prospective study of the one year stability of somatic 
symptoms and IEI, the strongest predictor of IEI was somatic attributions, 
followed by prominent cognitions of environmental threats and a tendency to 
focus on unpleasant bodily sensations and consider them as pathological 
(Bailer et al. 2007). In addition, a five-year follow-up study in a general 
population sample showed that anxiety (negative affect) associated with the 
development and persistence of symptoms and life impact attributed to 
common airborne chemicals (Skovbjerg et al. 2015). Recent data on the 
natural course of EI have shown that EI is reversible (Palmquist 2017). In a 
longitudinal population-based study over a six-year period, one fifth of the 
individuals with self-reported EI attributed it to chemicals, certain buildings, 
EMFs or everyday sounds recovered, especially those with less affective and 
behavioral changes (Palmquist 2017). Furthermore, increasing evidence of 
central mechanisms in chronic responsiveness, as an active inferential process 
that is highly dependent on prior experiences, expectations and contextual 
cues, provides a compelling explanation for EI (Van den Bergh et al. 2017a), 
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which enables treatment strategies for prevention and recovery to be targeted, 
even in severe EI. 
Various biopsychosocial factors have shown to influence building residents’ 
reports of symptoms. Previous clinical experiences of patients with indoor air-
related ill health have revealed long-lasting, disproportionate amounts of 
functional restrictions in everyday life and sustained symptoms over follow-
ups. This shows a need for a biopsychosocial approach in management (Al-
Ahmad et al. 2010; Edvardsson et al. 2008; Karvala et al. 2013, 2014) 
Effective, practical means of support and treatment for these individuals are 
lacking. 
The first RCT setting (Study I) aimed to decrease excess concerns, 
symptoms and disability through counseling and psychoeducation of patients 
with indoor air-related symptoms and work disability. Over the six-month 
follow-up, however, the limited counseling did not improve the patients’ 
symptom management skills or work ability. There may be several reasons for 
the ineffectiveness of the intervention. A plausible explanation would be the 
long-lasting symptom history related to disability, which requires more 
intensive intervention. Characterization revealed numerous persistent, 
ongoing indoor air-related non-specific symptoms and disability among 
patients, and the features of IEI and FSS. Counseling that provides knowledge 
regarding mechanisms does not necessarily affect patients’ interpretations of 
the causes of the symptoms. In a previous study of individuals with IEI-EMFs, 
accurate feedback after a placebo-controlled provocation study was 
insufficient to change their attributions to mobile phone signals or reduce 
symptoms over six-month follow-up (Nieto-Hernandez et al. 2008). In 
another previous study of patients with chronic health conditions, health 
promotion counseling provided by a physician seemed to improve health-
related QOL, although this was not apparent in those with anxiety or 
depression (Al Sayah et al. 2014). The counseling techniques used in Study I 
for management of symptoms may not have taken into account all the 
emotional and cognitive features of IEI and FSS, although they aimed to 
minimize the perceived harmfulness of indoor air-related factors. 
Although Study I found no intervention effect, it showed that this type of 
approach can be carried out, and that for features of IEI and FSS, the chosen 
framework may be helpful and suitable for health care. Therefore, the next 
RCT (Study III) was designed to target patients with a shorter symptom 
duration and aimed toward early detection of disability in OHS units. Taking 
into account previous findings regarding the features of IEI and FSS, inclusion 
was designed on the basis of IEI criteria and focused on indoor exposures. The 
intervention programs were developed on the basis of the evidence of effects 
in similar conditions. Thus, in the biopsychosocial approach, similar 
management strategies were applied as those for FSS (Henningsen et al. 2018; 
Van Dessel et al. 2014), despite a lack of evidence-based treatments for IEI. 
For FSS, CBT has shown positive effects; for example, reduction of somatic 
symptoms (Van Dessel et al. 2014). Therefore, CBT was the natural choice for 
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an intervention arm, as well as better counseling than that in Study I. Both 
arms in the RCT design (Study III) have focused on reducing stress and 
improving health behavior (e.g. mechanisms of physiological arousal and 
emotion-behavior-symptom cognitions) rather than on cognitive distortions. 
The unexpectedly slow recruitment processes in Study III may indicate the 
cultural, societal and general attitudes towards biopsychosocial approaches in 
the management of indoor air-related disability. In general, although precise 
data are lacking, the availability of psychosocial treatments (e.g. CBT) are 
probably inadequate in the Finnish healthcare system. Nevertheless, in many 
health problems, the functional nature is recognized and the care guidelines 
highlight psychosocial treatment options, such as in the case of different pains 
(e.g. Pain: Current Care Guidelines Abstract 2017) and insomnia (Insomnia: 
Current Care Guidelines Abstract 2017). 
In the management of indoor air-related disability, individuals’ social 
surroundings and responses (such as the environmental factors included in 
the ICF concept) can either support or hinder the well-being, health and work 
ability of individuals. This input may iatrogenically harm and maintain illness 
behaviors (Dantoft et al. 2015; Kirmayer and Taillefer 1997; Rief and 
Broadbent 2007; Watanabe et al. 2003a). For example, when interpretations 
of symptoms/physical sensations as a sign of illness lead individuals to seek 
medical advice, this in itself can lead to the individuals maintaining a sick role 
and to repeated tests and medicalization. In this model of a vicious circle in 
doctor-patient contact, the patient’s physician can initiate further 
investigations even if there is no organic basis for the symptoms (Henningsen 
et al. 2007). 
Disability from indoor air-related ill health can be identified and should be 
treated effectively. The findings of Study II showed that environmental control 
and avoiding factors perceived as harmful was a typical coping response 
among the patients. In IEI, the pathway toward disability is associated with 
avoidance due to perceived symptom triggers (Dantoft et al. 2015; Skovbjerg 
et al. 2009a, 2012b; Watanabe et al. 2003a). It is clear that when there is, for 
example, significant moisture and mold damage in buildings, avoidance before 
repairs may be reasonable; but needless avoidance should not be supported. 
Management to reduce fear response and adverse avoidance strategies 
requires that the patient feels in control of the exposure situation. This 
requires trust in health care providers’ explanations for symptom mechanisms 
and that no health hazard exits in the indoor environment. 
As regards indoor air-related ill health, recognition of features similar to 
IEI and FSS reduces the continuous search for medical and environmental 
explanations. Effective treatments for disability prevention are seriously 
needed. In the future, the course of interventions should be directed towards 
centrally mediated and threat-response mechanisms activated by 
environmental triggers. In addition, the stepped care FSS model, i.e. the more 
severe or complex the symptoms and limitations, the more intense and 
multifaceted is the treatment needed for patient recovery (Figure 7) (Fink and 
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Rosendal 2015; Henningsen et al. 2007, 2018; olde Hartman et al. 2017), could 
be utilized in the treatment strategy of BRI and other EIs. 
6.2 METHOLOGICAL CONSIDERATIONS 
The strength of this combination of studies is that the study participants were 
from different levels of health care, such as an occupational medicine clinic, 
OHS units, and maternity (preventative) clinics. In addition, the studies 
represent clinical characteristics, RCT settings and a questionnaire-based 
survey. 
The primary strength of clinical characterization (Study I, II) was that the 
patients with work-associated symptoms and disability had been thoroughly 
and systematically medically examined. In addition, nearly all the patients had 
been examined earlier in their OHS units and by other physicians. In Study I, 
the clinical examinations focused exclusively on biomedical aspects, as is 
stipulated by the Finnish Act on Occupational Diseases, revealing the 
relationship between exposure and the disease/symptoms. However, all work-
related and non-work-related symptoms and diseases were characterized 
during the differential diagnostics. It is thus highly unlikely that any 
underlying medical diseases resulting in disability would have remained 
unrevealed, despite the absence of a thorough evaluation of psychiatric 
disorders and psychological features. However, psychological counseling 
repeatedly revealed the emotional and cognitive symptoms and concerns of 
the subjective health condition. The consecutive patients with a suspected 
occupational disease made the study group (Study I) uniform, although very 
specific to an occupational medicine clinic. Although the eligible patients 
represented only a proportion of occupational medicine clinic material (41%; 
79/194), the results may be generalized to patient populations suffering from 
indoor air-related non-specific symptoms with disability. The 24 patients who 
refused to participate were not assumed to differ from the study patients on 
the basis of their reasons for non-participation. 
Study II focused on patients with indoor air-related disability. The clinical 
characterization (Study II) included a thorough, multi-professional clinical 
evaluation and the use of a large amount of various, validated and widely used 
instruments. The assessment of the individuals’ functioning and disability was 
based on the ICF framework. The wide-ranging scope enables us to 
characterize the indoor air-related disability despite the small number of 
patients. The biopsychosocial approach (ICF) was suitable for evaluating a 
condition that is not necessarily explained by disease or physical body 
functions/structures, but which causes a substantial number of functional 
restrictions in daily life. A limitation was the small number of patients, which 
restricted generalization of the results. 
In addition, selection bias may exist (Studies I–III) if the individuals who 
attended were better able to consider their condition from a biopsychosocial 
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viewpoint. Moreover, self-assessments in retrospective questions might have 
been affected by recall problems, such as time from the onset of symptoms. 
Therefore, in the clinical studies (Study I, II), data from medical records and 
clinical interviews were also gathered. 
The goal in both the RCT settings (Study I, III) was to develop effective 
interventions for individuals with indoor air-related non-specific symptoms 
and disability. The focus was on reducing symptoms and disability related to 
indoor environments. The limited counseling in the first RCT setting (Study I) 
was conducted at an occupational medicine clinic during the normal 
differential diagnostic process. To our knowledge, this was the first RCT 
setting with a biopsychosocial approach in the context of indoor air-related 
(work) disability prevention. In Study III, the CBT program has been 
developed on the basis of previous intervention protocols from similar 
conditions, like FSS. The strength of its RCT design (Study III) is that the 
individuals are recruited from OHS, which is part of Finland’s overall primary 
health care, and enables the evaluation of the usefulness of the psychosocial 
intervention in OHS and general practice settings. Based on the previous 
clinical (Study I) findings regarding the features of IEI and FSS, we included 
IEI criteria that focused on indoor exposures. We also target the early 
detection of indoor air-related disability. The well-defined inclusion and 
exclusion criteria diminish the heterogeneity among the participants verified 
by the recruiting physicians and help avoid obvious confounding factors. The 
individuals had also been clinically investigated by the recruiting physicians, 
and the additional clinical examination at FIOH was to ensure that there was 
no medical condition behind the patient’s symptomatology and disability. The 
detailed data of the individuals’ health conditions have generally been 
gathered via a questionnaire, and the longitudinal follow-up design increases 
the strength of the evaluation’s effectiveness. The purpose of the high number 
of assessment methods as outcome measures is to enable observation of 
various aspects of health and well-being in everyday life. The potential bias of 
missing data is taken into account by using a web-based questionnaire in 
which respondents are forced to respond. 
In both RCTs (Study I, III), potential contextual processes may have had 
an effect on the recruiting process, as well as on the outcomes of the 
intervention. The possible changes in OHS systems and/or at work, and other 
factors may affect motivation to participate and continue in the study. For 
example, pressure from social surroundings may affect individuals’ attitudes 
toward the chosen framework for support and treatment. During the 
recruitment and waiting period, individuals were contacted, clinically 
examined and randomized, which may have had a placebo effect on a patient’s 
condition in both RCTs. This in turn may have weakened intervention effects. 
Moreover, the CBT arm with eleven sessions (Study III), including homework 
and practicing, required longer commitment to treatment than limited 
psychoeducation (Study I, III). This might have increased the drop-out rate in 
the CBT group. 
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The strength of the maternity clinic survey (Study IV) was its representative 
sample of fertile-aged women, but its weakness was its low participation rate. 
The study focused on all fertile aged women who attended a birth clinic of the 
Kuopio central hospital region. The study succeeded in recruiting 27% of the 
pregnant women of the maternity clinic clients. The focus was on females 
because they typically report EI more often than men, and the sample 
represented an age group in which EI is prevalent (Dantoft et al. 2015; 
Watanabe et al. 2003a). Although the results represent EI among fertile aged 
women, the low participation rate calls for caution in the generalization of the 
results. 
The questionnaire (Study IV) contained typical characteristics of EI in 
terms of different degrees of severity based on the MCS literature. The 
literature had no generally agreed on EI definition to clarify its prevalence, nor 
a precise severity measure of disability. Thus, we defined EI in several ways, 
which enabled us to study its severity gradient and the spectrum of different 
EIs and their associations with symptoms, behavioral changes, co-occurrence 
and disability due to different environmental factors. In the outcomes, the 
female gender (Berg et al. 2008; Carlsson et al. 2005), pregnancy (Cameron 
2014), and the large spectrum of questioned environmental factors may 
explain at least the high prevalence of reported annoyance. The prevalence 
rates may also exaggerate whether individuals with environment-related 
annoyance are more likely to participate in a study investigating 
environmental issues. In addition, heightened perception of unpleasant 
qualities and odors is especially encountered in early pregnancy (Cameron 
2014; Nordin et al. 2004, 2007), which may have increased the reporting of 
EI. To avoid excess reporting, the respondents were asked to evaluate the time 
prior to their pregnancy, not limited to a certain period of time. These may be 
sources of information bias. If early pregnancy increases the reporting of 
annoyance, it is unlikely that this would increase the number of respondents 
reporting severe difficulties due to EI. The study did not focus on concomitant 
diseases, thus we were unable to study their associations. Regardless of 
concomitant somatic or psychiatric diseases, the important factor is whether 





7 CONCLUSIONS  
This thesis aimed to characterize the disability related to non-industrial work 
indoor environments and to develop interventions for individuals with indoor 
air-related disability. The results suggest that: 
 
- indoor air-related disability may be explained by EI (environmental 
intolerance) and shares features with FSS (functional somatic syndromes). 
 
- in disability, comorbidity of medical (somatic and psychiatric) diseases is 
common and should be taken into account in disability prevention. 
 
- indoor air-related disability encounters various signs of distress (physical, 
emotional and cognitive), which should be taken into account in disability 
prevention. 
 
- indoor air-related work disability emerges in several life areas, not only at 
work, but also in social areas, and in functioning at home.  
 
- indoor air-related disability is based on self-reports and is typically more 
severe than objective findings suppose.  
 
- the prevalence of EI depends on its definition. EI with disability is 
surprisingly prevalent, and should be differentiated from annoyance, 
which is less disabling and prevalent in the population. As the severity of 
disability increases, the number of organ systems, behavioral changes and 
the co-occurrence of various EIs also grow. 
 
- in Finland, in EI with severe disability, indoor molds seem to be the most 
common environmental factor to which individuals attribute symptoms. 
 
- recognition of EI is possible and enables better targeting of disability 
management and rehabilitation instead of continuously searching for 
medical and environmental explanations. 
 
- counseling including limited psychoeducation and symptom management 
among patients with indoor air-related disability seems to be insufficient. 
Effective treatments for disability prevention are desperately required, and 
need to be further developed. Similar treatment approaches that have been 
promising for FSS may already be in use, especially different psychosocial 
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